Pr GUILLEMIN Francis

One-year post-intervention effectiveness of a proportionate universal intervention in reducing social inequalities of weight status among adolescents.

Uwizeye M, Dakin M, Manneville F, Langlois J, Legrand K, Spitz E, Böhme P, Lecomte E, Guillemin F, Briançon S, Omorou A

J Epidemiol Popul Health. 2025 03 28;73(2):202977

Modified Rankin Scale at 90 Days Versus National Institutes of Health Stroke Scale at 24 Hours as Primary Outcome in Acute Stroke Trials.

Ospel JM, Brown S, Bosshart S, Stebner A, Uchida K, Demchuk A, Saver JL, White P, Muir KW, Dippel DWJ, Majoie CBLM, Jovin TG, Campbell BCV, Mitchell PJ, Bracard S, Guillemin F, Hill M, Goyal M,

J Am Heart Assoc. 2025 02 19;:e037752

Body composition is associated with changes in health-related quality of life in patients with knee and/or hip osteoarthritis.

Rat AC, Sellam J, Mazières B, Ngueyon Sime W, Fardellone P, Guillemin F

RMD Open. 2025 01 2;11(1):

A feasibility study for understanding the demand and acceptability of a systematic symptom monitoring process in end-stage kidney disease.

Ricci L, Couchoud C, Carvalho A, Buzzi M, Guillemin F, Ayav C,

J Nephrol. 2024 11 21;:

Can ChatGPT Provide Useful Guidance to Assess the Current State of and Future Priorities for Aging Research in the Social Sciences?

Wieczorek M, Kliegel M, Beard J, Guillemin F, Avendano M, Maurer J

J Aging Soc Policy. 2024 11 4;:1-16

Fostering patients' participation in oncology research by developing psychological empowerment and a sense of community.

Bauquier C, Pannard M, Andrin A, Biaudet J, Parnalland S, Dabakuyo S, Guillemin F, Paret G, Jacob G, Préau M,

J Epidemiol Popul Health. 2024 10 30;72(6):202781

Feasibility, Acceptability, Satisfaction, and Challenges of an mHealth App (e-ASCov) for Community-Based COVID-19 Screening by Community Health Workers in Rwanda: Mixed Methods Study.

Omorou AY, Ndishimye P, Hoen B, Mutesa L, Karame P, Nshimiyimana L, Galmiche S, Mugabo H, Murayire J, Mugisha M, Umulisa MM, Uwera YDN, Musanagabanwa C, Bigirimana N, Nsanzimana S, Guillemin F, Rwabihama JP

JMIR Mhealth Uhealth. 2024 10 14;12:e50745

Improved Outcomes with Leadless versus Single-Chamber Transvenous Pacemaker in Hemodialysis Patients.

Panico A, Flahault A, Guillemin F, Varlet E, Couchoud C, Bauwens M, Marijon E, Roueff S, Lazareth H

Europace. 2024 10 1;:

Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-D Report: Multi Criteria Decision Analysis.

Barbhaiya M, Zuily S, Amigo MC, Andrade D, Avcin T, Bertolaccini ML, Branch DW, Costedoat-Chalumeau N, Crowther M, de Jesus GR, Devreese KMJ, Frances C, Garcia D, Gómez-Puerta JA, Guillemin F, Levine SR, Levy RA, Lockshin MD, Ortel TL, Petri M, Sanna G, Sciascia S, Seshan SV, Tektonidou MG, Wahl D, Willis R, Yelnik C, Hendry A, Naden R, Costenbader K, Erkan D,

Arthritis Care Res (Hoboken). 2024 08 12;:

Health promotion expectations and perceptions of sport club participants.

Tézier B, Dogba MJ, Beck V, Cossou Gbeto I, Vuillemin A, Lemonnier F, Rostan F, Guillemin F, Van Hoye A

Health Promot Int. 2024 08 1;39(4):

HERMES-24 Score Derivation and Validation for Simple and Robust Outcome Prediction After Large Vessel Occlusion Treatment.

Tanaka K, Brown S, Goyal M, Menon BK, Campbell BCV, Mitchell PJ, Jovin TG, Saver JL, Muir KW, White PM, Bracard S, Guillemin F, Roos YBWEM, van Zwam WH, Najm M, Dowlatshahi D, Hill MD, Demchuk AM,

Stroke. 2024 08;55(8):1982-1990

The Flare-OA-16 questionnaire measuring flare in knee and hip osteoarthritis in the patient perspective: scale reduction and validation using a Rasch model.

Queiroga F, Epstein J, Erpelding ML, Spitz E, Maillefert JF, Fautrel B, Callahan LF, Hunter DJ, Guillemin F

J Clin Epidemiol. 2024 07 30;:111488

Building a composite score for patient self-report of flare in osteoarthritis: a comparison of methods with the Flare-OA-16 questionnaire.

Queiroga F, Epstein J, Erpelding ML, Soudant M, King L, Spitz E, Maillefert JF, Fautrel B, Callahan LF, March L, Hunter DJ, Guillemin F

J Clin Epidemiol. 2024 07 25;:111467

Collaterals at angiography guide clinical outcomes after endovascular stroke therapy in HERMES.

Liebeskind DS, Luff MK, Bracard S, Guillemin F, Jahan R, Jovin TG, Majoie CBLM, Mitchell PJ, van der Lugt A, Menon BK, San Roman L, Campbell B, Muir KW, Hill MD, Dippel DWJ, Saver JL, Demchuk AM, Davalos A, White P, Brown SB, Goyal M,

J Neurointerv Surg. 2024 07 11;:

Advancing composite outcome measures: Insights on weighting components from OMERACT 2023.

Wells GA, Guillemin F, Merkel PA, de Wit M, Mackie S, March L, Tómasson G, King LK, Cembalo SM, Grosskleg S, Maxwell LJ, Monti S, Quinn KA, Shea BJ, Tugwell P, Beaton D

Semin Arthritis Rheum. 2024 06 30;69:152503

Role of dietary intake and physical activity in reducing weight social inequalities among adolescents: an application of G-formula to PRALIMAP-INÈS trial.

Dakin M, Manneville F, Langlois J, Briançon S, Lecomte E, Spitz E, Legrand K, Böhme P, Guillemin F, Omorou A

Br J Nutr. 2024 05 27;:1-23

Listening to patients, for the patients: The COVAD Study-Vision, organizational structure, and challenges.

Joshi M, Darooka N, Saha S, Dyball S, Sen P, Yaadav P, Javaid M, Kadam E, Shinjo SK, Dey D, Cavagna L, Makol A, Gutiérrez CET, Caballero Uribe CV, Kuwana M, Burmester GR, Ziade N, Wincup C, Andreoli L, Parodis I, Tan AL, Guillemin F, Knitza J, Wang G, Dalbeth N, Velikova T, Gracia-Ramos AE, Nikiphorou E, Day J, Chinoy H, Aggarwal R, Agarwal V, Gupta L,

Int J Rheum Dis. 2024 05;27(5):e15161

Evolution of public funding since primary care research was considered as a priority research domain in france.

Scheer J, Leroy T, Guillo S, Tubach F, Rozès A, Verga-Gérard A, Guillemin F, Lapeyre-Mestre M, Chapron A

BMC Prim Care. 2024 04 27;25(1):142

Effectiveness of interventions to reduce social inequalities of weight status in adolescents: A systematic review and meta-analysis.

Dakin M, Omorou AY, Guillemin F

Obes Rev. 2024 04 21;:e13752

Collating the voice of people with autoimmune diseases: Methodology for the Third Phase of the COVAD Studies.

Kadam E, Javaid M, Sen P, Saha S, Ziade N, Day J, Wincup C, Andreoli L, Parodis I, Tan AL, Shinjo SK, Dey D, Cavagna L, Chatterjee T, Knitza J, Wang G, Dalbeth N, Velikova T, Battista S, Cheng K, Boyd P, Kobert L, Gracia-Ramos AE, Mittal S, Makol A, Gutiérrez CET, Uribe CVC, Kuwana M, Burmester GR, Guillemin F, Nikiphorou E, Chinoy H, Aggarwal V, Gupta L,

Rheumatol Int. 2024 04 12;:

[Pilot study of a health promotion intervention in sports clubs].

Tezier B, Van Hoye A, Vuillemin A, Lemonnier F, Rostan F, Guillemin F

Sante Publique. 2024 04 5;36(1):7-22

An effort to improve the collection of patient-generated data: readability and understandability of patient-reported outcomes measures in a survivorship cohort.

Chiodi C, Epstein J, Arvis J, Martin E, Barbier A, Di Meglio A, Gillanders E, Jacob G, Menvielle G, Everhard S, Guillemin F, Luis IV, Franzoi MA

Qual Life Res. 2024 03 5;:

What Is a Meaningful Difference When Using Infarct Volume as the Primary Outcome?: Results From the HERMES Database.

Rinkel LA, Ospel JM, Brown SB, Campbell BCV, Dippel DWJ, Demchuk AM, Majoie CBLM, Mitchell PJ, Bracard S, Guillemin F, Jovin TG, Muir KW, White P, Saver JL, Hill MD, Goyal M,

Stroke. 2024 03 5;:

Embracing unity at OMERACT: Valuing equity, promoting diversity, fostering inclusivity.

Maxwell LJ, Wright GC, Schultz G, Grosskleg S, Barton JL, Campbell W, Guillemin F, Hofstetter C, Shea BJ, Simon LS, Adebajo A, Barnabe C, Goel N, Hurley P, Nikiphorou E, Petkovic J, Tugwell P

Semin Arthritis Rheum. 2024 02 29;66:152422

Important issues in proposing autonomy training in home parenteral nutrition for short bowel syndrome patients: a qualitative insight from the patients' perspectives.

Ricci L, Joly F, Coly A, Guillemin F, Quilliot D

Eur J Clin Nutr. 2024 02 29;:

Risk of secondary progression in patients with highly active multiple sclerosis treated with natalizumab: a real-life study.

Scherer L, Soudant M, Pittion-Vouyovitch S, Debouverie M, Guillemin F, Epstein J, Mathey G

J Neurol. 2024 02 29;:

Quality-of-life measures and their psychometric properties used in African chronic kidney disease populations: a systematic review using COSMIN methodology.

Faye M, Manneville F, Faye A, Frimat L, Guillemin F

BMC Nephrol. 2024 02 9;25(1):50

Evolving and evaluating the OMERACT fellows program: insights and implications from OMERACT 2023 fellows.

Chapman LS, Kelly A, Balay-Dustrude E, Bekker C, Berthelsen DB, Ghosh N, Gordon RA, Haas R, Jones C, Luquini A, Weinbrecht-Mischkewitz M, Pickles T, Saygin D, Nielsen W, Webers C, Grosskleg S, Tugwell P, D'Agostino MA, Guillemin F, March L

Semin Arthritis Rheum. 2024 02 4;65:152391

Assessing domain match and feasibility of candidate instruments matching with OMERACT endorsed domains to measure flare in knee and hip osteoarthritis.

Queiroga F, Cembalo SM, Epstein J, Maxwell L, Buttel T, Copenhaver C, Cross M, Hunter D, King L, Callahan L, March L, Beaton DE, Guillemin F,

Semin Arthritis Rheum. 2024 02 1;65:152371

Consensus on the definitions and descriptions of the domains of the OMERACT Core Outcome Set for shared decision making interventions in rheumatology trials.

Décary S, de Wit M, Naye F, Barton JL, Fraenkel L, Li LC, Brooks P, Stacey D, Maxwell LJ, Campbell W, Hofstetter C, Voshaar M, Meara A, Christensen R, Boonen A, Suarez-Almazor ME, Meade T, March L, Jull JE, Alten R, Morgan EM, Stewart Hazlewood G, Barber CEH, Guillemin F, El-Miedany Y, Mittoo S, Robertson TW, Bartlett SJ, Singh JA, Mannion M, Nasef SI, Boel A, Adebajo A, Arnaud L, Gill TK, Moholt E, Burt J, Jayatilleke A, Hmamouchi I, Berthelsen DB, Blanco FJ, Mather K, Maharaj A, Sharma S, Caso F, Beaton D, Shea B, Fong C, Fernandez AP, Mackie S, Nikiphorou E, Jones A, Greer-Smith R, Sloan VS, Akpabio A, Strand V, Lee RR, Umaefulam V, Monti S, Abaza N, Schultz G, Stones S, Gossec L, Nielsen SM, Cavallo S, Srinivasalu H, Constien D, Evans V, Tugwell P, Toupin-April K

Semin Arthritis Rheum. 2024 01 15;65:152381

Generating a list of potentially important contextual factors covering randomized trials, cohorts, and measurement property studies: An OMERACT initiative.

Weinbrecht-Mischkewitz M, Kamal M, Asim F, Guillemin F, Goel N, Voshaar M, Boonen A, Berthelsen DB, Toupin-April K, Lopez-Olivo MA, Sloan VS, Boers M, Jones CA, van der Horst-Bruinsma I, Cashin AG, Sharma S, Leong A, Alten R, Shea B, March L, Tugwell P, Christensen R, Nielsen SM,

Semin Arthritis Rheum. 2024 01 10;65:152370

OMERACT Core outcome measurement set for shared decision making in rheumatic and musculoskeletal conditions: a scoping review to identify candidate instruments.

Naye F, Toupin-April K, de Wit M, LeBlanc A, Dubois O, Boonen A, Barton JL, Fraenkel L, Li LC, Stacey D, March L, Barber CEH, Hazlewood GS, Guillemin F, Bartlett SJ, Berthelsen DB, Mather K, Arnaud L, Akpabio A, Adebajo A, Schultz G, Sloan VS, Gill TK, Sharma S, Scholte-Voshaar M, Caso F, Nikiphorou E, Nasef SI, Campbell W, Meara A, Christensen R, Suarez-Almazor ME, Jull JE, Alten R, Morgan EM, El-Miedany Y, Singh JA, Burt J, Jayatilleke A, Hmamouchi I, Blanco FJ, Fernandez AP, Mackie S, Jones A, Strand V, Monti S, Stones SR, Lee RR, Nielsen SM, Evans V, Srinivasalu H, Gérard T, Demers JL, Bouchard R, Stefan T, Dugas M, Bergeron F, Beaton D, Maxwell LJ, Tugwell P, Décary S

Semin Arthritis Rheum. 2023 12 16;65:152344

Performance of administrative databases for identifying individuals with multiple sclerosis.

Ducatel P, Debouverie M, Soudant M, Guillemin F, Mathey G, Epstein J

Sci Rep. 2023 10 25;13(1):18310

A scoping review of patient self-report measures of flare in knee and hip osteoarthritis (OA): A report from the OMERACT flares in OA working group.

Queiroga F, Cross M, Thomas MJ, March L, Epstein J, Guillemin F

Semin Arthritis Rheum. 2023 10 14;63:152281

Real-life evaluation of the 2017 McDonald criteria for relapsing-remitting multiple sclerosis after a clinically isolated syndrome confirms a gain in time-to-diagnosis.

Ferrand M, Epstein J, Soudant M, Guillemin F, Pittion-Vouyovitch S, Debouverie M, Mathey G

J Neurol. 2023 08 31;:

2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria.

Barbhaiya M, Zuily S, Naden R, Hendry A, Manneville F, Amigo MC, Amoura Z, Andrade D, Andreoli L, Artim-Esen B, Atsumi T, Avcin T, Belmont MH, Bertolaccini ML, Branch DW, Carvalheiras G, Casini A, Cervera R, Cohen H, Costedoat-Chalumeau N, Crowther M, de Jesus G, Delluc A, Desai S, De Sancho M, Devreese KM, Diz-Kucukkaya R, Duarte-Garcia A, Frances C, Garcia D, Gris JC, Jordan N, Leaf RK, Kello N, Knight JS, Laskin C, Lee AI, Legault K, Levine SR, Levy RA, Limper M, Lockshin MD, Mayer-Pickel K, Musial J, Meroni PL, Orsolini G, Ortel TL, Pengo V, Petri M, Pons-Estel G, Gomez-Puerta JA, Raimboug Q, Roubey R, Sanna G, Seshan SV, Sciascia S, Tektonidou MG, Tincani A, Wahl D, Willis R, Yelnik C, Zuily C, Guillemin F, Costenbader K, Erkan D,

Arthritis Rheumatol. 2023 08 28;:

2023 ACR/EULAR antiphospholipid syndrome classification criteria.

Barbhaiya M, Zuily S, Naden R, Hendry A, Manneville F, Amigo MC, Amoura Z, Andrade D, Andreoli L, Artim-Esen B, Atsumi T, Avcin T, Belmont MH, Bertolaccini ML, Branch DW, Carvalheiras G, Casini A, Cervera R, Cohen H, Costedoat-Chalumeau N, Crowther M, de Jesús G, Delluc A, Desai S, Sancho M, Devreese KM, Diz-Kucukkaya R, Duarte-García A, Frances C, Garcia D, Gris JC, Jordan N, Leaf RK, Kello N, Knight JS, Laskin C, Lee AI, Legault K, Levine SR, Levy RA, Limper M, Lockshin MD, Mayer-Pickel K, Musial J, Meroni PL, Orsolini G, Ortel TL, Pengo V, Petri M, Pons-Estel G, Gomez-Puerta JA, Raimboug Q, Roubey R, Sanna G, Seshan SV, Sciascia S, Tektonidou MG, Tincani A, Wahl D, Willis R, Yelnik C, Zuily C, Guillemin F, Costenbader K, Erkan D,

Ann Rheum Dis. 2023 08 28;:

Endovascular therapy in acute ischemic stroke with poor reperfusion is associated with worse outcomes compared with best medical management: a HERMES substudy.

Rex N, Ospel JM, Brown SB, McDonough RV, Kashani N, Hill MD, Dippel DWJ, Campbell B, Muir KW, Demchuk AM, Bracard S, Guillemin F, Jovin TG, Mitchell PJ, White P, Majoie CBLM, Saver JL, Goyal M

J Neurointerv Surg. 2023 08 2;:

Developing a framework for the implementation of recommendations for lifestyle factors for people with RMDs across Europe: assessment of current materials and implementation needs.

Rodríguez-Carrio J, Cavalli G, Gwinnutt J, Wieczorek M, Guillemin F, Verstappen SMM

RMD Open. 2023 08;9(3):

Associations between School-Behavior-Health Difficulties and Subsequent Injuries among Younger Adolescents: A Population-based Study.

Chau N, Perrin P, Gauchard G, Bhattacherjee A, Senapati A, Belbraouet S, Guillemin F, Falissard B, Chau K

Psychiatry. 2023 07 31;:1-20

Development and Validation of a Postprocedural Model to Predict Outcome After Endovascular Treatment for Ischemic Stroke.

Chalos V, Venema E, Mulder MJHL, Roozenbeek B, Steyerberg EW, Wermer MJH, Lycklama À Nijeholt GJ, van der Worp HB, Goyal M, Campbell BCV, Muir KW, Guillemin F, Bracard S, White P, Dávalos A, Jovin TG, Hill MD, Mitchell PJ, Demchuk AM, Saver JL, van der Lugt A, Brown S, Dippel DWJ, Lingsma HF,

JAMA Neurol. 2023 07 31;:

The biological sample collection of the OFSEP French MS registry: An essential tool dedicated to researchers.

Brocard G, Casey R, Dufay N, Marignier R, Michel L, Hisbergues M, Ayrignac X, Lehmann S, Thouvenot E, Gallot G, Collongues N, Herpe YE, Lebrun-Frenay C, Cotton F, De Sèze J, Guillemin F, Moreau T, Pelletier J, Stankoff B, Vukusic S, Zephir H, Laplaud D,

Mult Scler Relat Disord. 2023 07 7;77:104872

The Association between Oxytocin and Lower Limb Osteoarthritis: A Prospective Cohort Study.

Roux CH, Rousseau AS, Iannelli A, Gautier N, Ferrero S, Hinault C, Chinetti G, Ngueyon-Sime W, Guillemin F, Amri EZ

Int J Mol Sci. 2023 06 5;24(11):

Validation and optimization of the French Generic Adherence for Chronic Diseases Profile (GACID-P) using classical test and item response theory.

Rotonda C, Guillemin F, Conroy T, Alleyrat C, Lefevre B, Soudant M, Tarquinio C

Health Qual Life Outcomes. 2023 05 24;21(1):49

[Clinical epidemiology and biostatistic innovations 2023 - Welcome In Nancy].

Guillemin F, Merlin JL

Rev Epidemiol Sante Publique. 2023 05;71 Suppl 2:101846

Seroprevalence and SARS-CoV-2 invasion in general populations: A scoping review over the first year of the pandemic.

Metzger C, Leroy T, Bochnakian A, Jeulin H, Gegout-Petit A, Legrand K, Schvoerer E, Guillemin F

PLoS One. 2023 04 19;18(4):e0269104

Suitability of the animated activity questionnaire for use as computer adaptive test: establishing the AAQ-CAT.

Liegl G, Roorda LD, Terwee CB, Steultjens M, Roos EM, Guillemin F, Benedetti MG, Dagfinrud H, de Carvalho Bastone A, Peter WF

Qual Life Res. 2023 04 3;:

Short version of the Inventory of Parental Representations, a self-report for attachment assessment among adolescents.

Lamourette M, Ligier F, Guillemin F, Epstein J

BMC Psychiatry. 2023 04 1;23(1):221

Digital contact tracing during the COVID-19 pandemic in France: Associated factors and reasons for non-use.

Touzani R, Schultz E, Vandentorren S, Arwidson P, Guillemin F, Bouhnik AD, Rouquette A, Mancini J

Int J Med Inform. 2023 01 13;171:104994

Development of a health-promoting sports club's intervention in France applying participatory action research.

Tezier B, Guillemin F, Vuillemin A, Johnson S, Lemonnier F, Rostan F, Van Hoye A

Health Promot Int. 2022 12 1;37(6):

Machine learning identifies a profile of inadequate responder to methotrexate in rheumatoid arthritis.

Duquesne J, Bouget V, Cournède PH, Fautrel B, Guillemin F, de Jong PHP, Heutz JW, Verstappen M, van der Helm-van Mil AHM, Mariette X, Bitoun S

Rheumatology (Oxford). 2022 11 23;:

Association of vocational interventions and work-related factors with disease and work outcomes in people with RMDs: A systematic review.

Wieczorek M, Verstappen SM, Putrik P, Gwinnutt JM, Balanescu A, Bischoff-Ferrari HA, Boonen A, Cavalli G, de Souza S, de Thurah A, Dorner TE, Moe RH, Rodríguez-Carrio J, Silva-Fernández L, Stamm T, Walker-Bone K, Welling J, Zlatković-Švenda M, Guillemin F

Semin Arthritis Rheum. 2022 11 13;58:152135

Exploring perceptions of using preference elicitation methods to inform clinical trial design in rheumatology: A qualitative study and OMERACT collaboration.

Thomas M, Marshall DA, Sanchez AL, Bartlett SJ, Boonen A, Fraenkel L, Proulx L, Voshaar M, Bansback N, Buchbinder R, Guillemin F, Hiligsmann M, Richards DP, Richards P, Shea B, Tugwell P, Falahee M, Hazlewood GS

Semin Arthritis Rheum. 2022 11 3;58:152112

Comparison of Three Scores of Collateral Status for Their Association With Clinical Outcome: The HERMES Collaboration.

Gensicke H, Al-Ajlan F, Fladt J, Campbell BCV, Majoie CBLM, Bracard S, Hill MD, Muir KW, Demchuk A, San Román L, van der Lugt A, Liebeskind DS, Brown S, White PM, Guillemin F, Dávalos A, Jovin TG, Saver JL, Dippel DWJ, Goyal M, Mitchell PJ, Menon BK,

Stroke. 2022 10 17;:

Evaluation of implementation and effects of a health-promoting sports club intervention using a mixed-method design: PROSCeSS protocol.

Tezier B, Guillemin F, Vuillemin A, Johnson S, Lemonnier F, Rostan F, Van Hoye A

BMJ Open Sport Exerc Med. 2022 10 5;8(4):e001444

Physical Activity and Eating Behavior Inequalities Mediating the Effects of Socioeconomic Status and Sex on Adolescent Quality of Life: Insights of the PRALIMAP Trial.

Manneville F, Briançon S, Legrand K, Langlois J, Lecomte E, Omorou AY, Guillemin F

J Phys Act Health. 2022 09 13;:1-10

Implementation of patient-reported outcome measures in a heart transplant recipient registry: First step toward a patient-centered approach.

Mahmoudi R, Moitie T, Dorent R, Guillemin F, Couchoud C

Clin Transplant. 2022 08;36(8):e14708

Machine learning predicts response to TNF inhibitors in rheumatoid arthritis: results on the ESPOIR and ABIRISK cohorts.

Bouget V, Duquesne J, Hassler S, Cournède PH, Fautrel B, Guillemin F, Pallardy M, Broët P, Mariette X, Bitoun S

RMD Open. 2022 08;8(2):

Improving prenatal care during lockdown: comparing telehealth and in-person care for low-risk pregnant women in the PROTECT study.

Avercenc L, Nguyeon-Sime W, Bertholdt C, Baumont S, Freitas AC, Morel O, Guillemin F, Ambroise G

J Gynecol Obstet Hum Reprod. 2022 07 24;:102445

Outcome Prediction Based on Automatically Extracted Infarct Core Image Features in Patients with Acute Ischemic Stroke.

Tolhuisen ML, Hoving JW, Koopman MS, Kappelhof M, van Voorst H, Bruggeman AE, Demchuck AM, Dippel DWJ, Emmer BJ, Bracard S, Guillemin F, van Oostenbrugge RJ, Mitchell PJ, van Zwam WH, Hill MD, Roos YBWEM, Jovin TG, Berkhemer OA, Campbell BCV, Saver J, White P, Muir KW, Goyal M, Marquering HA, Majoie CB, Caan MWA,

Diagnostics (Basel). 2022 07 23;12(8):

Clinical significance of a self-reported familial occurrence of rheumatoid arthritis among patients with recent-onset arthritis: data from the ESPOIR cohort.

Guellec D, Carvajal-Alegria G, Daïen C, Gossec L, Guillemin F, Berenbaum F, Constantin A, Dieude P, Dougados M, Flipo RM, Goupille P, Mariette X, Richez C, Vittecoq O, Combe B, Saraux A

Clin Exp Rheumatol. 2022 07 21;:

Utility values and its time to deterioration in breast cancer patients after diagnosis and during treatments.

Haidari RE, Anota A, Dabakuyo-Yonli TS, Guillemin F, Conroy T, Velten M, Jolly D, Causeret S, Cuisenier J, Graesslin O, Abbas LA, Nerich V

Qual Life Res. 2022 05 19;:

Osteoarthritis Flares.

Thomas MJ, Guillemin F, Neogi T

Clin Geriatr Med. 2022 May;38(2):239-257

Correlation Between Computed Tomography-Based Tissue Net Water Uptake and Volumetric Measures of Cerebral Edema After Reperfusion Therapy.

Ng FC, Yassi N, Sharma G, Brown SB, Goyal M, Majoie CBLM, Jovin TG, Hill MD, Muir KW, Saver JL, Guillemin F, Demchuk AM, Menon BK, San Roman L, White P, van der Lugt A, Ribo M, Bracard S, Mitchell PJ, Davis SM, Sheth KN, Kimberly WT, Campbell BCV,

Stroke. 2022 Apr 22;:101161STROKEAHA121037073

Well-being assessment in medical students since the COVID-19 pandemic: a mixed method study.

Michaud S, Mansoury O, Adarmouch L, Amine M, Guillemin F, Sebbani M

J Adv Med Educ Prof. 2022 Apr;10(2):83-90

Minimally Invasive and Open Donor Nephrectomy: Lessons Learned From a French Multicenter Experience.

Lecoanet P, Chammas MF, Sime WN, Guillemin F, Karam G, Ladrière M, Eschwège P, Mitre AI, Frimat L, Hubert J

Transplant Proc. 2022 Mar 16;:

Do corticosteroids injections increase the risk of knee osteoarthritis progression over 5 years?

Latourte A, Rat AC, Omorou A, Ngueyon Sime W, Eymard F, Sellam J, Roux C, Ea HK, Cohen-Solal M, Bardin T, Beaudreuil J, Guillemin F, Richette P

Arthritis Rheumatol. 2022 Mar 14;:

Behavioural risk patterns in adolescents with excess weight participating in the PRALIMAP-INÈS trial.

Julia C, Omorou A, Lecomte E, Langlois J, Touvier M, Hercberg S, Briançon S, Kesse-Guyot E, Guillemin F,

Public Health Nutr. 2022 Mar 11;:1-25

2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases.

Gwinnutt JM, Wieczorek M, Balanescu A, Bischoff-Ferrari HA, Boonen A, Cavalli G, de Souza S, de Thurah A, Dorner TE, Moe RH, Putrik P, Rodríguez-Carrio J, Silva-Fernández L, Stamm T, Walker-Bone K, Welling J, Zlatković-Švenda MI, Guillemin F, Verstappen SMM

Ann Rheum Dis. 2022 Mar 8;:

Effects of physical exercise and body weight on disease-specific outcomes of people with rheumatic and musculoskeletal diseases (RMDs): systematic reviews and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with

Gwinnutt JM, Wieczorek M, Cavalli G, Balanescu A, Bischoff-Ferrari HA, Boonen A, de Souza S, de Thurah A, Dorner TE, Moe RH, Putrik P, Rodríguez-Carrio J, Silva-Fernández L, Stamm T, Walker-Bone K, Welling J, Zlatković-Švenda MI, Guillemin F, Verstappen SMM

RMD Open. 2022 Mar;8(1):

Smoking, alcohol consumption and disease-specific outcomes in rheumatic and musculoskeletal diseases (RMDs): systematic reviews informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs.

Wieczorek M, Gwinnutt JM, Ransay-Colle M, Balanescu A, Bischoff-Ferrari H, Boonen A, Cavalli G, de Souza S, de Thurah A, Dorner TE, Moe RH, Putrik P, Rodríguez-Carrio J, Silva-Fernández L, Stamm TA, Walker-Bone K, Welling J, Zlatkovic-Svenda M, Verstappen SM, Guillemin F

RMD Open. 2022 Mar;8(1):

Clinical outcome of patients with mild pre-stroke morbidity following endovascular treatment: a HERMES substudy.

McDonough RV, Ospel JM, Majoie CBLM, Saver JL, White P, Dippel DWJ, Brown SB, Demchuk AM, Jovin TG, Mitchell PJ, Bracard S, Campbell BCV, Muir KW, Hill MD, Guillemin F, Goyal M,

J Neurointerv Surg. 2022 Feb 24;:

Association between screen time and cumulating school, behavior, and mental health difficulties in early adolescents: A population-based study.

Chau K, Bhattacherjee A, Senapati A, Guillemin F, Chau N

Psychiatry Res. 2022 Feb 22;310:114467

Risk factors of unexplained early neurological deterioration after treatment for ischemic stroke due to large vessel occlusion: a post hoc analysis of the HERMES study.

Bourcier R, Goyal M, Muir KW, Desal H, Dippel DWJ, Majoie CBLM, van Zwam WH, Jovin TG, Mitchell PJ, Demchuk AM, van Oostenbrugge RJ, Brown SB, Campbell B, White P, Hill MD, Saver JL, Weimar C, Jahan R, Guillemin F, Bracard S, Naggara O,

J Neurointerv Surg. 2022 Feb 15;:

Development and validation of the Flare-OA questionnaire for measuring flare in knee and hip osteoarthritis.

Traore Y, Epstein J, Spitz E, March L, Maillefert JF, Rutherford C, Ricatte C, Alleyrat C, Cross M, King LK, Callahan LF, Fautrel B, Buttel T, Hawker G, Hunter DJ, Guillemin F

Osteoarthritis Cartilage. 2022 Jan 20;:

Age-period-cohort analysis of the incidence of multiple sclerosis over twenty years in Lorraine, France.

Gbaguidi B, Guillemin F, Soudant M, Debouverie M, Mathey G, Epstein J

Sci Rep. 2022 Jan 19;12(1):1001

Characteristics of patients with knee and/or hip osteoarthritis undergoing spa treatment: the prospective KHOALA cohort study.

Zbitou A, Rat AC, Ngueyon Sime W, Chary-Valckenaere I, Guillemin F

Int J Biometeorol. 2022 Jan 15;:

The Economic, Medical and Psychosocial Consequences of Whole Genome Sequencing for the Genetic Diagnosis of Patients With Intellectual Disability: The DEFIDIAG Study Protocol.

Lejeune C, Robert-Viard C, Meunier-Beillard N, Borel MA, Gourvès L, Staraci S, Soilly AL, Guillemin F, Seror V, Achit H, Bouctot M, Asensio ML, Briffaut AS, Delmas C, Bruel AL, Benoit A, Simon A, Gerard B, Hadj Abdallah H, Lyonnet S, Faivre L, Thauvin-Robinet C, Odent S, Heron D, Sanlaville D, Frebourg T, Muller J, Duffourd Y, Boland A, Deleuze JF, Espérou H, Binquet C, Dollfus H

Front Genet. 2022 ;13:852472

Effect of the COVID-19 outbreak and lockdown on mental health among post-secondary students in the Grand Est region of France: results of the PIMS-CoV19 study.

Baumann C, Rousseau H, Tarquinio C, Batt M, Tarquinio P, Lebreuilly R, Sorsana C, Legrand K, Guillemin F, Bourion-Bédès S

Health Qual Life Outcomes. 2021 Dec 15;19(1):265

Thrombectomy With and Without Computed Tomography Perfusion Imaging in the Early Time Window: A Pooled Analysis of Patient-Level Data.

Jadhav AP, Goyal M, Ospel J, Campbell BC, Majoie CBLM, Dippel DW, White P, Bracard S, Guillemin F, Davalos A, Hill MD, Demchuk AM, Brown S, Saver JL, Muir KW, Mitchell P, Desai SM, Jovin TG

Stroke. 2021 Nov 30;:STROKEAHA121034331

Composite outcomes at OMERACT: Multi-outcome domains and composite outcome domains.

Wells GA, Tugwell P, Tomasson G, Guillemin F, Maxwell LJ, Shea BJ, Grosskleg S, Merkel PA, March L, Beaton DE

Semin Arthritis Rheum. 2021 Nov 6;:

Impact of Pretreatment Ischemic Location on Functional Outcome after Thrombectomy.

Xie Y, Oster J, Micard E, Chen B, Douros IK, Liao L, Zhu F, Soudant M, Felblinger J, Guillemin F, Hossu G, Bracard S, On Behalf Of The Thrace Investigators

Diagnostics (Basel). 2021 Nov 4;11(11):

Web-based and machine learning approaches for identification of patient-reported outcomes in inflammatory bowel disease.

Ricci L, Toussaint Y, Becker J, Najjar H, Renier A, Choukour M, Buisson A, Devos C, Epstein J, Peyrin Biroulet L, Guillemin F

Dig Liver Dis. 2021 Sep 26;:

Trajectories in early rheumatoid arthritis related fatigue over 10 years: results from the ESPOIR cohort.

Rodríguez-Muguruza S, Combe B, Guillemin F, Fautrel B, Olive A, Marsal S, Valero O, Lukas C

Clin Exp Rheumatol. 2021 Sep 21;:

French nurses' and allied health professionals' perception of research in their fields: A descriptive qualitative study.

Ricci L, Beguinet M, Guillemin F, Klein S

Int Nurs Rev. 2021 Sep 12;:

Comparative effectiveness of dimethyl fumarate in Multiple Sclerosis.

Bosco-Lévy P, Debouverie M, Brochet B, Guillemin F, Louapre C, Maillart E, Heinzlef O, Lignot S, Diez P, Abouelfath A, Lassalle R, Blin P, Droz-Perroteau C

Br J Clin Pharmacol. 2021 Sep 9;:

Value of infarct location in the prediction of functional outcome in patients with an anterior large vessel occlusion: results from the HERMES study.

Tolhuisen ML, Ernst M, Boers AMM, Brown S, Beenen LFM, Guillemin F, Roos YBWEM, Saver JL, van Oostenbrugge R, Demchuck AM, van Zwam W, Jovin TG, Berkhemer OA, Muir KW, Bracard S, Campbell BCV, van der Lugt A, White P, Hill MD, Dippel DWJ, Mitchell PJ, Goyal M, Caan MWA, Marquering HA, Majoie CBLM,

Neuroradiology. 2021 Sep 3;:

Cerebral Edema in Patients With Large Hemispheric Infarct Undergoing Reperfusion Treatment: A HERMES Meta-Analysis.

Ng FC, Yassi N, Sharma G, Brown SB, Goyal M, Majoie CBLM, Jovin TG, Hill MD, Muir KW, Saver JL, Guillemin F, Demchuk AM, Menon BK, San Roman L, Liebeskind DS, White P, Dippel DWJ, Davalos A, Bracard S, Mitchell PJ, Wald MJ, Davis SM, Sheth KN, Kimberly WT, Campbell BCV,

Stroke. 2021 Aug 13;:STROKEAHA120033246

Association of Baseline Cardiovascular Diseases with 5-Year Knee and Hip Osteoarthritis Progression in Non-Obese Patients: Data from the KHOALA Cohort.

Roubille C, Coste J, Sellam J, Rat AC, Guillemin F, Roux CH

J Clin Med. 2021 Jul 29;10(15):

Health Literacy throughout adolescence: Invariance and validity study of three measurement scales in the general population.

Rouquette A, Rigal L, Mancini J, Guillemin F, van den Broucke S, Allaire C, Azogui-Levy S, Ringa V, Hassler C

Patient Educ Couns. 2021 Jul 28;:

Endovascular Treatment Effect Diminishes With Increasing Thrombus Perviousness: Pooled Data From 7 Trials on Acute Ischemic Stroke.

Kappelhof M, Tolhuisen ML, Treurniet KM, Dutra BG, Alves H, Zhang G, Brown S, Muir KW, Dávalos A, Roos YBWEM, Saver JL, Demchuk AM, Jovin TG, Bracard S, Campbell BCV, van der Lugt A, Guillemin F, White P, Hill MD, Dippel DWJ, Mitchell PJ, Goyal M, Marquering HA, Majoie CBLM

Stroke. 2021 Jul 20;:STROKEAHA120033124

Prediction of Outcome and Endovascular Treatment Benefit: Validation and Update of the MR PREDICTS Decision Tool.

Venema E, Roozenbeek B, Mulder MJHL, Brown S, Majoie CBLM, Steyerberg EW, Demchuk AM, Muir KW, Dávalos A, Mitchell PJ, Bracard S, Berkhemer OA, Lycklama À Nijeholt GJ, van Oostenbrugge RJ, Roos YBWEM, van Zwam WH, van der Lugt A, Hill MD, White P, Campbell BCV, Guillemin F, Saver JL, Jovin TG, Goyal M, Dippel DWJ, Lingsma HF,

Stroke. 2021 Jul 16;:STROKEAHA120032935

Comparing the Prognostic Impact of Age and Baseline National Institutes of Health Stroke Scale in Acute Stroke due to Large Vessel Occlusion.

Ospel JM, Brown S, Kappelhof M, van Zwam W, Jovin T, Roy D, Campbell BCV, Mitchell P, Roos Y, Guillemin F, Buck B, Muir K, Bracard S, White P, du Mesnil de Rochemont R, Goyal M,

Stroke. 2021 Jul 8;:STROKEAHA120032364

Clinical imaging factors of excellent outcome after thrombolysis in large-vessel stroke: a THRACE subgroup analysis.

Riou-Comte N, Gory B, Soudant M, Zhu F, Xie Y, Humbertjean L, Mione G, Oppenheim C, Guillemin F, Bracard S, Richard S,

Stroke Vasc Neurol. 2021 Jun 8;:

Seroprevalence of SARS-CoV-2, Symptom Profiles and Sero-Neutralization in a Suburban Area, France.

Gégout Petit A, Jeulin H, Legrand K, Jay N, Bochnakian A, Vallois P, Schvoerer E, Guillemin F

Viruses. 2021 Jun 4;13(6):

Sociodemographic and psychological characteristics associated with discrepancy between body satisfaction and weight change among adolescents.

Manneville F, Omorou AY, Legrand K, Lecomte E, Rydberg JA, Briançon S, Guillemin F,

Prev Med. 2021 Jun 1;150:106668

Patient preferences to value health outcomes in rheumatology clinical trials: Report from the OMERACT special interest group.

Thomas M, Fraenkel L, Boonen A, Bansback N, Buchbinder R, Marshall D, Proulx L, Voshaar M, Richards P, Richards DP, Hiligsmann M, Guillemin F, Shea B, Tugwell P, Hazlewood G

Semin Arthritis Rheum. 2021 May 24;:

Clinical, biological, and molecular genetic features of Richter syndrome and prognostic significance: a study of the French Innovative Leukemia Organization.

Moulin C, Guillemin F, Remen T, Bouclet F, Hergalant S, Quinquenel A, Dartigeas C, Tausch E, Lazarian G, Blanchet O, Lomazzi S, Chapiro E, Schneider C, Nguyen-Khac F, Davi F, Hunault M, Tomowiak C, Roos-Weil D, Siebert R, Thieblemont C, Cymbalista F, Laribi K, Béné MC, Stilgenbauer S, Guièze R, Feugier P, Broséus J

Am J Hematol. 2021 May 17;:

Best-practice clinical management of flares in people with osteoarthritis: A scoping review of behavioral, lifestyle and adjunctive treatments.

Bowden JL, Kobayashi S, Hunter DJ, Mills K, Peat G, Guillemin F, Parry E, Thomas MJ, Eyles JP

Semin Arthritis Rheum. 2021 May 5;51(4):749-760

Healthy Life-Year Costs of Treatment Speed From Arrival to Endovascular Thrombectomy in Patients With Ischemic Stroke: A Meta-analysis of Individual Patient Data From 7 Randomized Clinical Trials.

Almekhlafi MA, Goyal M, Dippel DWJ, Majoie CBLM, Campbell BCV, Muir KW, Demchuk AM, Bracard S, Guillemin F, Jovin TG, Mitchell P, White P, Hill MD, Brown S, Saver JL,

JAMA Neurol. 2021 May 3;:

Intra-database validation of case-identifying algorithms using reconstituted electronic health records from healthcare claims data.

Thurin NH, Bosco-Levy P, Blin P, Rouyer M, Jové J, Lamarque S, Lignot S, Lassalle R, Abouelfath A, Bignon E, Diez P, Gross-Goupil M, Soulié M, Roumiguié M, Le Moulec S, Debouverie M, Brochet B, Guillemin F, Louapre C, Maillart E, Heinzlef O, Moore N, Droz-Perroteau C

BMC Med Res Methodol. 2021 May 1;21(1):95

Clinical and radiological activity of secondary progressive multiple sclerosis in a population-based cohort.

Mathey G, Ancel T, Garot T, Soudant M, Pittion-Vouyovitch S, Guillemin F, Debouverie M, Epstein J

Eur J Neurol. 2021 Apr 10;:

EULAR Points to Consider (PtC) for designing, analysing and reporting of studies with work participation as an outcome domain in patients with inflammatory arthritis.

Boonen A, Putrik P, Marques ML, Alunno A, Abasolo L, Beaton D, Betteridge N, Bjørk M, Boers M, Boteva B, Fautrel B, Guillemin F, Mateus EF, Nikiphorou E, Péntek M, Pimentel Santos F, Severens JL, Verstappen SMM, Walker-Bone K, Wallman JK, Ter Wee MM, Westhovens R, Ramiro S

Ann Rheum Dis. 2021 Apr 8;:

Endorsement of the OMERACT core domain set for shared decision making interventions in rheumatology trials: Results from a multi-stepped consensus-building approach.

Toupin-April K, Décary S, de Wit M, Meara A, Barton JL, Fraenkel L, Li LC, Brooks P, Shea B, Stacey D, Légaré F, Lydiatt A, Hofstetter C, Proulx L, Christensen R, Voshaar M, Suarez-Almazor ME, Boonen A, Meade T, March L, Jull JE, Campbell W, Alten R, Morgan EM, Kelly A, Kaufman J, Hill S, Maxwell LJ, Guillemin F, Beaton D, El-Miedany Y, Mittoo S, Westrich Robertson T, Bartlett SJ, Singh JA, Mannion M, Nasef SI, de Souza S, Boel A, Adebajo A, Arnaud L, Gill TK, Moholt E, Burt J, Jayatilleke A, Hmamouchi I, Carrott D, Blanco FJ, Mather K, Maharaj A, Sharma S, Caso F, Fong C, Fernandez AP, Mackie S, Nikiphorou E, Jones A, Greer-Smith R, Sloan VS, Akpabio A, Strand V, Umaefulam V, Monti S, Melburn C, Abaza N, Schultz K, Stones S, Kiwalkar S, Srinivasalu H, Constien D, King LK, Tugwell P

Semin Arthritis Rheum. 2021 Apr 6;:

OMERACT consensus-based operational definition of contextual factors in rheumatology clinical trials: A mixed methods study.

Nielsen SM, Boers M, de Wit M, Shea B, van der Windt DA, Reeves BC, Beaton D, Alten R, Toupin April K, Boonen A, Escorpizo R, Flurey C, Furst DE, Guillemin F, Leong A, Pohl C, Rasmussen MU, Singh JA, Smolen JS, Strand V, Verstappen SMM, Voshaar M, Woodworth TG, Ellingsen T, March L, Wells GA, Tugwell P, Christensen R

Semin Arthritis Rheum. 2021 Apr 2;:

Cut-off value to identify a flare using the Flare Assessment in Rheumatoid Arthritis (FLARE-RA) questionnaire: analysis of the TOSCA study.

Aouad K, Gaudin P, Vittecoq O, Morel J, Berthelot JM, Senbel E, Schaeverbeke T, Lioté F, Flipo RM, Pinta A, Guillemin F, Fautrel B

Rheumatology (Oxford). 2021 Mar 31;:

Long-term analysis of patients with benign multiple sclerosis: new insights about the disability course.

Mathey G, Pisché G, Soudant M, Pittion-Vouyovitch S, Guillemin F, Debouverie M, Epstein J

J Neurol. 2021 Mar 31;:

Endorsement of the domains of knee and hip osteoarthritis (OA) flare: A report from the OMERACT 2020 inaugural virtual consensus vote from the flares in OA working group.

King LK, Epstein J, Cross M, Buzzi M, Buttel T, Cembalo SM, Spitz E, Adams CL, Adebajo A, Bennell K, Blanco B, Courage U, Décary S, Gill M, Gill TK, Hajji R, Hinman RS, Jones A, Li LC, Mather K, Mani R, Nasef SI, Oo WM, Østerås N, Otobo TM, Ramiro S, Sharma S, April KT, Touma Z, Whittaker JL, Wluka AE, Grosskleg S, Hunter DJ, Shea B, Hawker GA, Callahan LF, March L, Guillemin F

Semin Arthritis Rheum. 2021 Mar 20;:

Direct transfer to angiosuite for patients with severe acute stroke treated with thrombectomy: the multicentre randomised controlled DIRECT ANGIO trial protocol.

Riou-Comte N, Zhu F, Cherifi A, Richard S, Nace L, Audibert G, Achit H, Costalat V, Arquizan C, Beaufils O, Consoli A, Lapergue B, Loeb T, Rouchaud A, Macian F, Cailloce D, Biondi A, Moulin T, Desmettre T, Marnat G, Sibon I, Combes X, Lebedinsky AP, Vuillemet F, Kempf N, Pierot L, Moulin S, Lemmel P, Mazighi M, Blanc R, Sabben C, Schluck E, Bracard S, Anxionnat R, Guillemin F, Hossu G, Gory B,

BMJ Open. 2021 Mar 15;11(3):e040522

Kidney function monitoring to prevent 5-aminosalicylic acid nephrotoxicity: What the gastroenterologist should know.

Guillo L, D'Amico F, Achit H, Ayav C, Guillemin F, Danese S, Frimat L, Peyrin-Biroulet L

Dig Liver Dis. 2021 Feb 6;:

Therapeutic alliance is associated to treatment adherence in children with juvenile idiopathic arthritis.

Lohse A, Lemelle I, Pillet P, Duquesne A, Ballot C, Tran TA, Sparsa L, Goumy L, Reumaux H, Rossi L, Solau-Gervais E, Arbault A, Alleyrat C, Guillemin F, Devauchelle-Pensec V

Joint Bone Spine. 2021 Feb 6;:105151

EULAR recommendations for the reporting of ultrasound studies in rheumatic and musculoskeletal diseases (RMDs).

Costantino F, Carmona L, Boers M, Backhaus M, Balint PV, Bruyn GA, Christensen R, Conaghan PG, Ferreira RJO, Garrido-Castro JL, Guillemin F, Hammer HB, van der Heijde D, Iagnocco A, Kortekaas MC, Landewé RB, Mandl P, Naredo E, Schmidt WA, Terslev L, Terwee CB, Thiele R, D'Agostino MA

Ann Rheum Dis. 2021 Jan 22;:

Genome Sequencing for Genetics Diagnosis of Patients With Intellectual Disability: The DEFIDIAG Study.

Binquet C, Lejeune C, Faivre L, Bouctot M, Asensio ML, Simon A, Deleuze JF, Boland A, Guillemin F, Seror V, Delmas C, Espérou H, Duffourd Y, Lyonnet S, Odent S, Heron D, Sanlaville D, Frebourg T, Gerard B, Dollfus H

Front Genet. 2021 ;12:766964

Pain in women with knee and/or hip osteoarthritis is related to systemic inflammation and to adipose tissue dysfunction: Cross-sectional results of the KHOALA cohort.

Sellam J, Rat AC, Fellahi S, Bastard JP, Ngueyon Sime W, Ea HK, Chevalier X, Richette P, Capeau J, Guillemin F, Berenbaum F

Semin Arthritis Rheum. 2020 Dec 18;51(1):129-136

Ten years psychosocial outcomes among adolescents following suicide attempts - early recurrence and psychosocial outcomes.

Ligier F, Kurzenne M, Kabuth B, Guillemin F

Encephale. 2020 Dec 5;:

Development of New International Antiphospholipid Syndrome Classification Criteria Phase I/II Report: Generation and Reduction of Candidate Criteria.

Barbhaiya M, Zuily S, Ahmadzadeh Y, Amigo MC, Avcin T, Bertolaccini ML, Branch DW, de Jesus G, Devreese KMJ, Frances C, Garcia D, Guillemin F, Levine SR, Levy RA, Lockshin MD, Ortel TL, Seshan SV, Tektonidou M, Wahl D, Willis R, Naden R, Costenbader K, Erkan D,

Arthritis Care Res (Hoboken). 2020 Nov 30;:

Knowledge of 5-aminosalicylic acid nephrotoxicity and adherence to kidney function monitoring of patients with inflammatory bowel disease.

Weislinger L, Guillo L, D'Amico F, Danese S, Achit H, Ayav C, Guillemin F, Peyrin-Biroulet L, Frimat L

Eur J Gastroenterol Hepatol. 2020 Nov 30;:

Cost assessment of health interventions and diseases.

Fautrel B, Boonen A, de Wit M, Grimm S, Joore M, Guillemin F

RMD Open. 2020 Nov;6(3):

Health technology assessment: a framework.

Joore M, Grimm S, Boonen A, de Wit M, Guillemin F, Fautrel B

RMD Open. 2020 Nov;6(3):

Patient engagement in health technology assessment (HTA) and the regulatory process: what about rheumatology?

de Wit M, Guillemin F, Grimm S, Boonen A, Fautrel B, Joore M

RMD Open. 2020 Nov;6(3):

Steps in implementing a health economic evaluation.

Guillemin F, de Wit M, Fautrel B, Grimm S, Joore M, Boonen A

RMD Open. 2020 Nov;6(3):

Impact of terminating reimbursement of symptomatic slow-acting drugs in osteoarthritis in France on volume and cost of drug deliveries, assessed with administrative databases.

Mari K, Rannou F, Guillemin F, Elegbede M, Gueyffier F, Badot G, Mistretta F

Semin Arthritis Rheum. 2020 Sep 23;50(6):1307-1313

Impact of smoking on femorotibial and hip osteoarthritis progression: 3-year follow-up data from the KHOALA cohort.

Roux CH, Coste J, Roger C, Fontas E, Rat AC, Guillemin F

Joint Bone Spine. 2020 Sep 17;:

Public health and cost consequences of time delays to thrombectomy for acute ischemic stroke.

Kunz WG, Hunink MG, Almekhlafi MA, Menon BK, Saver JL, Dippel DWJ, Majoie CBLM, Jovin TG, Davalos A, Bracard S, Guillemin F, Campbell BCV, Mitchell PJ, White P, Muir KW, Brown S, Demchuk AM, Hill MD, Goyal M,

Neurology. 2020 Sep 17;:

Effect of age and baseline ASPECTS on outcomes in large-vessel occlusion stroke: results from the HERMES collaboration.

Ospel JM, Kappelhof M, Kashani N, Menon BK, Campbell BCV, San Roman L, Demchuk AM, Dippel DWJ, Saver JL, Jovin TG, Mitchell P, Bracard S, Muir K, White P, Guillemin F, Majoie CBLM, Hill MD, Brown S, Goyal M,

J Neurointerv Surg. 2020 Sep 14;:

Predictive factors of functional independence after optimal reperfusion in anterior circulation ischemic stroke with indication for intravenous thrombolysis plus mechanical thrombectomy.

Riou-Comte N, Guillemin F, Gory B, Lapergue B, Zhu F, Soudant M, Piotin M, Humbertjean L, Mione G, Lacour JC, Anxionnat R, Hossu G, Bracard S, Richard S,

Eur. J. Neurol.. 2020 Sep 11;:

Pauline BL, Lignot S, Abdelilah A, Marc D, Bruno B, Guillemin F, Patrick B

Rev. Neurol. (Paris). 2020 Sep;176S:S76

Spa therapy with physical rehabilitation is an alternative to usual spa therapy protocol in symptomatic knee osteoarthritis.

Rat AC, Loeuille D, Vallata A, Bernard L, Spitz E, Desvignes A, Boulange M, Paysant J, Guillemin F, Chary-Valckenaere I

Sci Rep. 2020 Jul 3;10(1):11004

Discontinuation of disease-modifying treatments for multiple sclerosis in patients aged over 50 with disease Inactivity.

Kaminsky AL, Omorou AY, Soudant M, Pittion-Vouyovitch S, Michaud M, Anxionnat R, Guillemin F, Debouverie M, Mathey G

J. Neurol.. 2020 Jul 2;:

Flare-IBD: development and validation of a questionnaire based on patients' messages on an internet forum for early detection of flare in inflammatory bowel disease: study protocol.

Ricci L, Epstein J, Buisson A, Devos C, Toussaint Y, Peyrin-Biroulet L, Guillemin F

BMJ Open. 2020 Jul 1;10(7):e037211

Anti-Domain I β2-Glycoprotein I Antibodies and Activated Protein C Resistance Predict Thrombosis in Antiphospholipid Syndrome: TAC(I)T Study.

Zuily S, de Laat B, Guillemin F, Kelchtermans H, Magy-Bertrand N, Desmurs-Clavel H, Lambert M, Poindron V, de Maistre E, Dufrost V, Risse J, Shums Z, Norman GL, de Groot PG, Lacolley P, Lecompte T, Regnault V, Wahl D,

J Appl Lab Med. 2020 Jun 23;:

Cross-cultural adaptation and validation of the Moroccan version of the incontinence quality of life questionnaire (I-QoL) in urinary incontinence patients.

Otmani N, Epstein J, Benaicha N, Alaoui AC, Kinany KE, Atassi M, Qarmiche N, Tachfouti N, Guillemin F, Fakir SE

J Gynecol Obstet Hum Reprod. 2020 Jun 10;:101830

Effect of emergent carotid stenting during endovascular therapy for acute anterior circulation stroke patients with tandem occlusion: A multicenter, randomized, clinical trial (TITAN) protocol.

Zhu F, Hossu G, Soudant M, Richard S, Achit H, Beguinet M, Costalat V, Arquizan C, Consoli A, Lapergue B, Rouchaud A, Macian-Montoro F, Biondi A, Moulin T, Marnat G, Sibon I, Paya C, Vannier S, Cognard C, Viguier A, Mazighi M, Obadia M, Hassen WB, Turc G, Clarençon F, Samson Y, Dumas-Duport B, Preterre C, Barbier C, Boulanger M, Janot K, Annan M, Bricout N, Henon H, Soize S, Moulin S, Labeyrie MA, Reiner P, Pop R, Wolff V, Ognard J, Timsit S, Reyre A, Perot C, Papagiannaki C, Triquenot-Bagan A, Bracard S, Anxionnat R, Derelle AL, Tonnelet R, Liao L, Schmitt E, Planel S, Guillemin F, Gory B

Int J Stroke. 2020 Jun 9;:1747493020929948

Global, regional and national burden of osteoarthritis 1990-2017: a systematic analysis of the Global Burden of Disease Study 2017.

Safiri S, Kolahi AA, Smith E, Hill C, Bettampadi D, Mansournia MA, Hoy D, Ashrafi-Asgarabad A, Sepidarkish M, Almasi-Hashiani A, Collins G, Kaufman J, Qorbani M, Moradi-Lakeh M, Woolf AD, Guillemin F, March L, Cross M

Ann. Rheum. Dis.. 2020 May 12;:

Trajectory analysis combining pain and physical function in individuals with knee and hip osteoarthritis: results from the French KHOALA cohort.

Wieczorek M, Rotonda C, Coste J, Pouchot J, Saraux A, Guillemin F, Rat AC

Rheumatology (Oxford). 2020 May 6;:

Predictors of fatigue and persistent fatigue in early rheumatoid arthritis: a longitudinal observational study, data from the ESPOIR cohort.

Rodríguez-Muguruza S, Combe B, Guillemin F, Fautrel B, Olive A, Marsal S, Valero O, Rincheval N, Lukas C

Scand. J. Rheumatol.. 2020 Apr 30;:1-8

Patient global assessment and radiographic progression in early arthritis: 3-year results from the ESPOIR cohort.

Ferreira RJO, Fautrel B, Saraux A, Gaujoux-Viala C, Rat AC, Guillemin F, da Silva JAP, Dougados M, Gossec L

Arthritis Care Res (Hoboken). 2020 Apr 27;:

Translation and cross-cultural adaptation into Italian of the self-administered FLARE-RA questionnaire for rheumatoid arthritis.

Ughi N, Schioppo T, Scotti I, Merlino V, Murgo A, De Lucia O, Fautrel B, Guillemin F, Christensen R, Ingegnoli F

Reumatismo. 2020 Apr 10;72(1):21-30

Five-year evolution patterns of physical activity and sedentary behavior in patients with lower-limb osteoarthritis and their sociodemographic and clinical correlates.

Bitar S, Omorou AY, Van Hoye A, Guillemin F, Rat AC

J. Rheumatol.. 2020 Mar 15;:

Physical activity rather than sedentary behaviour is socially determined in French adolescents with overweight and obesity.

Omorou AY, Manneville F, Langlois J, Legrand K, Böhme P, Muller L, Guillemin F, Briançon S, Lecomte E,

Prev Med. 2020 Feb 22;:106043

Nuclear power plant: state of knowledge of the population living in the area of the Cattenom special intervention plan. A cross sectional study.

Schweitzer ML, Guillemin F, Guerci B, Ayav C, Klein M

J Radiol Prot. 2020 Feb 7;:

Influence of coping strategies on the efficacy of YAM (Youth Aware of Mental Health): a universal school-based suicide preventive program.

Kahn JP, Cohen RF, Tubiana A, Legrand K, Wasserman C, Carli V, Apter A, Balazs J, Banzer R, Baralla F, Barzilai S, Bobes J, Brunner R, Corcoran P, Cosman D, Guillemin F, Haring C, Kaess M, Bitenc UM, Mészàros G, McMahon E, Postuvan V, Saiz P, Varnik A, Varnik P, Sarchiapone M, Hoven CW, Wasserman D

Eur Child Adolesc Psychiatry. 2020 Feb 5;:

Public Health and Cost Benefits of Successful Reperfusion After Thrombectomy for Stroke.

Kunz WG, Almekhlafi MA, Menon BK, Saver JL, Hunink MG, Dippel DWJ, Majoie CBLM, Liebeskind DS, Jovin TG, Davalos A, Bracard S, Guillemin F, Campbell BCV, Mitchell PJ, White P, Muir KW, Brown S, Demchuk AM, Hill MD, Goyal M,

Stroke. 2020 Jan 22;:STROKEAHA119027874

Evaluation of osteoarthritis knee and hip quality of life (OAKHQoL): adaptation and validation of the questionnaire in the Hungarian population.

Fekete H, Guillemin F, Pallagi E, Fekete R, Lippai Z, Luterán F, Tóth I, Tóth K, Vallata A, Varjú C, Csóka I

Ther Adv Musculoskelet Dis. 2020 ;12:1759720X20959570

The burden of osteoarthritis: self-reported severity in the KHOALA population-based cohort.

Cross M, Ngueyon Sime W, March L, Guillemin F

Rheumatology (Oxford). 2019 Dec 31;:

Optimizing DyNaChron instrument for assessing chronic nasal dysfunction symptoms by Rasch analysis.

Rotonda C, Soudant M, Epstein J, Goetz C, Jankowski R, Guillemin F

Rhinology. 2019 Dec 30;:

Automatic segmentation of cerebral infarcts in follow-up computed tomography images with convolutional neural networks.

Sales Barros R, Tolhuisen ML, Boers AM, Jansen I, Ponomareva E, Dippel DWJ, van der Lugt A, van Oostenbrugge RJ, van Zwam WH, Berkhemer OA, Goyal M, Demchuk AM, Menon BK, Mitchell P, Hill MD, Jovin TG, Davalos A, Campbell BCV, Saver JL, Roos YBWEM, Muir KW, White P, Bracard S, Guillemin F, Olabarriaga SD, Majoie CBLM, Marquering HA

J Neurointerv Surg. 2019 Dec 23;:

Chondrocalcinosis of the knee and the risk for osteoarthritis progression: data from the KHOALA cohort.

Latourte A, Rat AC, Ngueyon Sime W, Ea HK, Bardin T, Mazières B, Roux C, Guillemin F, Richette P

. 2019 Dec 5;:

Comparison of a video versus paper questionnaire on functional limitation in lower limb osteoarthritis.

Dubouis L, Ngueyon-Sime W, Peter W, Vallata A, Epstein J, Rat AC, Agrinier N, Terwee CB, Guillemin F

BMC Musculoskelet Disord. 2019 Nov 3;20(1):507

Impact of a medical interview on the decision to switch from originator infliximab to its biosimilar in patients with inflammatory bowel disease.

Haghnejad V, Le Berre C, Dominique Y, Zallot C, Guillemin F, Peyrin-Biroulet L

Dig Liver Dis. 2019 Oct 21;:

What have we learned from trajectory analysis of clinical outcomes in knee and hip osteoarthritis before surgery?

Wieczorek M, Rotonda C, Guillemin F, Rat AC

Arthritis Care Res (Hoboken). 2019 Sep 17;:

Definition and construct validation of clinically relevant cutoffs on the Flare Assessment in Rheumatoid Arthritis (FLARE-RA) questionnaire.

Myasoedova E, De Thurah A, Erpelding ML, Schneeberger EE, Maribo T, Citera G, Davis JM, Matteson EL, Crowson CS, Fautrel B, Guillemin F

Semin. Arthritis Rheum.. 2019 Sep 11;:

The American English version of the validated French Flare Assessment in RA Questionnaire (FLARE-RA).

Barroso N, Woodworth TG, Furst DE, Guillemin F, Fautrel BJ, Borazan N, Kafaja S, Brook J, Elashoff DA, Ranganath VK

Clin. Rheumatol.. 2019 Sep 6;:

Confirmatory Study of Time-Dependent Computed Tomographic Perfusion Thresholds for Use in Acute Ischemic Stroke.

Qiu W, Kuang H, Lee TY, Boers AM, Brown S, Muir K, Majoie CBLM, Dippel DWJ, White P, Guillemin F, Mitchell PJ, Dávalos A, Bracard S, Campbell B, Saver JL, Jovin TG, Hill MD, Demchuk AM, Goyal M, Menon BK,

Stroke. 2019 Sep 4;:STROKEAHA119026281

Universal School-Based Intervention Does Not Reduce Socioeconomic Inequalities in Weight Status among Adolescents.

Manneville F, Omorou AY, Legrand K, Langlois J, Lecomte E, Guillemin F, Briançon S,

Child Obes. 2019 Aug 26;:

Patients with rheumatoid arthritis facing sick leave or work disability meet varying regulations: a study among rheumatologists and patients from 44 European countries.

Putrik P, Ramiro S, Guillemin F, Péntek M, Sivera F, Sokka T, de Wit M, Woolf AD, Zink A, Andersone D, Berghea F, Butrimiene I, Brouwer S, Cassar K, Charalambous P, Caporali R, Deseatnicova E, Damjanov NS, Finckh A, FitzGerald O, Gröndal G, Gobejishjvili N, Gluszko P, Hirsch M, Jovanovic I, Vencovský J, Janssens X, Keszei AP, Kovarova M, Kull M, Cunha Miranda L, Mayer M, Misevska-Percinkova S, Inanc N, Nadashkevich O, Petersson IF, Puolakka K, Rojkovich B, Radner H, Szabados F, Slobodin G, Shirinsky I, Soroka N, Sidiropoulos P, Shumnalieva R, Sokolovic S, Shukurova S, Tafaj A, Tomšič M, Uhlig T, Verstappen SMM, Boonen A

Ann. Rheum. Dis.. 2019 Aug 19;:

What have we learned about the course of clinical outcomes after total knee or hip arthroplasty?

Wieczorek M, Rotonda C, Guillemin F, Rat AC

Arthritis Care Res (Hoboken). 2019 Aug 17;:

Does Sex Modify the Effect of Endovascular Treatment for Ischemic Stroke?

Chalos V, de Ridder IR, Lingsma HF, Brown S, van Oostenbrugge RJ, Goyal M, Campbell BCV, Muir KW, Guillemin F, Bracard S, White P, Dávalos A, Jovin TG, Hill MD, Mitchell PJ, Demchuk AM, Saver JL, van Zwam WH, Dippel DWJ,

Stroke. 2019 Aug 15;:STROKEAHA118023743

Cost-effectiveness of four living-donor nephrectomy techniques from a hospital perspective.

Achit H, Guillemin F, Karam G, Ladrière M, Baumann C, Frimat L, Hosseini K, Hubert J

Nephrol. Dial. Transplant.. 2019 Aug 3;:

Cost-of-illness of inflammatory bowel disease patients treated with anti-tumour necrosis factor: A French large single-centre experience.

Lawton J, Achit H, Pouillon L, Boschetti E, Demore B, Matton T, Tournier C, Prodel M, Peyrin-Biroulet L, Guillemin F

United European Gastroenterol J. 2019 Aug;7(7):908-913

Stroke Laterality Did Not Modify Outcomes in the HERMES Meta-Analysis of Individual Patient Data of 7 Trials.

Almekhlafi MA, Hill MD, Roos YM, Campbell BCV, Muir KW, Demchuk AM, Bracard S, Gomis M, Guillemin F, Jovin TG, Menon BK, Mitchell P, White P, van der Lugt A, Saver J, Brown S, Goyal M

Stroke. 2019 Jul 5;:STROKEAHA118023102

Impact of comorbidities and functional impairment on 5-year loss of health utility in patients with lower-limb osteoarthritis in the KHOALA cohort.

Omorou AY, Achit H, Wieczorek M, Pouchot J, Fautrel B, Rat AC, Guillemin F

Qual Life Res. 2019 Jul 4;:

Factors of the evolution of fatigue dimensions in patients with breast cancer during the 2 years after surgery.

Person H, Guillemin F, Conroy T, Velten M, Rotonda C

Int. J. Cancer. 2019 Jun 22;:

Developing a Preliminary Definition and Domains of Flare in Knee and Hip Osteoarthritis (OA): Consensus Building of the Flare-in-OA OMERACT Group.

Guillemin F, Ricatte C, Barcenilla-Wong A, Schoumacker A, Cross M, Alleyrat C, Buttel T, Cembalo M, Manseur H, Urban H, Fautrel B, Conaghan PG, Hawker G, Rutherford C, March L, Spitz E, Hunter DJ

J. Rheumatol.. 2019 May 15;:

[Osteoarthritis, association with morbidity and mortality].

Wieczorek M, Guillemin F

Rev Prat. 2019 May;69(5):505-506

Efficacy of endovascular thrombectomy in patients with M2 segment middle cerebral artery occlusions: meta-analysis of data from the HERMES Collaboration.

Menon BK, Hill MD, Davalos A, Roos YBWEM, Campbell BCV, Dippel DWJ, Guillemin F, Saver JL, van der Lugt A, Demchuk AM, Muir K, Brown S, Jovin T, Mitchell P, White P, Bracard S, Goyal M

J Neurointerv Surg. 2019 Apr 11;:

Health resource use and costs of symptomatic knee and/or hip osteoarthritis.

Salmon JH, Rat AC, Achit H, Ngueyon-Sime W, Gard C, Guillemin F, Jolly D, Fautrel B

Osteoarthr. Cartil.. 2019 Mar 25;:

A definition of flare in low back pain (LBP): A multiphase process involving perspectives of individuals with LBP and expert consensus.

Costa N, Ferreira ML, Setchell J, Makovey J, Dekroo T, Downie A, Diwan A, Koes B, Natvig B, Vicenzino B, Hunter D, Roseen E, Rasmussen-Barr E, Guillemin F, Hartvigsen J, Bennell K, Costa L, Macedo L, Pinheiro M, Underwood M, Van Tulder M, Johansson M, Enthoven P, Kent P, O'Sullivan P, Suri P, Genevay S, Hodges PW

J Pain. 2019 Mar 20;:

Uptake of the OMERACT-OARSI Hip and Knee Osteoarthritis Core Outcome Set: Review of Randomized Controlled Trials from 1997 to 2017.

Smith TO, Mansfield M, Hawker GA, Hunter DJ, March LM, Boers M, Shea BJ, Christensen R, Guillemin F, Terwee CB, Williamson PR, Roos EM, Loeser RF, Schnitzer TJ, Kloppenburg M, Neogi T, Ladel CH, Kalsi G, Kaiser U, Buttel TW, Ashford AE, Mobasheri A, Arden NK, Tennant A, Hochberg MC, de Wit M, Tugwell P, Conaghan PG

J. Rheumatol.. 2019 Mar 1;:

Glucose Modifies the Effect of Endovascular Thrombectomy in Patients With Acute Stroke.

Chamorro Á, Brown S, Amaro S, Hill MD, Muir KW, Dippel DWJ, van Zwam W, Butcher K, Ford GA, den Hertog HM, Mitchell PJ, Demchuk AM, Majoie CBLM, Bracard S, Sibon I, Jadhav AP, Lara-Rodriguez B, van der Lugt A, Osei E, Renú A, Richard S, Rodriguez-Luna D, Donnan GA, Dixit A, Almekhlafi M, Deltour S, Epstein J, Guillon B, Bakchine S, Gomis M, du Mesnil de Rochemont R, Lopes D, Reddy V, Rudel G, Roos YBWEM, Bonafe A, Diener HC, Berkhemer OA, Cloud GC, Davis SM, van Oostenbrugge R, Guillemin F, Goyal M, Campbell BCV, Menon BK,

Stroke. 2019 Feb 19;:STROKEAHA118023769

Similar alteration for mental and physical aspects in health-related quality of life over 5 to 8 years in 1347 patients with early arthritis and early inflammatory back pain.

Puyraimond-Zemmour D, Granger B, Molto A, Gaujoux-Viala C, Guillemin F, Ruyssen-Witrand A, Dougados M, Fautrel B, Gossec L

Arthritis Res. Ther.. 2019 Feb 19;21(1):63

Rapid Alteplase Administration Improves Functional Outcomes in Patients With Stroke due to Large Vessel Occlusions.

Goyal M, Almekhlafi M, Dippel DW, Campbell BCV, Muir K, Demchuk AM, Bracard S, Davalos A, Guillemin F, Jovin TG, Menon BK, Mitchell PJ, Brown S, White P, Majoie CBLM, Saver JL, Hill MD,

Stroke. 2019 Feb 14;:STROKEAHA118021840

Magnetic Resonance Imaging or Computed Tomography Before Treatment in Acute Ischemic Stroke.

Provost C, Soudant M, Legrand L, Ben Hassen W, Xie Y, Soize S, Bourcier R, Benzakoun J, Edjlali M, Boulouis G, Raoult H, Guillemin F, Naggara O, Bracard S, Oppenheim C

Stroke. 2019 Feb 12;:STROKEAHA118023882

High performance of cerebrospinal fluid immunoglobulin G analysis for diagnosis of multiple sclerosis.

Gamraoui S, Mathey G, Debouverie M, Malaplate C, Anxionnat R, Guillemin F, Epstein J

J. Neurol.. 2019 Feb 1;:

Personalised medicine in inflammatory bowel diseases: a patient survey.

Choukour M, Kivits J, Baker A, Baumann C, Guillemin F, Peyrin-Biroulet L

Scand. J. Gastroenterol.. 2019 Jan 20;:1

Identifying Provisional Generic Contextual Factor Domains for Clinical Trials in Rheumatology: Results from an OMERACT Initiative.

Nielsen SM, Tugwell P, de Wit MPT, Boers M, Beaton DE, Woodworth TG, Escorpizo R, Shea B, Toupin-April K, Guillemin F, Strand V, Singh JA, Kloppenburg M, Furst DE, Wells GA, Smolen JS, Veselý R, Boonen A, Storgaard H, Voshaar M, March L, Christensen R,

J. Rheumatol.. 2019 Jan 15;:

The OMERACT-OARSI Core Domain Set for Measurement in Clinical Trials of Hip and/or Knee Osteoarthritis.

Smith TO, Hawker GA, Hunter DJ, March LM, Boers M, Shea BJ, Christensen R, Guillemin F, Terwee CB, Williamson PR, Dodd S, Roos EM, Loeser RF, Schnitzer TJ, Kloppenburg M, Neogi T, Ladel CH, Kalsi G, Kaiser U, Buttel TW, Ashford AE, Mobasheri A, Arden NK, Tennant A, Hochberg MC, de Wit M, Tugwell P, Conaghan PG

J. Rheumatol.. 2019 Jan 15;:

Mediation of the Relationship Between Endovascular Therapy and Functional Outcome by Follow-up Infarct Volume in Patients With Acute Ischemic Stroke.

Boers AMM, Jansen IGH, Brown S, Lingsma HF, Beenen LFM, Devlin TG, Román LS, Heo JH, Ribó M, Almekhlafi MA, Liebeskind DS, Teitelbaum J, Cuadras P, du Mesnil de Rochemont R, Beaumont M, Brown MM, Yoo AJ, Donnan GA, Mas JL, Oppenheim C, Dowling RJ, Moulin T, Agrinier N, Lopes DK, Aja Rodríguez L, Compagne KCJ, Al-Ajlan FS, Madigan J, Albers GW, Soize S, Blasco J, Davis SM, Nogueira RG, Dávalos A, Menon BK, van der Lugt A, Muir KW, Roos YBWEM, White P, Mitchell PJ, Demchuk AM, van Zwam WH, Jovin TG, van Oostenbrugge RJ, Dippel DWJ, Campbell BCV, Guillemin F, Bracard S, Hill MD, Goyal M, Marquering HA, Majoie CBLM

JAMA Neurol. 2019 Jan 7;:

An Ergonomic Assessment Of Four Different Donor Nephrectomy Approaches For The Surgeons And Their Assistants.

Marçon B, Ngueyon Sime W, Guillemin F, Hubert N, Lagrange F, Huselstein C, Hubert J

Res Rep Urol. 2019 ;11:261-268

Observatoire Français de la Sclérose en Plaques (OFSEP): A unique multimodal nationwide MS registry in France.

Vukusic S, Casey R, Rollot F, Brochet B, Pelletier J, Laplaud DA, De Sèze J, Cotton F, Moreau T, Stankoff B, Fontaine B, Guillemin F, Debouverie M, Clanet M

Mult. Scler.. 2018 Dec 13;:1352458518815602

Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data.

Campbell BCV, Majoie CBLM, Albers GW, Menon BK, Yassi N, Sharma G, van Zwam WH, van Oostenbrugge RJ, Demchuk AM, Guillemin F, White P, Dávalos A, van der Lugt A, Butcher KS, Cherifi A, Marquering HA, Cloud G, Macho Fernández JM, Madigan J, Oppenheim C, Donnan GA, Roos YBWEM, Shankar J, Lingsma H, Bonafé A, Raoult H, Hernández-Pérez M, Bharatha A, Jahan R, Jansen O, Richard S, Levy EI, Berkhemer OA, Soudant M, Aja L, Davis SM, Krings T, Tisserand M, San Román L, Tomasello A, Beumer D, Brown S, Liebeskind DS, Bracard S, Muir KW, Dippel DWJ, Goyal M, Saver JL, Jovin TG, Hill MD, Mitchell PJ,

Lancet Neurol. 2018 Nov 6;:

Volumetric and Spatial Accuracy of Computed Tomography Perfusion Estimated Ischemic Core Volume in Patients With Acute Ischemic Stroke.

Hoving JW, Marquering HA, Majoie CBLM, Yassi N, Sharma G, Liebeskind DS, van der Lugt A, Roos YB, van Zwam W, van Oostenbrugge RJ, Goyal M, Saver JL, Jovin TG, Albers GW, Davalos A, Hill MD, Demchuk AM, Bracard S, Guillemin F, Muir KW, White P, Mitchell PJ, Donnan GA, Davis SM, Campbell BCV

Stroke. 2018 Oct;49(10):2368-2375

Treatment of active rheumatoid arthritis: comparison of patients younger vs older than 75 years (CORPUS cohort).

Oishi S, Wendling D, Sibilia J, Job-Deslandre C, Guillevin L, Benichou J, Flipo RM, Duquenne C, Guillemin F, Saraux A

Hum Vaccin Immunother. 2018 Sep 19;:

eTICI reperfusion: defining success in endovascular stroke therapy.

Liebeskind DS, Bracard S, Guillemin F, Jahan R, Jovin TG, Majoie CB, Mitchell PJ, van der Lugt A, Menon BK, San Román L, Campbell BC, Muir KW, Hill MD, Dippel DW, Saver JL, Demchuk AM, Dávalos A, White P, Brown S, Goyal M,

J Neurointerv Surg. 2018 Sep 7;:

Prognostic factors of colostomy free survival in patients presenting with locally advanced anal canal carcinoma: A pooled analysis of two prospective trials (KANAL 2 and ACCORD 03).

Faivre JC, Peiffert D, Vendrely V, Lemanski C, Hannoun-Levi JM, Mirabel X, Stanbury T, Salleron J, Guillemin F

Radiother Oncol. 2018 Aug 29;:

Development of a Web-Based Formative Self-Assessment Tool for Physicians to Practice Breaking Bad News (BRADNET).

Rat AC, Ricci L, Guillemin F, Ricatte C, Pongy M, Vieux R, Spitz E, Muller L

JMIR Med Educ. 2018 Jul 19;4(2):e17

Clinical follow-up of 411 relapsing and progressive patients with multiple sclerosis 10 years after discontinuing mitoxantrone treatment: a real-life cohort study.

Chartier N, Epstein J, Soudant M, Dahan C, Michaud M, Pittion-Vouyovitch S, Guillemin F, Debouverie M, Mathey G

Eur. J. Neurol.. 2018 Jul 11;:

Can the e-OAKHQOL be an alternative to measure health-related quality of life in knee osteoarthritis?

Wieczorek M, Rotonda C, Epstein J, Guillemin F, Rat AC

Qual Life Res. 2018 Jun 12;:

Phrasing of the patient global assessment in the rheumatoid arthritis ACR/EULAR remission criteria: an analysis of 967 patients from two databases of early and established rheumatoid arthritis patients.

Gossec L, Kirwan JR, de Wit M, Balanescu A, Gaujoux-Viala C, Guillemin F, Rat AC, Saraux A, Fautrel B, Kvien TK, Dougados M,

Clin. Rheumatol.. 2018 Jun;37(6):1503-1510

Prevalence of Rheumatoid Arthritis and Spondyloarthritis in Turkey: A Nationwide Study.

Tuncer T, Gilgil E, Kaçar C, Kurtaiş Y, Kutlay Ş, Bütün B, Yalçin P, Akarirmak Ü, Altan L, Ardiç F, Ardiçoğlu Ö, Altay Z, Cantürk F, Cerrahoğlu L, Çevik R, Demir H, Durmaz B, Dursun N, Duruöz T, Erdoğan C, Evcik D, Gürsoy S, Hizmetli S, Kaptanoğlu E, Kayhan Ö, Kirnap M, Kokino S, Kozanoğlu E, Kuran B, Nas K, Öncel S, Sindel D, Orkun S, Sarpel T, Savaş S, Şendur ÖF, Şenel K, Uğurlu H, Uzunca K, Tekeoğlu İ, Guillemin F

Arch Rheumatol. 2018 Jun;33(2):128-136

Qualitative Methods Used to Generate Questionnaire Items: A Systematic Review.

Ricci L, Lanfranchi JB, Lemetayer F, Rotonda C, Guillemin F, Coste J, Spitz E

Qual Health Res. 2018 Jun 1;:1049732318783186

Effect of cumulative exposure to corticosteroid and DMARD on radiographic progression in rheumatoid arthritis: results from the ESPOIR cohort.

Louveau B, De Rycke Y, Lafourcade A, Saraux A, Guillemin F, Tubach F, Fautrel B, Hajage D

Rheumatology (Oxford). 2018 May 22;:

Association of follow-up infarct volume with functional outcome in acute ischemic stroke: a pooled analysis of seven randomized trials.

Boers AMM, Jansen IGH, Beenen LFM, Devlin TG, San Roman L, Heo JH, Ribó M, Brown S, Almekhlafi MA, Liebeskind DS, Teitelbaum J, Lingsma HF, van Zwam WH, Cuadras P, du Mesnil de Rochemont R, Beaumont M, Brown MM, Yoo AJ, van Oostenbrugge RJ, Menon BK, Donnan GA, Mas JL, Roos YBWEM, Oppenheim C, van der Lugt A, Dowling RJ, Hill MD, Davalos A, Moulin T, Agrinier N, Demchuk AM, Lopes DK, Aja Rodríguez L, Dippel DWJ, Campbell BCV, Mitchell PJ, Al-Ajlan FS, Jovin TG, Madigan J, Albers GW, Soize S, Guillemin F, Reddy VK, Bracard S, Blasco J, Muir KW, Nogueira RG, White PM, Goyal M, Davis SM, Marquering HA, Majoie CBLM

J Neurointerv Surg. 2018 Apr 7;:

Prognostic impact of main frailty domain trajectories on 5-year mortality in very old adults: results from the PARTAGE cohort study.

Agrinier N, Erpelding ML, Labat C, Gautier S, Guillemin F, Benetos A

Am. J. Epidemiol.. 2018 Mar 15;:

Outcome After Reperfusion Therapies in Patients With Large Baseline Diffusion-Weighted Imaging Stroke Lesions: A THRACE Trial (Mechanical Thrombectomy After Intravenous Alteplase Versus Alteplase Alone After Stroke) Subgroup Analysis.

Gautheron V, Xie Y, Tisserand M, Raoult H, Soize S, Naggara O, Bourcier R, Richard S, Guillemin F, Bracard S, Oppenheim C

Stroke. 2018 03;49(3):750-753

The impact of physical activity on fatigue and quality of life during and after adjuvant treatment for breast cancer.

Manneville F, Rotonda C, Conroy T, Bonnetain F, Guillemin F, Omorou AY

Cancer. 2018 Feb 15;124(4):797-806

Prevalence of pelvic Paget's disease of bone in France.

Mazières B, Coste J, Euller-Ziegler L, Fardellone P, Fautrel B, Pouchot J, Rat AC, Roux CH, Saraux A, Verrouil E, Guillemin F

Bone. 2018 Feb;107:143-144

Generational changes in multiple sclerosis phenotype in North African immigrants in France: A population-based observational study.

Nardin C, Latarche C, Soudant M, Dahan C, Michaud M, Pittion-Vouyovitch S, Guillemin F, Debouverie M, Mathey G

PLoS ONE. 2018 ;13(3):e0194115

Pretreatment lesional volume impacts clinical outcome and thrombectomy efficacy.

Xie Y, Oppenheim C, Guillemin F, Gautheron V, Gory B, Raoult H, Soize S, Felblinger J, Hossu G, Bracard S,

Ann. Neurol.. 2018 Jan;83(1):178-185

Nephrectomy Complication Is a Risk Factor of Clinically Meaningful Decrease in Health Utility among Living Kidney Donors.

Hosseini K, Omorou AY, Hubert J, Ngueyon Sime W, Ladrière M, Guillemin F

Value Health. 2017 12;20(10):1376-1382

Body composition and clinical symptoms in patients with hip or knee osteoarthritis: Results from the KHOALA cohort.

Jeanmaire C, Mazières B, Verrouil E, Bernard L, Guillemin F, Rat AC

Semin. Arthritis Rheum.. 2017 Oct 18;:

Identifying patterns of adaptation in breast cancer patients with cancer-related fatigue using response shift analyses at subgroup level.

Salmon M, Blanchin M, Rotonda C, Guillemin F, Sébille V

Cancer Med. 2017 Oct;:

Cost-Effectiveness of Thrombectomy in Patients With Acute Ischemic Stroke: The THRACE Randomized Controlled Trial.

Achit H, Soudant M, Hosseini K, Bannay A, Epstein J, Bracard S, Guillemin F,

Stroke. 2017 Sep;:

Content and Construct Validity, Reliability, and Responsiveness of the Rheumatoid Arthritis Flare Questionnaire: OMERACT 2016 Workshop Report.

Bartlett SJ, Barbic SP, Bykerk VP, Choy EH, Alten R, Christensen R, den Broeder A, Fautrel B, Furst DE, Guillemin F, Hewlett S, Leong AL, Lyddiatt A, March L, Montie P, Pohl C, Scholte Voshaar M, Woodworth TG, Bingham CO

J. Rheumatol.. 2017 Aug;:

Older Age at Multiple Sclerosis Onset Is an Independent Factor of Poor Prognosis: A Population-Based Cohort Study.

Guillemin F, Baumann C, Epstein J, Kerschen P, Garot T, Mathey G, Debouverie M,

Neuroepidemiology. 2017 Aug;48(3-4):179-187

Defining Flare in Osteoarthritis of the Hip and Knee: A Systematic Literature Review - OMERACT Virtual Special Interest Group.

Cross M, Dubouis L, Mangin M, Hunter DJ, March L, Hawker G, Guillemin F

J. Rheumatol.. 2017 Jul;:

Kidneys in five year-old preterm-born children: A longitudinal cohort monitoring of renal function.

Vieux R, Gerard M, Roussel A, Sow A, Gatin A, Guillemin F, Hascoet JM

Pediatr. Res.. 2017 Jun;:

An OMERACT Initiative Toward Consensus to Identify and Characterize Candidate Contextual Factors: Report from the Contextual Factors Working Group.

Finger ME, Boonen A, Woodworth TG, Escorpizo R, Christensen R, Nielsen SM, Leong AL, Scholte Voshaar M, Flurey CA, Milman N, Verstappen SM, Alten R, Guillemin F, Kloppenburg M, Beaton DE, Tugwell PS, March LM, Furst DE, Pohl C

J. Rheumatol.. 2017 May;:

Glucocorticoid-sparing effect of first-year anti-TNFα treatment in rheumatoid arthritis (CORPUS Cohort).

Duquenne C, Wendling D, Sibilia J, Job-Deslandre C, Guillevin L, Benichou J, Flipo RM, Guillemin F, Saraux A

Clin. Exp. Rheumatol.. 2017 May;:

Emerging Guidelines for Patient Engagement in Research.

Kirwan JR, de Wit M, Frank L, Haywood KL, Salek S, Brace-McDonnell S, Lyddiatt A, Barbic SP, Alonso J, Guillemin F, Bartlett SJ

Value Health. 2017 Mar;20(3):481-486

OMERACT Quality-adjusted Life-years (QALY) Working Group: Do Current QALY Measures Capture What Matters to Patients?

Trenaman L, Boonen A, Guillemin F, Hiligsmann M, Hoens A, Marra C, Taylor W, Barton J, Tugwell P, Wells G, Bansback N

J. Rheumatol.. 2017 Mar;:

Health Equity Considerations for Developing and Reporting Patient-reported Outcomes in Clinical Trials: A Report from the OMERACT Equity Special Interest Group.

Petkovic J, Barton JL, Flurey C, Goel N, Bartels CM, Barnabe C, de Wit MP, Lyddiatt A, Lacaille D, Welch V, Boonen A, Shea B, Christensen R, Maxwell LJ, Campbell W, Jull J, Toupin-April K, Singh JA, Goldsmith CH, Sreih AG, Pohl C, Hofstetter C, Beaton DE, Buchbinder R, Guillemin F, Tugwell PS

J. Rheumatol.. 2017 Feb;:

The presence of cardiovascular disease does not modify the weak impact obesity has on health-related quality of life in patients with hip osteoarthritis in the KHOALA cohort.

Renaudin L, Guillemin F, Pouchot J, Rat AC

Joint Bone Spine. 2017 Feb;:

Validation of FLARE-RA, a Self-Administered Tool to Detect Recent or Current Rheumatoid Arthritis Flare.

Fautrel B, Morel J, Berthelot JM, Constantin A, De Bandt M, Gaudin P, Maillefert JF, Meyer O, Pham T, Saraux A, Solau-Gervais E, Vittecoq O, Wendling D, Erpelding ML, Guillemin F,

. 2017 Feb;69(2):309-319

Corrigendum to "Recurrence of suicide attempt in adolescents lost to contact early by clinicians: The 10-year REPEATERS cohort of French adolescents" [Journal of Adolescence 43 (2015) 111-118].

Ligier F, Guillemin F, Angot C, Bourion S, Kabuth B

J Adolesc. 2017 Jan;54:135-136

Incidence of solitary pulmonary nodules in Northeastern France: a population-based study in five regions.

Marrer É, Jolly D, Arveux P, Lejeune C, Woronoff-Lemsi MC, Jégu J, Guillemin F, Velten M

BMC Cancer. 2017 Jan;17(1):47

Cost utility modeling of early vs late total knee replacement in osteoarthritis patients.

Mari K, Dégieux P, Mistretta F, Guillemin F, Richette P

Osteoarthr. Cartil.. 2016 Dec;24(12):2069-2076

Impact of the occurrence of a response shift on the determination of the minimal important difference in a health-related quality of life score over time.

Ousmen A, Conroy T, Guillemin F, Velten M, Jolly D, Mercier M, Causeret S, Cuisenier J, Graesslin O, Hamidou Z, Bonnetain F, Anota A

Health Qual Life Outcomes. 2016 Dec;14(1):167

Cross-cultural and construct validity of the Animated Activity Questionnaire.

Peter WF, Cw de Vet H, Boers M, Harlaar J, Roorda LD, Poolman RW, Ab Scholtes V, Steultjens M, Hendry GJ, Roos EM, Guillemin F, Benedetti MG, Cavazzuti L, Escobar A, Dagfinrud H, Terwee CB

Arthritis Care Res (Hoboken). 2016 Oct;:

Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial.

Bracard S, Ducrocq X, Mas JL, Soudant M, Oppenheim C, Moulin T, Guillemin F,

Lancet Neurol. 2016 10;15(11):1138-47

Economic impact of lower-limb osteoarthritis worldwide: a systematic review of cost-of-illness studies.

Salmon JH, Rat AC, Sellam J, Michel M, Eschard JP, Guillemin F, Jolly D, Fautrel B

Osteoarthr. Cartil.. 2016 Sep;24(9):1500-8

Association between hip morphology and prevalence, clinical severity and progression of hip osteoarthritis over 3 years: The knee and hip osteoarthritis long-term assessment cohort results.

Bouyer B, Mazieres B, Guillemin F, Bouttier R, Fautrel B, Morvan J, Pouchot J, Rat AC, Roux CH, Verrouil E, Saraux A, Coste J,

Joint Bone Spine. 2016 Jul;83(4):432-8

MEDIACONNEX: a multicenter randomised trial based on short message service to reduce suicide attempt recurrence in adolescents.

Ligier F, Kabuth B, Guillemin F

BMC Psychiatry. 2016 Jul;16:251

Prediction of Remission in a French Early Arthritis Cohort by RAPID3 and other Core Data Set Measures, but Not by the Absence of Rheumatoid Factor, Anticitrullinated Protein Antibodies, or Radiographic Erosions.

Castrejón I, Dougados M, Combe B, Fautrel B, Guillemin F, Pincus T

J. Rheumatol.. 2016 Jul;43(7):1285-91

Using the Evaluative Linguistic Framework for Questionnaires to Assess Comprehensibility of Self-Report Health Questionnaires.

Clerehan R, Guillemin F, Epstein J, Buchbinder R

Value Health. 2016 Jun;19(4):335-42

Geographical Heterogeneity of Multiple Sclerosis Prevalence in France.

Pivot D, Debouverie M, Grzebyk M, Brassat D, Clanet M, Clavelou P, Confavreux C, Edan G, Leray E, Moreau T, Vukusic S, Hédelin G, Guillemin F

PLoS ONE. 2016 ;11(12):e0167556

Performance of matrices developed to identify patients with early rheumatoid arthritis with rapid radiographic progression despite methotrexate therapy: an external validation study based on the ESPOIR cohort data.

Granger B, Combe B, Le Loet X, Saraux A, Guillemin F, Fautrel B

RMD Open. 2016 ;2(1):e000245

Femoro-tibial knee osteoarthritis: One or two X-rays? Results from a population-based study.

Roux CH, Mazieres B, Verrouil E, Rat AC, Fardellone P, Fautrel B, Pouchot J, Saraux A, Guillemin F, Euller-Ziegler L, Coste J

Joint Bone Spine. 2015 Oct 28. pii: S1297-319X(15)00189-X

Prevalence of spondyloarthritis in Serbia: a EULAR endorsed study.

Zlatkovic-Svenda MI, Stojanovic RM, Sipetic-Grujicic SB, Radak-Perovic MM, Damjanov NS, Guillemin F

Ann. Rheum. Dis.. 2015 Oct;74(10):1940-2

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Forouzanfar MH, Alexander L, Anderson HR, Bachman VF, Biryukov S, Brauer M, Burnett R, Casey D, Coates MM, Cohen A, Delwiche K, Estep K, Frostad JJ, Kc A, Kyu HH, Moradi-Lakeh M, Ng M, Slepak EL, Thomas BA, Wagner J, Aasvang GM, Abbafati C, Ozgoren AA, Abd-Allah F, Abera SF, Aboyans V, Abraham B, Abraham JP, Abubakar I, Abu-Rmeileh NM, Aburto TC, Achoki T, Adelekan A, Adofo K, Adou AK, Adsuar JC, Afshin A, Agardh EE, Al Khabouri MJ, Al Lami FH, Alam SS, Alasfoor D, Albittar MI, Alegretti MA, Aleman AV, Alemu ZA, Alfonso-Cristancho R, Alhabib S, Ali R, Ali MK, Alla F, Allebeck P, Allen PJ, Alsharif U, Alvarez E, Alvis-Guzman N, Amankwaa AA, Amare AT, Ameh EA, Ameli O, Amini H, Ammar W, Anderson BO, Antonio CA, Anwari P, Cunningham SA, Arnlov J, Arsenijevic VS, Artaman A, Asghar RJ, Assadi R, Atkins LS, Atkinson C, Avila MA, Awuah B, Badawi A, Bahit MC, Bakfalouni T, Balakrishnan K, Balalla S, Balu RK, Banerjee A, Barber RM, Barker-Collo SL, Barquera S, Barregard L, Barrero LH, Barrientos-Gutierrez T, Basto-Abreu AC, Basu A, Basu S, Basulaiman MO, Ruvalcaba CB, Beardsley J, Bedi N, Bekele T, Bell ML, Benjet C, Bennett DA, Benzian H, Bernabe E, Beyene TJ, Bhala N, Bhalla A, Bhutta ZA, Bikbov B, Abdulhak AA, Blore JD, Blyth FM, Bohensky MA, Basara BB, Borges G, Bornstein NM, Bose D, Boufous S, Bourne RR, Brainin M, Brazinova A, Breitborde NJ, Brenner H, Briggs AD, Broday DM, Brooks PM, Bruce NG, Brugha TS, Brunekreef B, Buchbinder R, Bui LN, Bukhman G, Bulloch AG, Burch M, Burney PG, Campos-Nonato IR, Campuzano JC, Cantoral AJ, Caravanos J, Cardenas R, Cardis E, Carpenter DO, Caso V, Castaneda-Orjuela CA, Castro RE, Catala-Lopez F, Cavalleri F, Cavlin A, Chadha VK, Chang JC, Charlson FJ, Chen H, Chen W, Chen Z, Chiang PP, Chimed-Ochir O, Chowdhury R, Christophi CA, Chuang TW, Chugh SS, Cirillo M, Classen TK, Colistro V, Colomar M, Colquhoun SM, Contreras AG, Cooper C, Cooperrider K, Cooper LT, Coresh J, Courville KJ, Criqui MH, Cuevas-Nasu L, Damsere-Derry J, Danawi H, Dandona L, Dandona R, Dargan PI, Davis A, Davitoiu DV, Dayama A, de Castro EF, De la Cruz-Gongora V, De Leo D, de Lima G, Degenhardt L, Del Pozo-Cruz B, Dellavalle RP, Deribe K, Derrett S, Jarlais DC, Dessalegn M, deVeber GA, Devries KM, Dharmaratne SD, Dherani MK, Dicker D, Ding EL, Dokova K, Dorsey ER, Driscoll TR, Duan L, Durrani AM, Ebel BE, Ellenbogen RG, Elshrek YM, Endres M, Ermakov SP, Erskine HE, Eshrati B, Esteghamati A, Fahimi S, Faraon EJ, Farzadfar F, Fay DF, Feigin VL, Feigl AB, Fereshtehnejad SM, Ferrari AJ, Ferri CP, Flaxman AD, Fleming TD, Foigt N, Foreman KJ, Paleo UF, Franklin RC, Gabbe B, Gaffikin L, Gakidou E, Gamkrelidze A, Gankpe FG, Gansevoort RT, Garcia-Guerra FA, Gasana E, Geleijnse JM, Gessner BD, Gething P, Gibney KB, Gillum RF, Ginawi IA, Giroud M, Giussani G, Goenka S, Goginashvili K, Dantes HG, Gona P, de Cosio TG, Gonzalez-Castell D, Gotay CC, Goto A, Gouda HN, Guerrant RL, Gugnani HC, Guillemin F, Gunnell D, Gupta R, Gupta R, Gutierrez RA, Hafezi-Nejad N, Hagan H, Hagstromer M, Halasa YA, Hamadeh RR, Hammami M, Hankey GJ, Hao Y, Harb HL, Haregu TN, Haro JM, Havmoeller R, Hay SI, Hedayati MT, Heredia-Pi IB, Hernandez L, Heuton KR, Heydarpour P, Hijar M, Hoek HW, Hoffman HJ, Hornberger JC, Hosgood HD, Hoy DG, Hsairi M, Hu G, Hu H, Huang C, Huang JJ, Hubbell BJ, Huiart L, Husseini A, Iannarone ML, Iburg KM, Idrisov BT, Ikeda N, Innos K, Inoue M, Islami F, Ismayilova S, Jacobsen KH, Jansen HA, Jarvis DL, Jassal SK, Jauregui A, Jayaraman S, Jeemon P, Jensen PN, Jha V, Jiang F, Jiang G, Jiang Y, Jonas JB, Juel K, Kan H, Roseline SS, Karam NE, Karch A, Karema CK, Karthikeyan G, Kaul A, Kawakami N, Kazi DS, Kemp AH, Kengne AP, Keren A, Khader YS, Khalifa SE, Khan EA, Khang YH, Khatibzadeh S, Khonelidze I, Kieling C, Kim D, Kim S, Kim Y, Kimokoti RW, Kinfu Y, Kinge JM, Kissela BM, Kivipelto M, Knibbs LD, Knudsen AK, Kokubo Y, Kose MR, Kosen S, Kraemer A, Kravchenko M, Krishnaswami S, Kromhout H, Ku T, Defo BK, Bicer BK, Kuipers EJ, Kulkarni C, Kulkarni VS, Kumar GA, Kwan GF, Lai T, Balaji AL, Lalloo R, Lallukka T, Lam H, Lan Q, Lansingh VC, Larson HJ, Larsson A, Laryea DO, Lavados PM, Lawrynowicz AE, Leasher JL, Lee JT, Leigh J, Leung R, Levi M, Li Y, Li Y, Liang J, Liang X, Lim SS, Lindsay MP, Lipshultz SE, Liu S, Liu Y, Lloyd BK, Logroscino G, London SJ, Lopez N, Lortet-Tieulent J, Lotufo PA, Lozano R, Lunevicius R, Ma J, Ma S, Machado VM, MacIntyre MF, Magis-Rodriguez C, Mahdi AA, Majdan M, Malekzadeh R, Mangalam S, Mapoma CC, Marape M, Marcenes W, Margolis DJ, Margono C, Marks GB, Martin RV, Marzan MB, Mashal MT, Masiye F, Mason-Jones AJ, Matsushita K, Matzopoulos R, Mayosi BM, Mazorodze TT, McKay AC, McKee M, McLain A, Meaney PA, Medina C, Mehndiratta MM, Mejia-Rodriguez F, Mekonnen W, Melaku YA, Meltzer M, Memish ZA, Mendoza W, Mensah GA, Meretoja A, Mhimbira FA, Micha R, Miller TR, Mills EJ, Misganaw A, Mishra S, Ibrahim NM, Mohammad KA, Mokdad AH, Mola GL, Monasta L, Hernandez JC, Montico M, Moore AR, Morawska L, Mori R, Moschandreas J, Moturi WN, Mozaffarian D, Mueller UO, Mukaigawara M, Mullany EC, Murthy KS, Naghavi M, Nahas Z, Naheed A, Naidoo KS, Naldi L, Nand D, Nangia V, Narayan KV, Nash D, Neal B, Nejjari C, Neupane SP, Newton CR, Ngalesoni FN, de Dieu Ngirabega J, Nguyen G, Nguyen NT, Nieuwenhuijsen MJ, Nisar MI, Nogueira JR, Nolla JM, Nolte S, Norheim OF, Norman RE, Norrving B, Nyakarahuka L, Oh IH, Ohkubo T, Olusanya BO, Omer SB, Opio JN, Orozco R, Pagcatipunan RS Jr, Pain AW, Pandian JD, Panelo CI, Papachristou C, Park EK, Parry CD, Caicedo AJ, Patten SB, Paul VK, Pavlin BI, Pearce N, Pedraza LS, Pedroza A, Stokic LP, Pekericli A, Pereira DM, Perez-Padilla R, Perez-Ruiz F, Perico N, Perry SA, Pervaiz A, Pesudovs K, Peterson CB, Petzold M, Phillips MR, Phua HP, Plass D, Poenaru D, Polanczyk GV, Polinder S, Pond CD, Pope CA, Pope D, Popova S, Pourmalek F, Powles J, Prabhakaran D, Prasad NM, Qato DM, Quezada AD, Quistberg DA, Racape L, Rafay A, Rahimi K, Rahimi-Movaghar V, Rahman SU, Raju M, Rakovac I, Rana SM, Rao M, Razavi H, Reddy KS, Refaat AH, Rehm J, Remuzzi G, Ribeiro AL, Riccio PM, Richardson L, Riederer A, Robinson M, Roca A, Rodriguez A, Rojas-Rueda D, Romieu I, Ronfani L, Room R, Roy N, Ruhago GM, Rushton L, Sabin N, Sacco RL, Saha S, Sahathevan R, Sahraian MA, Salomon JA, Salvo D, Sampson UK, Sanabria JR, Sanchez LM, Sanchez-Pimienta TG, Sanchez-Riera L, Sandar L, Santos IS, Sapkota A, Satpathy M, Saunders JE, Sawhney M, Saylan MI, Scarborough P, Schmidt JC, Schneider IJ, Schottker B, Schwebel DC, Scott JG, Seedat S, Sepanlou SG, Serdar B, Servan-Mori EE, Shaddick G, Shahraz S, Levy TS, Shangguan S, She J, Sheikhbahaei S, Shibuya K, Shin HH, Shinohara Y, Shiri R, Shishani K, Shiue I, Sigfusdottir ID, Silberberg DH, Simard EP, Sindi S, Singh A, Singh GM, Singh JA, Skirbekk V, Sliwa K, Soljak M, Soneji S, Soreide K, Soshnikov S, Sposato LA, Sreeramareddy CT, Stapelberg NJ, Stathopoulou V, Steckling N, Stein DJ, Stein MB, Stephens N, Stockl H, Straif K, Stroumpoulis K, Sturua L, Sunguya BF, Swaminathan S, Swaroop M, Sykes BL, Tabb KM, Takahashi K, Talongwa RT, Tandon N, Tanne D, Tanner M, Tavakkoli M, Te Ao BJ, Teixeira CM, Tellez Rojo MM, Terkawi AS, Texcalac-Sangrador JL, Thackway SV, Thomson B, Thorne-Lyman AL, Thrift AG, Thurston GD, Tillmann T, Tobollik M, Tonelli M, Topouzis F, Towbin JA, Toyoshima H, Traebert J, Tran BX, Trasande L, Trillini M, Trujillo U, Dimbuene ZT, Tsilimbaris M, Tuzcu EM, Uchendu US, Ukwaja KN, Uzun SB, van de Vijver S, Van Dingenen R, van Gool CH, van Os J, Varakin YY, Vasankari TJ, Vasconcelos AM, Vavilala MS, Veerman LJ, Velasquez-Melendez G, Venketasubramanian N, Vijayakumar L, Villalpando S, Violante FS, Vlassov VV, Vollset SE, Wagner GR, Waller SG, Wallin MT, Wan X, Wang H, Wang J, Wang L, Wang W, Wang Y, Warouw TS, Watts CH, Weichenthal S, Weiderpass E, Weintraub RG, Werdecker A, Wessells KR, Westerman R, Whiteford HA, Wilkinson JD, Williams HC, Williams TN, Woldeyohannes SM, Wolfe CD, Wong JQ, Woolf AD, Wright JL, Wurtz B, Xu G, Yan LL, Yang G, Yano Y, Ye P, Yenesew M, Yentur GK, Yip P, Yonemoto N, Yoon SJ, Younis MZ, Younoussi Z, Yu C, Zaki ME, Zhao Y, Zheng Y, Zhou M, Zhu J, Zhu S, Zou X, Zunt JR, Lopez AD, Vos T, Murray CJ

Lancet. 2015 Sep 10. pii: S0140-6736(15)00128-2

Recurrence of suicide attempt in adolescents lost to contact early by clinicians: The 10-year REPEATERS cohort of French adolescents.

Ligier F, Guillemin F, Angot C, Bourion S, Kabuth B

J Adolesc. 2015 Aug;43:111-8

Type of plasma preparation used for plasma exchange and clinical outcome of adult patients with acquired idiopathic thrombotic thrombocytopenic purpura: a French retrospective multicenter cohort study.

Toussaint-Hacquard M, Coppo P, Soudant M, Chevreux L, Mathieu-Nafissi S, Lecompte T, Gross S, Guillemin F, Schneider T

Transfusion. 2015 Jul 14

Validity of the global anti-phospholipid syndrome score to predict thrombosis: a prospective multicentre cohort study.

Zuily S, de Laat B, Mohamed S, Kelchtermans H, Shums Z, Albesa R, Norman GL, Lamboux-Matthieu C, Rat AC, Ninet J, Magy-Bertrand N, Pasquali JL, Lambert M, Lorcerie B, Kaminsky P, Guillemin F, Regnault V, Wahl D

Rheumatology (Oxford). 2015 Jul 10. pii: kev238.

Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology.

Buch MH, Silva-Fernandez L, Carmona L, Aletaha D, Christensen R, Combe B, Emery P, Ferraccioli G, Guillemin F, Kvien TK, Landewe R, Pavelka K, Saag K, Smolen JS, Symmons D, van der Heijde D, Welling J, Wells G, Westhovens R, Zink A, Boers M

Ann Rheum Dis. 2015 Jun;74(6):963-9

The Mini-OAKHQOL for knee and hip osteoarthritis quality of life was obtained following recent shortening guidelines.

Guillemin F, Rat AC, Goetz C, Spitz E, Pouchot J, Coste J

J Clin Epidemiol. 2015 Jun 22. pii: S0895-4356(15)00313-3

Toward Ensuring Health Equity: Readability and Cultural Equivalence of OMERACT Patient-reported Outcome Measures.

Petkovic J, Epstein J, Buchbinder R, Welch V, Rader T, Lyddiatt A, Clerehan R, Christensen R, Boonen A, Goel N, Maxwell LJ, Toupin-April K, De Wit M, Barton J, Flurey C, Jull J, Barnabe C, Sreih AG, Campbell W, Pohl C, Duruoz MT, Singh JA, Tugwell PS, Guillemin F

J Rheumatol. 2015 Jun 15. pii: jrheum.141168.

Responsiveness of the 36-item Short Form Health Survey and the Lupus Quality of Life questionnaire in SLE.

Devilliers H, Amoura Z, Besancenot JF, Bonnotte B, Pasquali JL, Wahl D, Maurier F, Kaminsky P, Pennaforte JL, Magy-Bertrand N, Arnaud L, Binquet C, Guillemin F, Bonithon-Kopp C

Rheumatology (Oxford). 2015 May;54(5):940-9

A review of guidelines for cross-cultural adaptation of questionnaires could not bring out a consensus.

Epstein J, Santo RM, Guillemin F

J Clin Epidemiol. 2015 Apr;68(4):435-41

Cross-cultural adaptation of the Health Education Impact Questionnaire: experimental study showed expert committee, not back-translation, added value.

Epstein J, Osborne RH, Elsworth GR, Beaton DE, Guillemin F

J Clin Epidemiol. 2015 Apr;68(4):360-9

Development of a Draft Core Set of Domains for Measuring Shared Decision Making in Osteoarthritis: An OMERACT Working Group on Shared Decision Making.

Toupin-April K, Barton J, Fraenkel L, Li L, Grandpierre V, Guillemin F, Rader T, Stacey D, Legare F, Jull J, Petkovic J, Scholte-Voshaar M, Welch V, Lyddiatt A, Hofstetter C, De Wit M, March L, Meade T, Christensen R, Gaujoux-Viala C, Suarez-Almazor ME, Boonen A, Pohl C, Martin R, Tugwell PS

J Rheumatol. 2015 Apr 15. pii: jrheum.141205.

Impairment of quality of life in patients with antiphospholipid syndrome.

Zuily S, Rat AC, Regnault V, Kaminsky P, Mismetti P, Ninet J, Baillet N, Magy-Bertrand N, Pasquali JL, Lambert M, Pasquier E, Lorcerie B, Lecompte T, Guillemin F, Wahl D

Lupus. 2015 Apr 10. pii: 0961203315580871.

School-based suicide prevention programmes: the SEYLE cluster-randomised, controlled trial.

Wasserman D, Hoven CW, Wasserman C, Wall M, Eisenberg R, Hadlaczky G, Kelleher I, Sarchiapone M, Apter A, Balazs J, Bobes J, Brunner R, Corcoran P, Cosman D, Guillemin F, Haring C, Iosue M, Kaess M, Kahn JP, Keeley H, Musa GJ, Nemes B, Postuvan V, Saiz P, Reiter-Theil S, Varnik A, Varnik P, Carli V

Lancet. 2015 Apr 18;385(9977):1536-44

RespOnse Shift ALgorithm in Item response theory (ROSALI) for response shift detection with missing data in longitudinal patient-reported outcome studies.

Guilleux A, Blanchin M, Vanier A, Guillemin F, Falissard B, Schwartz CE, Hardouin JB, Sebille V

Qual Life Res. 2015 Mar;24(3):553-64

The EULAR Outcome Measures Library: development and an example from a systematic review for systemic lupus erythematous instruments.

Castrejon I, Carmona L, Agrinier N, Andres M, Briot K, Caron M, Christensen R, Consolaro A, Curbelo R, Ferrer M, Foltz V, Gonzalez C, Guillemin F, Machado PM, Prodinger B, Ravelli A, Scholte-Voshaar M, Uhlig T, van Tuyl LH, Zink A, Gossec L

Clin Exp Rheumatol. 2015 Mar 23.

Assessment of quality-of-life outcomes after surgery for nasal polyposis with the DyNaChron questionnaire.

Nguyen DT, Guillemin F, Arous F, Jankowski R

Eur Arch Otorhinolaryngol. 2015 Feb;272(2):367-75

Feasibility and Domain Validation of Rheumatoid Arthritis (RA) Flare Core Domain Set: Report of the OMERACT 2014 RA Flare Group Plenary.

Bartlett SJ, Bykerk VP, Cooksey R, Choy EH, Alten R, Christensen R, Furst DE, Guillemin F, Halls S, Hewlett S, Leong AL, Lyddiatt A, March L, Montie P, Orbai AM, Pohl C, Scholte Voshaar M, Woodworth TG, Bingham CO 3rd

J Rheumatol. 2015 Feb 15. pii: jrheum.141169.

Development and preliminary testing of a computerized animated activity questionnaire in patients with hip and knee osteoarthritis.

Peter WF, Loos M, de Vet HC, Boers M, Harlaar J, Roorda LD, Poolman RW, Scholtes VA, Boogaard J, Buitelaar H, Steultjens M, Roos EM, Guillemin F, Rat AC, Benedetti MG, Escobar A, Osteras N, Terwee CB

Arthritis Care Res (Hoboken). 2015 Jan;67(1):32-9

No prognostic value of routine cerebrospinal fluid biomarkers in a population-based cohort of 407 multiple sclerosis patients.

Becker M, Latarche C, Roman E, Debouverie M, Malaplate-Armand C, Guillemin F

BMC Neurol. 2015 May 13;15:79

A reference case for economic evaluations in osteoarthritis: an expert consensus article from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).

Hiligsmann M, Cooper C, Guillemin F, Hochberg MC, Tugwell P, Arden N, Berenbaum F, Boers M, Boonen A, Branco JC, Maria-Luisa B, Bruyere O, Gasparik A, Kanis JA, Kvien TK, Martel-Pelletier J, Pelletier JP, Pinedo-Villanueva R, Pinto D, Reiter-Niesert S, Rizzoli R, Rovati LC, Severens JL, Silverman S, Reginster JY

Semin Arthritis Rheum. 2014 Dec;44(3):271-82

An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).

Bruyere O, Cooper C, Pelletier JP, Branco J, Luisa Brandi M, Guillemin F, Hochberg MC, Kanis JA, Kvien TK, Martel-Pelletier J, Rizzoli R, Silverman S, Reginster JY

Semin Arthritis Rheum. 2014 Dec;44(3):253-63

Chronic urinary obstruction: evaluation of dynamic contrast-enhanced MR urography for measurement of split renal function.

Claudon M, Durand E, Grenier N, Prigent A, Balvay D, Chaumet-Riffaud P, Chaumoitre K, Cuenod CA, Filipovic M, Galloy MA, Lemaitre L, Mandry D, Micard E, Pasquier C, Sebag GH, Soudant M, Vuissoz PA, Guillemin F

Radiology. 2014 Dec;273(3):801-12

Work productivity loss in early arthritis during the first 3 years of disease: a study from a French National Multicenter Cohort.

Dadoun S, Guillemin F, Lucier S, Looten V, Saraux A, Berenbaum F, Durand-Zaleski I, Chevreul K, Fautrel B

Arthritis Care Res (Hoboken). 2014 Sep;66(9):1310-8

Facilitators to implement standards of care for rheumatoid arthritis and osteoarthritis: the EUMUSC.NET project.

Moe RH, Petersson IF, Carmona L, Greiff R, Guillemin F, Udrea G, Loza E, Stoffer MA, de Wit M, Wiek D, Vliet Vlieland T, Woolf AD, Uhlig T

Ann Rheum Dis. 2014 Aug;73(8):1545-8

Impact of mode of delivery on the birth experience in first-time mothers: a qualitative study.

Guittier MJ, Cedraschi C, Jamei N, Boulvain M, Guillemin F

BMC Pregnancy Childbirth. 2014 Aug 1;14(1):254.

The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study.

Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M, Bridgett L, Williams S, Guillemin F, Hill CL, Laslett LL, Jones G, Cicuttini F, Osborne R, Vos T, Buchbinder R, Woolf A, March L

Ann Rheum Dis. 2014 Jul;73(7):1323-30

Determinants of MSK health and disability--social determinants of inequities in MSK health.

Guillemin F, Carruthers E, Li LC

Best Pract Res Clin Rheumatol. 2014 Jun;28(3):411-33

Patterns of systemic lupus erythematosus expression in Europe.

Cervera R, Doria A, Amoura Z, Khamashta M, Schneider M, Guillemin F, Maurel F, Garofano A, Roset M, Perna A, Murray M, Schmitt C, Boucot I

Autoimmun Rev. 2014 Jun;13(6):621-9

Assessing health-related quality of life in patients with heart failure: a systematic, standardized comparison of available measures.

Garin O, Herdman M, Vilagut G, Ferrer M, Ribera A, Rajmil L, Valderas JM, Guillemin F, Revicki D, Alonso J

Heart Fail Rev. 2014 May;19(3):359-67

Prevalence of rheumatoid arthritis in Serbia.

Zlatkovic-Svenda MI, Stojanovic RM, B Sipetic-Grujicic S, Guillemin F

Rheumatol Int. 2014 May;34(5):649-58

Updating the OMERACT filter: core areas as a basis for defining core outcome sets.

Kirwan JR, Boers M, Hewlett S, Beaton D, Bingham CO 3rd, Choy E, Conaghan PG, D'Agostino MA, Dougados M, Furst DE, Guillemin F, Gossec L, van der Heijde DM, Kloppenburg M, Kvien TK, Landewe RB, Mackie SL, Matteson EL, Mease PJ, Merkel PA, Ostergaard M, Saketkoo LA, Simon L, Singh JA, Strand V, Tugwell P

J Rheumatol. 2014 May;41(5):994-9

Updating the OMERACT filter: discrimination and feasibility.

Wells G, Beaton DE, Tugwell P, Boers M, Kirwan JR, Bingham CO 3rd, Boonen A, Brooks P, Conaghan PG, D'Agostino MA, Dougados M, Furst DE, Gossec L, Guillemin F, Helliwell P, Hewlett S, Kvien TK, Landewe RB, March L, Mease PJ, Ostergaard M, Simon L, Singh JA, Strand V, van der Heijde DM

J Rheumatol. 2014 May;41(5):1005-10

Updating the OMERACT filter: implications for imaging and soluble biomarkers.

D'Agostino MA, Boers M, Kirwan J, van der Heijde D, Ostergaard M, Schett G, Landewe RB, Maksymowych WP, Naredo E, Dougados M, Iagnocco A, Bingham CO 3rd, Brooks PM, Beaton DE, Gandjbakhch F, Gossec L, Guillemin F, Hewlett SE, Kloppenburg M, March L, Mease PJ, Moller I, Simon LS, Singh JA, Strand V, Wakefield RJ, Wells GA, Tugwell P, Conaghan PG

J Rheumatol. 2014 May;41(5):1016-24

Updating the OMERACT filter: implications for patient-reported outcomes.

Kirwan JR, Bartlett SJ, Beaton DE, Boers M, Bosworth A, Brooks PM, Choy E, de Wit M, Guillemin F, Hewlett S, Kvien TK, Landewe RB, Leong AL, Lyddiatt A, March L, May J, Montie PL, Nikai E, Richards P, Voshaar MM, Smeets W, Strand V, Tugwell P, Gossec L

J Rheumatol. 2014 May;41(5):1011-5

Updating the OMERACT filter: implications of filter 2.0 to select outcome instruments through assessment of "truth": content, face, and construct validity.

Tugwell P, Boers M, D'Agostino MA, Beaton D, Boonen A, Bingham CO 3rd, Choy E, Conaghan PG, Dougados M, Duarte C, Furst DE, Guillemin F, Gossec L, Heiberg T, van der Heijde DM, Hewlett S, Kirwan JR, Kvien TK, Landewe RB, Mease PJ, Ostergaard M, Simon L, Singh JA, Strand V, Wells G

J Rheumatol. 2014 May;41(5):1000-4

The minimal clinically important difference determined using item response theory models: an attempt to solve the issue of the association with baseline score.

Rouquette A, Blanchin M, Sebille V, Guillemin F, Cote SM, Falissard B, Hardouin JB

J Clin Epidemiol. 2014 Apr;67(4):433-40

Prevalence and incidence of juvenile idiopathic arthritis: a systematic review.

Thierry S, Fautrel B, Lemelle I, Guillemin F

Joint Bone Spine. 2014 Mar;81(2):112-7

Statistical challenges of quality of life and cancer: new avenues for future research.

Boyer L, Baumstarck K, Michel P, Boucekine M, Anota A, Bonnetain F, Coste J, Falissard B, Guilleux A, Hardouin JB, Loundou A, Mercier M, Mesbah M, Rouquette A, Sebille V, Verdam MG, Ghattas B, Guillemin F, Auquier P

Expert Rev Pharmacoecon Outcomes Res. 2014 Feb;14(1):19-22

A simple ratio-based approach for power and sample size determination for 2-group comparison using Rasch models.

Sebille V, Blanchin M, Guillemin F, Falissard B, Hardouin JB

BMC Med Res Methodol. 2014 Jul 5;14:87

Annual direct medical cost of active systemic lupus erythematosus in five European countries.

Doria A, Amoura Z, Cervera R, Khamastha MA, Schneider M, Richter J, Guillemin F, Kobelt G, Maurel F, Garofano A, Perna A, Murray M, Schmitt C, Boucot I

Ann Rheum Dis. 2014 Jan;73(1):154-60

Evolution of direct costs in the first years of rheumatoid arthritis: impact of early versus late biologic initiation--an economic analysis based on the ESPOIR cohort.

Chevreul K, Haour G, Lucier S, Harvard S, Laroche ML, Mariette X, Saraux A, Durand-Zaleski I, Guillemin F, Fautrel B

PLoS One. 2014 May 8;9(5):e97077

Impact of response shift on time to deterioration in quality of life scores in breast cancer patients.

Hamidou Z, Dabakuyo-Yonli TS, Guillemin F, Conroy T, Velten M, Jolly D, Causeret S, Graesslin O, Gauthier M, Mercier M, Bonnetain F

PLoS One. 2014 May 14;9(5):e96848

Including health equity considerations in development of instruments for rheumatology research: an introduction to a novel OMERACT paradigm.

O'Neill J, Rader T, Guillemin F, Boonen A, Christensen R, Lyddiatt A, Pardo JP, Welch V, Singh JA, Tugwell P

J Rheumatol. 2014 Jan;41(1):150-2

Item response theory and factor analysis as a mean to characterize occurrence of response shift in a longitudinal quality of life study in breast cancer patients.

Anota A, Bascoul-Mollevi C, Conroy T, Guillemin F, Velten M, Jolly D, Mercier M, Causeret S, Cuisenier J, Graesslin O, Hamidou Z, Bonnetain F

Health Qual Life Outcomes. 2014 Mar 8;12:32

Quality of life after the initial treatments of non-small cell lung cancer: a persistent predictor for patients' survival.

Lemonnier I, Guillemin F, Arveux P, Clement-Duchene C, Velten M, Woronoff-Lemsi MC, Jolly D, Baumann C

Health Qual Life Outcomes. 2014 May 15;12:73

Recommendations of the French Society for Rheumatology (SFR) on the everyday management of patients with spondyloarthritis.

Wendling D, Lukas C, Paccou J, Claudepierre P, Carton L, Combe B, Goupille P, Guillemin F, Hudry C, Miceli-Richard C, Dougados M

Joint Bone Spine. 2014 Jan;81(1):6-14

Fear of falling, fracture history, and comorbidities are associated with health-related quality of life among European and US women with osteoporosis in a large international study.

Guillemin F, Martinez L, Calvert M, Cooper C, Ganiats T, Gitlin M, Horne R, Marciniak A, Pfeilschifter J, Shepherd S, Tosteson A, Wade S, Macarios D, Freemantle N

Osteoporos Int. 2013 Dec;24(12):3001-10

Health economics in the field of osteoarthritis: an expert's consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).

Hiligsmann M, Cooper C, Arden N, Boers M, Branco JC, Luisa Brandi M, Bruyère O, Guillemin F, Hochberg MC, Hunter DJ, Kanis JA, Kvien TK, Laslop A, Pelletier JP, Pinto D, Reiter-Niesert S, Rizzoli R, Rovati LC, Severens JL, Silverman S, Tsouderos Y, Tugwell P, Reginster JY

Semin. Arthritis Rheum.. 2013 Dec;43(3):303-13

Five-year favorable outcome of patients with early rheumatoid arthritis in the 2000s: data from the ESPOIR cohort.

Combe B, Rincheval N, Benessiano J, Berenbaum F, Cantagrel A, Daures JP, Dougados M, Fardellone P, Fautrel B, Flipo RM, Goupille P, Guillemin F, Le Loet X, Logeart I, Mariette X, Meyer O, Ravaud P, Saraux A, Schaeverbeke T, Sibilia J

J Rheumatol. 2013 Oct;40(10):1650-7

Hypnosis for the control of pain associated with external cephalic version: a comparative study.

Guittier MJ, Guillemin F, Farinelli EB, Irion O, Boulvain M, de Tejada BM

J Altern Complement Med. 2013 Oct;19(10):820-5

Relationship between hip dysplasia, pain, and osteoarthritis in a cohort of patients with hip symptoms.

Morvan J, Bouttier R, Mazieres B, Verrouil E, Pouchot J, Rat AC, Guellec D, Guillemin F, Coste J, Saraux A

J Rheumatol. 2013 Sep;40(9):1583-9

Social determinants of health-related quality of life.

Kivits J, Erpelding ML, Guillemin F

Rev Epidemiol Sante Publique. 2013 Aug;61 Suppl 3:S189-94

Item reduction based on rigorous methodological guidelines is necessary to maintain validity when shortening composite measurement scales.

Goetz C, Coste J, Lemetayer F, Rat AC, Montel S, Recchia S, Debouverie M, Pouchot J, Spitz E, Guillemin F

J Clin Epidemiol. 2013 Jul;66(7):710-8

Who are the patients with early arthritis with worse than death scores on the EQ-5D? Results from the ESPOIR cohort.

Gaujoux-Viala C, Fautrel B, Guillemin F, Flipo RM, Bourgeois P, Rat AC

Rheumatology (Oxford). 2013 May;52(5):832-8

Can remission in rheumatoid arthritis be assessed without laboratory tests or a formal joint count? possible remission criteria based on a self-report RAPID3 score and careful joint examination in the ESPOIR cohort.

Castrejon I, Dougados M, Combe B, Guillemin F, Fautrel B, Pincus T

J Rheumatol. 2013 Apr;40(4):386-93

Estimating the prevalence of systemic sclerosis in the Lorraine region, France, by the capture-recapture method.

El Adssi H, Cirstea D, Virion JM, Guillemin F, de Korwin JD

Semin Arthritis Rheum. 2013 Apr;42(5):530-8

Validation of a self-administered inflammatory arthritis detection tool for rheumatology triage.

Tavares R, Wells GA, Bykerk VP, Guillemin F, Tugwell P, Bell MJ

J Rheumatol. 2013 Apr;40(4):417-24

Prognostic value of early therapeutic alliance in weight recovery: a prospective cohort of 108 adolescents with anorexia nervosa.

Bourion-Bedes S, Baumann C, Kermarrec S, Ligier F, Feillet F, Bonnemains C, Guillemin F, Kabuth B

J Adolesc Health. 2013 Mar;52(3):344-50

Response shift effects on measuring post-operative quality of life among breast cancer patients: a multicenter cohort study.

Dabakuyo TS, Guillemin F, Conroy T, Velten M, Jolly D, Mercier M, Causeret S, Cuisenier J, Graesslin O, Gauthier M, Bonnetain F

Qual Life Res. 2013 Feb;22(1):1-11

AST classification of proximal humeral fractures: introduction and interobserver reliability assessment.

Cuny C, Baumann C, Mayer J, Guignand D, Irrazi M, Berrichi A, Ionescu N, Guillemin F

Eur J Orthop Surg Traumatol. 2013 Jan;23(1):35-40

Cost-effectiveness of osteoporosis treatments in postmenopausal women using FRAX thresholds for decision.

Alzahouri K, Bahrami S, Durand-Zaleski I, Guillemin F, Roux C

Joint Bone Spine. 2013 Jan;80(1):64-9

Factors associated with fatigue after surgery in women with early-stage invasive breast cancer.

Rotonda C, Guillemin F, Bonnetain F, Velten M, Conroy T

Oncologist. 2013;18(4):467-75

Power and sample size determination for the group comparison of patient-reported outcomes with Rasch family models.

Blanchin M, Hardouin JB, Guillemin F, Falissard B, Sebille V

PLoS One. 2013;8(2):e57279

Reproducibility of radiographic hip measurements in adults.

Bouttier R, Morvan J, Mazieres B, Rat AC, Ziegler LE, Fardellone P, Fautrel B, Guillemin F, Pouchot J, Roux C, Coste J, Saraux A

Joint Bone Spine. 2013 Jan;80(1):52-6

Target organ damage assessment in French hypertensive patients without established cardiovascular or renal disease: results of the PREVENT-A study.

Rossignol P, Hosseini K, Tropeano AI, Fay R, Tsatsaris A, Guillemin F, Mounier-Vehier C

J Hypertens. 2013 Jan;31(1):177-85

The relationship between traits optimism and anxiety and health-related quality of life in patients hospitalized for chronic diseases: data from the SATISQOL study.

Kepka S, Baumann C, Anota A, Buron G, Spitz E, Auquier P, Guillemin F, Mercier M

Health Qual Life Outcomes. 2013 Aug 5;11(1):134

The saving and empowering young lives in Europe (SEYLE) randomized controlled trial (RCT): methodological issues and participant characteristics.

Carli V, Wasserman C, Wasserman D, Sarchiapone M, Apter A, Balazs J, Bobes J, Brunner R, Corcoran P, Cosman D, Guillemin F, Haring C, Kaess M, Kahn JP, Keeley H, Kereszteny A, Iosue M, Mars U, Musa G, Nemes B, Postuvan V, Reiter-Theil S, Saiz P, Varnik P, Varnik A, Hoven CW

BMC Public Health. 2013 May 16;13:479

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.

Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J, Ackerman I, Aggarwal R, Ahn SY, Ali MK, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Bahalim AN, Barker-Collo S, Barrero LH, Bartels DH, Basanez MG, Baxter A, Bell ML, Benjamin EJ, Bennett D, Bernabe E, Bhalla K, Bhandari B, Bikbov B, Bin Abdulhak A, Birbeck G, Black JA, Blencowe H, Blore JD, Blyth F, Bolliger I, Bonaventure A, Boufous S, Bourne R, Boussinesq M, Braithwaite T, Brayne C, Bridgett L, Brooker S, Brooks P, Brugha TS, Bryan-Hancock C, Bucello C, Buchbinder R, Buckle G, Budke CM, Burch M, Burney P, Burstein R, Calabria B, Campbell B, Canter CE, Carabin H, Carapetis J, Carmona L, Cella C, Charlson F, Chen H, Cheng AT, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahiya M, Dahodwala N, Damsere-Derry J, Danaei G, Davis A, De Leo D, Degenhardt L, Dellavalle R, Delossantos A, Denenberg J, Derrett S, Des Jarlais DC, Dharmaratne SD, Dherani M, Diaz-Torne C, Dolk H, Dorsey ER, Driscoll T, Duber H, Ebel B, Edmond K, Elbaz A, Ali SE, Erskine H, Erwin PJ, Espindola P, Ewoigbokhan SE, Farzadfar F, Feigin V, Felson DT, Ferrari A, Ferri CP, Fevre EM, Finucane MM, Flaxman S, Flood L, Foreman K, Forouzanfar MH, Fowkes FG, Fransen M, Freeman MK, Gabbe BJ, Gabriel SE, Gakidou E, Ganatra HA, Garcia B, Gaspari F, Gillum RF, Gmel G, Gonzalez-Medina D, Gosselin R, Grainger R, Grant B, Groeger J, Guillemin F, Gunnell D, Gupta R, Haagsma J, Hagan H, Halasa YA, Hall W, Haring D, Haro JM, Harrison JE, Havmoeller R, Hay RJ, Higashi H, Hill C, Hoen B, Hoffman H, Hotez PJ, Hoy D, Huang JJ, Ibeanusi SE, Jacobsen KH, James SL, Jarvis D, Jasrasaria R, Jayaraman S, Johns N, Jonas JB, Karthikeyan G, Kassebaum N, Kawakami N, Keren A, Khoo JP, King CH, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Laden F, Lalloo R, Laslett LL, Lathlean T, Leasher JL, Lee YY, Leigh J, Levinson D, Lim SS, Limb E, Lin JK, Lipnick M, Lipshultz SE, Liu W, Loane M, Ohno SL, Lyons R, Mabweijano J, MacIntyre MF, Malekzadeh R, Mallinger L, Manivannan S, Marcenes W, March L, Margolis DJ, Marks GB, Marks R, Matsumori A, Matzopoulos R, Mayosi BM, McAnulty JH, McDermott MM, McGill N, McGrath J, Medina-Mora ME, Meltzer M, Mensah GA, Merriman TR, Meyer AC, Miglioli V, Miller M, Miller TR, Mitchell PB, Mock C, Mocumbi AO, Moffitt TE, Mokdad AA, Monasta L, Montico M, Moradi-Lakeh M, Moran A, Morawska L, Mori R, Murdoch ME, Mwaniki MK, Naidoo K, Nair MN, Naldi L, Narayan KM, Nelson PK, Nelson RG, Nevitt MC, Newton CR, Nolte S, Norman P, Norman R, O'Donnell M, O'Hanlon S, Olives C, Omer SB, Ortblad K, Osborne R, Ozgediz D, Page A, Pahari B, Pandian JD, Rivero AP, Patten SB, Pearce N, Padilla RP, Perez-Ruiz F, Perico N, Pesudovs K, Phillips D, Phillips MR, Pierce K, Pion S, Polanczyk GV, Polinder S, Pope CA 3rd, Popova S, Porrini E, Pourmalek F, Prince M, Pullan RL, Ramaiah KD, Ranganathan D, Razavi H, Regan M, Rehm JT, Rein DB, Remuzzi G, Richardson K, Rivara FP, Roberts T, Robinson C, De Leon FR, Ronfani L, Room R, Rosenfeld LC, Rushton L, Sacco RL, Saha S, Sampson U, Sanchez-Riera L, Sanman E, Schwebel DC, Scott JG, Segui-Gomez M, Shahraz S, Shepard DS, Shin H, Shivakoti R, Singh D, Singh GM, Singh JA, Singleton J, Sleet DA, Sliwa K, Smith E, Smith JL, Stapelberg NJ, Steer A, Steiner T, Stolk WA, Stovner LJ, Sudfeld C, Syed S, Tamburlini G, Tavakkoli M, Taylor HR, Taylor JA, Taylor WJ, Thomas B, Thomson WM, Thurston GD, Tleyjeh IM, Tonelli M, Towbin JA, Truelsen T, Tsilimbaris MK, Ubeda C, Undurraga EA, van der Werf MJ, van Os J, Vavilala MS, Venketasubramanian N, Wang M, Wang W, Watt K, Weatherall DJ, Weinstock MA, Weintraub R, Weisskopf MG, Weissman MM, White RA, Whiteford H, Wiebe N, Wiersma ST, Wilkinson JD, Williams HC, Williams SR, Witt E, Wolfe F, Woolf AD, Wulf S, Yeh PH, Zaidi AK, Zheng ZJ, Zonies D, Lopez AD, AlMazroa MA, Memish ZA

Lancet. 2012 Dec 15;380(9859):2197-223

One-year outcome after a first clinically possible epileptic seizure: predictive value of clinical classification and early EEG.

Maillard L, Jonas J, Boyer R, Frismand S, Mathey G, Vignal JP, Guillemin F, Maignan M, Vespignani H

Neurophysiol Clin. 2012 Dec;42(6):355-62

Prevalence of pathological internet use among adolescents in Europe: demographic and social factors.

Durkee T, Kaess M, Carli V, Parzer P, Wasserman C, Floderus B, Apter A, Balazs J, Barzilay S, Bobes J, Brunner R, Corcoran P, Cosman D, Cotter P, Despalins R, Graber N, Guillemin F, Haring C, Kahn JP, Mandelli L, Marusic D, Meszaros G, Musa GJ, Postuvan V, Resch F, Saiz PA, Sisask M, Varnik A, Sarchiapone M, Hoven CW, Wasserman D

Addiction. 2012 Dec;107(12):2210-22

Recourse to alternative medicine during pregnancy: motivations of women and impact of research findings.

Guittier MJ, Pichon M, Irion O, Guillemin F, Boulvain M

J Altern Complement Med. 2012 Dec;18(12):1147-53

The KHOALA cohort of knee and hip osteoarthritis in France.

Guillemin F, Rat AC, Roux CH, Fautrel B, Mazieres B, Chevalier X, Euller-Ziegler L, Fardellone P, Verrouil E, Morvan J, Pouchot J, Coste J, Saraux A

Joint Bone Spine. 2012 Dec;79(6):597-603

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.

Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J, Ackerman I, Aggarwal R, Ahn SY, Ali MK, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Bahalim AN, Barker-Collo S, Barrero LH, Bartels DH, Basanez MG, Baxter A, Bell ML, Benjamin EJ, Bennett D, Bernabe E, Bhalla K, Bhandari B, Bikbov B, Bin Abdulhak A, Birbeck G, Black JA, Blencowe H, Blore JD, Blyth F, Bolliger I, Bonaventure A, Boufous S, Bourne R, Boussinesq M, Braithwaite T, Brayne C, Bridgett L, Brooker S, Brooks P, Brugha TS, Bryan-Hancock C, Bucello C, Buchbinder R, Buckle G, Budke CM, Burch M, Burney P, Burstein R, Calabria B, Campbell B, Canter CE, Carabin H, Carapetis J, Carmona L, Cella C, Charlson F, Chen H, Cheng AT, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahiya M, Dahodwala N, Damsere-Derry J, Danaei G, Davis A, De Leo D, Degenhardt L, Dellavalle R, Delossantos A, Denenberg J, Derrett S, Des Jarlais DC, Dharmaratne SD, Dherani M, Diaz-Torne C, Dolk H, Dorsey ER, Driscoll T, Duber H, Ebel B, Edmond K, Elbaz A, Ali SE, Erskine H, Erwin PJ, Espindola P, Ewoigbokhan SE, Farzadfar F, Feigin V, Felson DT, Ferrari A, Ferri CP, Fevre EM, Finucane MM, Flaxman S, Flood L, Foreman K, Forouzanfar MH, Fowkes FG, Franklin R, Fransen M, Freeman MK, Gabbe BJ, Gabriel SE, Gakidou E, Ganatra HA, Garcia B, Gaspari F, Gillum RF, Gmel G, Gosselin R, Grainger R, Groeger J, Guillemin F, Gunnell D, Gupta R, Haagsma J, Hagan H, Halasa YA, Hall W, Haring D, Haro JM, Harrison JE, Havmoeller R, Hay RJ, Higashi H, Hill C, Hoen B, Hoffman H, Hotez PJ, Hoy D, Huang JJ, Ibeanusi SE, Jacobsen KH, James SL, Jarvis D, Jasrasaria R, Jayaraman S, Johns N, Jonas JB, Karthikeyan G, Kassebaum N, Kawakami N, Keren A, Khoo JP, King CH, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Lalloo R, Laslett LL, Lathlean T, Leasher JL, Lee YY, Leigh J, Lim SS, Limb E, Lin JK, Lipnick M, Lipshultz SE, Liu W, Loane M, Ohno SL, Lyons R, Ma J, Mabweijano J, MacIntyre MF, Malekzadeh R, Mallinger L, Manivannan S, Marcenes W, March L, Margolis DJ, Marks GB, Marks R, Matsumori A, Matzopoulos R, Mayosi BM, McAnulty JH, McDermott MM, McGill N, McGrath J, Medina-Mora ME, Meltzer M, Mensah GA, Merriman TR, Meyer AC, Miglioli V, Miller M, Miller TR, Mitchell PB, Mocumbi AO, Moffitt TE, Mokdad AA, Monasta L, Montico M, Moradi-Lakeh M, Moran A, Morawska L, Mori R, Murdoch ME, Mwaniki MK, Naidoo K, Nair MN, Naldi L, Narayan KM, Nelson PK, Nelson RG, Nevitt MC, Newton CR, Nolte S, Norman P, Norman R, O'Donnell M, O'Hanlon S, Olives C, Omer SB, Ortblad K, Osborne R, Ozgediz D, Page A, Pahari B, Pandian JD, Rivero AP, Patten SB, Pearce N, Padilla RP, Perez-Ruiz F, Perico N, Pesudovs K, Phillips D, Phillips MR, Pierce K, Pion S, Polanczyk GV, Polinder S, Pope CA 3rd, Popova S, Porrini E, Pourmalek F, Prince M, Pullan RL, Ramaiah KD, Ranganathan D, Razavi H, Regan M, Rehm JT, Rein DB, Remuzzi G, Richardson K, Rivara FP, Roberts T, Robinson C, De Leon FR, Ronfani L, Room R, Rosenfeld LC, Rushton L, Sacco RL, Saha S, Sampson U, Sanchez-Riera L, Sanman E, Schwebel DC, Scott JG, Segui-Gomez M, Shahraz S, Shepard DS, Shin H, Shivakoti R, Singh D, Singh GM, Singh JA, Singleton J, Sleet DA, Sliwa K, Smith E, Smith JL, Stapelberg NJ, Steer A, Steiner T, Stolk WA, Stovner LJ, Sudfeld C, Syed S, Tamburlini G, Tavakkoli M, Taylor HR, Taylor JA, Taylor WJ, Thomas B, Thomson WM, Thurston GD, Tleyjeh IM, Tonelli M, Towbin JA, Truelsen T, Tsilimbaris MK, Ubeda C, Undurraga EA, van der Werf MJ, van Os J, Vavilala MS, Venketasubramanian N, Wang M, Wang W, Watt K, Weatherall DJ, Weinstock MA, Weintraub R, Weisskopf MG, Weissman MM, White RA, Whiteford H, Wiersma ST, Wilkinson JD, Williams HC, Williams SR, Witt E, Wolfe F, Woolf AD, Wulf S, Yeh PH, Zaidi AK, Zheng ZJ, Zonies D, Lopez AD, Murray CJ, AlMazroa MA, Memish ZA

Lancet. 2012 Dec 15;380(9859):2163-96

Effect of adherence to European treatment recommendations on early arthritis outcome: data from the ESPOIR cohort.

Escalas C, Dalichampt M, Combe B, Fautrel B, Guillemin F, Durieux P, Dougados M, Ravaud P

Ann Rheum Dis. 2012 Nov;71(11):1803-8

Aptamers as remarkable diagnostic and therapeutic agents in cancer treatment.

Lassalle HP, Marchal S, Guillemin F, Reinhard A, Bezdetnaya L

Curr Drug Metab. 2012 Oct;13(8):1130-44.

Impact of co-morbidities on measuring indirect utility by the Medical Outcomes Study Short Form 6D in lower-limb osteoarthritis.

Hosseini K, Gaujoux-Viala C, Coste J, Pouchot J, Fautrel B, Rat AC, Guillemin F

Best Pract Res Clin Rheumatol. 2012 Oct;26(5):627-35

LupusQoL-FR is valid to assess quality of life in patients with systemic lupus erythematosus.

Devilliers H, Amoura Z, Besancenot JF, Bonnotte B, Pasquali JL, Wahl D, Maurier F, Kaminsky P, Pennaforte JL, Magy-Bertrand N, Arnaud L, Binquet C, Guillemin F

Rheumatology (Oxford). 2012 Oct;51(10):1906-15

Mortality and cardiovascular events are best predicted by low central/peripheral pulse pressure amplification but not by high blood pressure levels in elderly nursing home subjects: the PARTAGE (Predictive Values of Blood Pressure and Arterial Stiffness

Benetos A, Gautier S, Labat C, Salvi P, Valbusa F, Marino F, Toulza O, Agnoletti D, Zamboni M, Dubail D, Manckoundia P, Rolland Y, Hanon O, Perret-Guillaume C, Lacolley P, Safar ME, Guillemin F

J Am Coll Cardiol. 2012 Oct 16;60(16):1503-11

Estimating the prevalence and incidence of multiple sclerosis in the Lorraine region, France, by the capture-recapture method.

El Adssi H, Debouverie M, Guillemin F,

Mult. Scler.. 2012 Sep;18(9):1244-50

Responsiveness of EQ-5D and SF-6D in patients with early arthritis: results from the ESPOIR cohort.

Gaujoux-Viala C, Rat AC, Guillemin F, Flipo RM, Fardellone P, Bourgeois P, Fautrel B

Ann. Rheum. Dis.. 2012 Sep;71(9):1478-83

A tool to identify recent or present rheumatoid arthritis flare from both patient and physician perspectives: the 'FLARE' instrument.

Berthelot JM, De Bandt M, Morel J, Benatig F, Constantin A, Gaudin P, Le Loet X, Maillefert JF, Meyer O, Pham T, Saraux A, Solau-Gervais E, Spitz E, Wendling D, Fautrel B, Guillemin F,

Ann. Rheum. Dis.. 2012 Jul;71(7):1110-6

Factors associated with fatigue in early arthritis: results from a multicenter national French cohort study.

Rat AC, Pouchot J, Fautrel B, Boumier P, Goupille P, Guillemin F

Arthritis Care Res (Hoboken). 2012 Jul;64(7):1061-9

Impaired quality of life after chikungunya virus infection: a 2-year follow-up study.

Couturier E, Guillemin F, Mura M, Leon L, Virion JM, Letort MJ, De Valk H, Simon F, Vaillant V

Rheumatology (Oxford). 2012 Jul;51(7):1315-22

Measurement of matrilin-3 levels in human serum and synovial fluid using a competitive enzyme-linked immunosorbent assay.

Vincourt JB, Gillet P, Rat AC, Guillemin F, Netter P, Mainard D, Magdalou J

Osteoarthritis Cartilage. 2012 Jul;20(7):783-6

Increased albuminuria in 4-year-old preterm-born children with normal height.

Vieux R, Hascoet JM, Franck P, Guillemin F

J Pediatr. 2012 Jun;160(6):923-8.e1

Describing the epidemiology of rheumatic diseases: methodological aspects.

Guillemin F

Curr Opin Rheumatol. 2012 Mar;24(2):187-92.

Gender differences in the association between depressive mood and mortality: a 12-year follow-up population-based study.

Lemogne C, Niedhammer I, Khlat M, Ravaud JF, Guillemin F, Consoli SM, Fossati P, Chau N

J Affect Disord. 2012 Feb;136(3):267-75

Development and validity of the DyNaChron questionnaire for chronic nasal dysfunction.

Kacha S, Guillemin F, Jankowski R

Eur Arch Otorhinolaryngol. 2012 Jan;269(1):143-53

Matrix to predict rapid radiographic progression of early rheumatoid arthritis patients from the community treated with methotrexate or leflunomide: results from the ESPOIR cohort.

Fautrel B, Granger B, Combe B, Saraux A, Guillemin F, Le Loet X

Arthritis Res Ther. 2012 Nov 19;14(6):R249

Importance of patient satisfaction with care in predicting osteoarthritis-specific health-related quality of life one year after total joint arthroplasty.

Baumann C, Rat AC, Mainard D, Cuny C, Guillemin F

Qual Life Res. 2011 Dec;20(10):1581-8

Long-term antioxidant supplementation has no effect on health-related quality of life: the randomized, double-blind, placebo-controlled, primary prevention SU.VI.MAX trial.

Briancon S, Boini S, Bertrais S, Guillemin F, Galan P, Hercberg S

Int J Epidemiol. 2011 Dec;40(6):1605-16.

Prevalence of symptomatic hip and knee osteoarthritis: a two-phase population-based survey.

Guillemin F, Rat AC, Mazieres B, Pouchot J, Fautrel B, Euller-Ziegler L, Fardellone P, Morvan J, Roux CH, Verrouil E, Saraux A, Coste J,

Osteoarthr. Cartil.. 2011 Nov;19(11):1314-22

National, multicentre, prospective study of quality of life in patients with osteoarthritis of the knee treated with hylane G-F 20.

Rat AC, Baumann C, Guillemin F

Clin Rheumatol. 2011 Oct;30(10):1285-93

Comparison of the EQ-5D and the SF-6D utility measures in 813 patients with early arthritis: results from the ESPOIR cohort.

Gaujoux-Viala C, Rat AC, Guillemin F, Flipo RM, Fardellone P, Bourgeois P, Fautrel B

J Rheumatol. 2011 Aug;38(8):1576-84

Nonpharmacologic interventions need outcomes for evaluating complex interventions in rheumatic diseases.

Guillemin F, Iversen MD, Rat AC, Osborne R, Petersson IF

J Rheumatol. 2011 Aug;38(8):1803-5.

Perinatal drug exposure and renal function in very preterm infants.

Vieux R, Fresson J, Guillemin F, Hascoet JM

Arch Dis Child Fetal Neonatal Ed. 2011 Jul;96(4):F290-5

Stability of peptides and therapeutic success in cancer.

Pernot M, Vanderesse R, Frochot C, Guillemin F, Barberi-Heyob M

Expert Opin Drug Metab Toxicol. 2011 Jul;7(7):793-802

Cost of pretherapeutic staging of patients with colorectal cancer metastases in a French population.

Lejeune C, Loge P, Arveux P, Velten M, Jolly D, Woronoff-Lemsi MC, Guillemin F

Clin Res Hepatol Gastroenterol. 2011 May;35(5):399-407

Health-related quality of life in French adolescents and adults: norms for the DUKE Health Profile.

Baumann C, Erpelding ML, Perret-Guillaume C, Gautier A, Régat S, Collin JF, Guillemin F, Briançon S

BMC Public Health. 2011 May;11:401

Intradermal tacrolimus prevent scar hypertrophy in a rabbit ear model: a clinical, histological and spectroscopical analysis.

Gisquet H, Liu H, Blondel WC, Leroux A, Latarche C, Merlin JL, Chassagne JF, Peiffert D, Guillemin F

Skin Res Technol. 2011 May;17(2):160-6

Factors correlated with fatigue in breast cancer patients before, during and after adjuvant chemotherapy: the FATSEIN study.

Rotonda C, Guillemin F, Bonnetain F, Conroy T

Contemp Clin Trials. 2011 Mar;32(2):244-9

Measurement properties of the osteoarthritis of knee and hip quality of life OAKHQOL questionnaire: an item response theory analysis.

Goetz C, Ecosse E, Rat AC, Pouchot J, Coste J, Guillemin F

Rheumatology (Oxford). 2011 Mar;50(3):500-5

Solitary pulmonary nodules: consequences for patient quality of life.

Lemonnier I, Baumann C, Jolly D, Arveux P, Woronoff-Lemsi MC, Velten M, Guillemin F

Qual Life Res. 2011 Feb;20(1):101-9

Reaching those most in need: a scoping review of interventions to improve health care quality for disadvantaged populations with osteoarthritis.

Borkhoff CM, Wieland ML, Myasoedova E, Ahmad Z, Welch V, Hawker GA, Li LC, Buchbinder R, Ueffing E, Beaton D, Cardiel MH, Gabriel SE, Guillemin F, Adebajo AO, Bombardier C, Hajjaj-Hassouni N, Tugwell P

Arthritis Care Res (Hoboken). 2011 Jan;63(1):39-52

Responsiveness of EORTC QLQ-C30, QLQ-CR38 and FACT-C quality of life questionnaires in patients with colorectal cancer.

Uwer L, Rotonda C, Guillemin F, Miny J, Kaminsky MC, Mercier M, Tournier-Rangeard L, Leonard I, Montcuquet P, Rauch P, Conroy T

Health Qual Life Outcomes. 2011 Aug 22;9:70.

Baseline observations from the POSSIBLE EU® study: characteristics of postmenopausal women receiving bone loss medications.

Freemantle N, Cooper C, Roux C, Díez-Pérez A, Guillemin F, Jonsson B, Ortolani S, Pfeilschifter J, Horne R, Kakad S, Shepherd S, Möller G, Marciniak A, Martinez L

Arch Osteoporos. 2010 Dec;5(1-2):61-72

Cross-cultural adaptation and validation of the French version of the Rheumatoid and Arthritis Outcome Score (RAOS).

Duval A, Maillefert JF, Gossec L, Laroche D, Tavernier C, Roos EM, Guillemin F, Ornetti P

Clin Exp Rheumatol. 2010 Nov-Dec;28(6):806-12

Development and validation of the French ASQoL questionnaire.

Pham T, van der Heijde DM, Pouchot J, Guillemin F

Clin Exp Rheumatol. 2010 May-Jun;28(3):379-85

Glomerular filtration rate reference values in very preterm infants.

Vieux R, Hascoet JM, Merdariu D, Fresson J, Guillemin F

Pediatrics. 2010 May;125(5):e1186-92

Survey of the therapeutic management of rheumatoid arthritis in France: the OPALE study.

Saraux A, Combe B, Blin P, Bregman B, Chartier M, Durieux-Mehlman S, Guillemin F

Clin Exp Rheumatol. 2010 May-Jun;28(3):325-32

Cross-cultural adaptation and validation of the French version of the Hip disability and Osteoarthritis Outcome Score (HOOS) in hip osteoarthritis patients.

Ornetti P, Parratte S, Gossec L, Tavernier C, Argenson JN, Roos EM, Guillemin F, Maillefert JF

Osteoarthritis Cartilage. 2010 Apr;18(4):522-9

Which generic health related Quality of Life questionnaire should be used in older inpatients: comparison of the Duke Health Profile and the MOS Short-Form SF-36?

Perret-Guillaume C, Briancon S, Guillemin F, Wahl D, Empereur F, Nguyen Thi PL

J Nutr Health Aging. 2010 Apr;14(4):325-31

[Protocols for lung cancer screening: Limitations, and consequences]

Clement-Duchene C, Guillemin F, Paris C, Regent D, Martinet Y

Rev Mal Respir. 2010 Apr;27(4):314-28

Ibuprofen in very preterm infants impairs renal function for the first month of life.

Vieux R, Desandes R, Boubred F, Semama D, Guillemin F, Buchweiller MC, Fresson J, Hascoet JM

Pediatr Nephrol. 2010 Feb;25(2):267-74

Blood pressure and pulse wave velocity values in the institutionalized elderly aged 80 and over: baseline of the PARTAGE study.

Benetos A, Buatois S, Salvi P, Marino F, Toulza O, Dubail D, Manckoundia P, Valbusa F, Rolland Y, Hanon O, Gautier S, Miljkovic D, Guillemin F, Zamboni M, Labat C, Perret-Guillaume C

J Hypertens. 2010 Jan;28(1):41-50.

Development of a self-administered early inflammatory arthritis detection tool.

Bell MJ, Tavares R, Guillemin F, Bykerk VP, Tugwell P, Wells GA

BMC Musculoskelet Disord. 2010 Mar 17;11:50.

Early referral to the rheumatologist for early arthritis patients: evidence for suboptimal care. Results from the ESPOIR cohort.

Fautrel B, Benhamou M, Foltz V, Rincheval N, Rat AC, Combe B, Berenbaum F, Bourgeois P, Guillemin F

Rheumatology (Oxford). 2010 Jan;49(1):147-55

How accurate are physicians in the prediction of patient survival in advanced lung cancer?

Clement-Duchene C, Carnin C, Guillemin F, Martinet Y

Oncologist. 2010;15(7):782-9

Measure of function in rheumatoid arthritis: individualised or classical scales?

Seror R, Tubach F, Baron G, Guillemin F, Ravaud P

Ann Rheum Dis. 2010 Jan;69(1):97-101

Methodological issues regarding power of classical test theory (CTT) and item response theory (IRT)-based approaches for the comparison of patient-reported outcomes in two groups of patients--a simulation study.

Sebille V, Hardouin JB, Le Neel T, Kubis G, Boyer F, Guillemin F, Falissard B

BMC Med Res Methodol. 2010 Mar 25;10:24.

Quality of Life in elderly inpatients with atrial fibrillation as compared with controlled subjects.

Perret-Guillaume C, Briancon S, Wahl D, Guillemin F, Empereur F

J Nutr Health Aging. 2010;14(2):161-6.

Saving and empowering young lives in Europe (SEYLE): a randomized controlled trial.

Wasserman D, Carli V, Wasserman C, Apter A, Balazs J, Bobes J, Bracale R, Brunner R, Bursztein-Lipsicas C, Corcoran P, Cosman D, Durkee T, Feldman D, Gadoros J, Guillemin F, Haring C, Kahn JP, Kaess M, Keeley H, Marusic D, Nemes B, Postuvan V, Reiter-Theil S, Resch F, Saiz P, Sarchiapone M, Sisask M, Varnik A, Hoven CW

BMC Public Health. 2010 Apr 13;10:192.

Total hip or knee replacement for osteoarthritis: mid- and long-term quality of life.

Rat AC, Guillemin F, Osnowycz G, Delagoutte JP, Cuny C, Mainard D, Baumann C

Arthritis Care Res (Hoboken). 2010 Jan 15;62(1):54-62.

Impact of PACS implementation in a university center on radiology practice profile

Lefevre F, Blum A, Bracard S, Regent D, Stines J, Guillemin F, Felblinger J, Claudon M

J Radiol. 2009 Sep;90(9 Pt 1):1046-54.

Assessment of determinants for osteoporosis in elderly men.

Scholtissen S, Guillemin F, Bruyere O, Collette J, Dousset B, Kemmer C, Culot S, Cremer D, Dejardin H, Hubermont G, Lefebvre D, Pascal-Vigneron V, Weryha G, Reginster JY

Osteoporos Int. 2009 Jul;20(7):1157-66

Transcultural adaptation and psychometric validation of a French-language version of the QoL-AD.

Wolak A, Novella JL, Drame M, Guillemin F, Di Pollina L, Ankri J, Aquino JP, Morrone I, Blanchard F, Jolly D

Aging Ment Health. 2009 Jul;13(4):593-600.

Assessment of apoptosis by immunohistochemistry to active caspase-3, active caspase-7, or cleaved PARP in monolayer cells and spheroid and subcutaneous xenografts of human carcinoma.

Bressenot A, Marchal S, Bezdetnaya L, Garrier J, Guillemin F, Plenat F

J Histochem Cytochem. 2009 Apr;57(4):289-300

Choice of second-line disease-modifying antirheumatic drugs after failure of methotrexate therapy for rheumatoid arthritis: a decision tree for clinical practice based on rheumatologists' preferences.

Fautrel B, Guillemin F, Meyer O, de Bandt M, Berthelot JM, Flipo RM, Liote F, Maillefert JF, Wendling D, Saraux A, Combe B, Le Loet X

Arthritis Rheum. 2009 Apr 15;61(4):425-34.

[Reconsidering fatigue at the onset of multiple sclerosis].

Debouverie M, Pittion-Vouyovitch S, Guillemin F

Rev. Neurol. (Paris). 2009 Mar;165 Suppl 4:S135-44

Earlier disability of the patients followed in Multiple Sclerosis centers compared to outpatients.

Debouverie M, Laforest L, Van Ganse E, Guillemin F,

Mult. Scler.. 2009 Feb;15(2):251-7

A case-control study to assess sensitivity and specificity of a questionnaire for the detection of hip and knee osteoarthritis.

Morvan J, Roux CH, Fautrel B, Rat AC, Euller-Ziegler L, Loeuille D, Banal F, Mazieres B, Coste J, Saraux A, Guillemin F

Arthritis Rheum. 2009 Jan 15;61(1):92-9.

Determining a low disease activity threshold for decision to maintain disease-modifying antirheumatic drug treatment unchanged in rheumatoid arthritis patients

de Bandt M, Fautrel B, Maillefert JF, Berthelot JM, Combe B, Flipo RM, Liote F, Meyer O, Saraux A, Wendling D, Le Loet X, Guillemin F

Arthritis Res Ther. 2009;11(5):R157

Does the availability of positron emission tomography modify diagnostic strategies for solitary pulmonary nodules? An observational study in France.

Lemonnier I, Baumann C, Jay N, Alzahouri K, Arveux P, Jolly D, Lejeune C, Velten M, Vitry F, Woronoff-Lemsi MC, Guillemin F

BMC Cancer. 2009 May 11;9:139.

Factors determining a DMARD initiation in early inflammatory arthritis patients. The ESPOIR cohort study.

Lukas C, Guillemin F, Landewe R, van der Heijde D, Logeart I, Fautrel B, Daures JP, Combe B

Clin Exp Rheumatol. 2009 Jan-Feb;27(1):84-91.

Satisfaction with care after total hip or knee replacement predicts self-perceived health status after surgery.

Baumann C, Rat AC, Osnowycz G, Mainard D, Cuny C, Guillemin F

BMC Musculoskelet Disord. 2009 Dec 3;10:150.

Mapping the osteoarthritis knee and hip quality of life (OAKHQOL) instrument to the international classification of functioning, disability and health and comparison to five health status instruments used in osteoarthritis.

Rat AC, Guillemin F, Pouchot J

Rheumatology (Oxford). 2008 Nov;47(11):1719-25

Psychometric evaluation of a Moroccan version of health assessment questionnaire for use in Moroccan patients with rheumatoid arthritis.

Abourazzak FE, Benbouazza K, Amine B, Bahiri R, Lazrak N, Bzami F, Jroundi I, Abouqal R, Guillemin F, Hajjaj-Hassouni N

Rheumatol Int. 2008 Oct;28(12):1197-203

Screening for hip and knee osteoarthritis in the general population: predictive value of a questionnaire and prevalence estimates.

Roux CH, Saraux A, Mazieres B, Pouchot J, Morvan J, Fautrel B, Testa J, Fardellone P, Rat AC, Coste J, Guillemin F, Euller-Ziegler L

Ann Rheum Dis. 2008 Oct;67(10):1406-11

Natural history of multiple sclerosis in a population-based cohort.

Debouverie M, Pittion-Vouyovitch S, Louis S, Guillemin F

Eur J Neurol. 2008 Sep;15(9):916-21

Physical dimension of fatigue correlated with disability change over time in patients with multiple sclerosis

Debouverie M, Pittion-Vouyovitch S, Brissart H, Guillemin F

J Neurol. 2008 May;255(5):633-6

[Critical analysis of the ISUIA study: the methodological point of view]

Guillemin F

J Neuroradiol. 2008 May;35(2):104-8

Cross-cultural adaptation and validation of the French version of the Knee injury and Osteoarthritis Outcome Score (KOOS) in knee osteoarthritis patients.

Ornetti P, Parratte S, Gossec L, Tavernier C, Argenson JN, Roos EM, Guillemin F, Maillefert JF

Osteoarthritis Cartilage. 2008 Apr;16(4):423-8

Effect of order of presentation of a generic and a specific health-related quality of life instrument in knee and hip osteoarthritis: a randomized study.

Rat AC, Baumann C, Klein S, Loeuille D, Guillemin F

Osteoarthritis Cartilage. 2008 Apr;16(4):429-35

Prevalence in two-phase surveys: accuracy of screening procedure and corrected estimates.

Morvan J, Coste J, Roux CH, Euller-Ziegler L, Saraux A, Guillemin F

Ann Epidemiol. 2008 Apr;18(4):261-9.

Effect of the shipment of cadaveric renal allografts on allograft survival.

Kessler M, Virion JM, Hachicha M, Moulin B, Toupance O, Rebibou JM, Guillemin F

Nephrol Dial Transplant. 2008 Mar;23(3):1054-60

Prevalence survey of rheumatoid arthritis and spondyloarthropathy in Lithuania.

Adomaviciute D, Pileckyte M, Baranauskaite A, Morvan J, Dadoniene J, Guillemin F

Scand J Rheumatol. 2008 Mar-Apr;37(2):113-9.

Unruptured Intracranial Aneurysms A Critical Review of the International Study of Unruptured Intracranial Aneurysms (ISUIA) and of Appropriate Methods to Address the Clinical Problem

Raymond J, Guillemin F, Proust E, Molyneux AJ, Fox AJ, Claiborne JS, Meder JF, Rouleau I

Interv Neuroradiol. 2008 Mar;14(1):85-96

Unruptured Intracranial Aneurysms. A Critical Review of the International Study of Unruptured Intracranial Aneurysms (ISUIA) and of Appropriate Methods to Address the Clinical Problem.

Raymond J, Guillemin F, Proust F, Molyneux AJ, Fox AJ, Claiborne JS, Meder JF, Rouleau I,

Interv Neuroradiol. 2008 Mar;14(1):85-96

Voiding ultrasonography: evaluation of the detection of vesicoureteral reflux based on the review of digital ultrasound clips.

Galloy MA, Guillemin F, Couture A, Pracros JP, Didier F, Ducou Le Pointe H, Pefoubou Y, Aubert D, Lortat-Jacob S, Roederer T, Claudon M

Ultraschall Med. 2008 Feb;29(1):53-9

[Research in clinical epidemiology: which rules should be applied?]

Claudot F, Fresson J, Coudane H, Guillemin F, Demore B, Alla F

Rev Epidemiol Sante Publique. 2008 Feb;56(1):63-70

Association of physical job demands, smoking and alcohol abuse with subsequent premature mortality: A 9-year follow-up population-based study

Bourgkard E, Wild P, Massin N, Meyer JP, Sierra CO, Fontana JM, Benamghar L, Mur JM, Ravaud JF, Guillemin F, Chau N

J Occup Health. 2008 Jan;50(1):31-40.

Management of SPN in France. Pathways for definitive diagnosis of solitary pulmonary nodule: a multicentre study in 18 French districts.

Alzahouri K, Velten M, Arveux P, Woronoff-Lemsi MC, Jolly D, Guillemin F

BMC Cancer. 2008 Apr 10;8:93.

Content of quality-of-life instruments is affected by item-generation methods.

Rat AC, Pouchot J, Guillemin F, Baumann M, Retel-Rude N, Spitz E, Coste J

Int J Qual Health Care. 2007 Dec;19(6):390-8

Recommendations of the French Society for Rheumatology regarding TNFalpha antagonist therapy in patients with ankylosing spondylitis or psoriatic arthritis: 2007 update.

Pham T, Fautrel B, Dernis E, Goupille P, Guillemin F, Le Loet X, Ravaud P, Claudepierre P, Miceli-Richard C, de Bandt M, Breban M, Maillefert JF, Masson C, Saraux A, Schaeverbeke T, Wendling D, Mariette X, Combe B

Joint Bone Spine. 2007 Dec;74(6):638-46

Recommendations of the French Society for Rheumatology regarding TNFalpha antagonist therapy in patients with rheumatoid arthritis.

Fautrel B, Pham T, Mouterde G, Le Loet X, Goupille P, Guillemin F, Ravaud P, Cantagrel A, Dougados M, Puechal X, Sibilia J, Soubrier M, Mariette X, Combe B

Joint Bone Spine. 2007 Dec;74(6):627-37

The ESPOIR cohort: a ten-year follow-up of early arthritis in France: methodology and baseline characteristics of the 813 included patients.

Combe B, Benessiano J, Berenbaum F, Cantagrel A, Daures JP, Dougados M, Fardellone P, Fautrel B, Flipo RM, Goupille P, Guillemin F, Le Loet X, Logeart I, Mariette X, Meyer O, Ravaud P, Rincheval N, Saraux A, Schaeverbeke T, Sibilia J

Joint Bone Spine. 2007 Oct;74(5):440-5

Functional disability in France and its relationship with health-related quality of life - a population-based prevalence study.

Loos-Ayav C, Chau N, Riani C, Guillemin F

Clin Exp Rheumatol. 2007 Sep-Oct;25(5):701-8.

Increasing incidence of multiple sclerosis among women in Lorraine, Eastern France.

Debouverie M, Pittion-Vouyovitch S, Louis S, Roederer T, Guillemin F

Mult Scler. 2007 Sep;13(8):962-7

Validity of a French version of the fatigue impact scale in multiple sclerosis.

Debouverie M, Pittion-Vouyovitch S, Louis S, Guillemin F

Mult Scler. 2007 Sep;13(8):1026-32.

Primer: the fallacy of subgroup analysis.

Guillemin F

Nat Clin Pract Rheumatol. 2007 Jul;3(7):407-13.

Evaluation of the expectations osteoarthritis patients have concerning healthcare, and their implications for practitioners.

Baumann M, Euller-Ziegler L, Guillemin F

Clin Exp Rheumatol. 2007 May-Jun;25(3):404-9.

The photodynamic therapy

Barberi-Heyob M, Frochot C, Bezdetnaya-Bolotine L, Brault D, Dumas D, Guillemin F, Krausz P, Maillard P, Maunit B, Merlin JL, Mordon S, Muller JF, Patrice T, Simonneaux G, Tanielian C

Actual Chim. 2007 May-jun;:26-34

Association between leisure-time physical activity and health-related quality of life changes over time.

Tessier S, Vuillemin A, Bertrais S, Boini S, Le Bihan E, Oppert JM, Hercberg S, Guillemin F, Briancon S

Prev Med. 2007 Mar;44(3):202-8

Costs of rheumatoid arthritis: new estimates from the human capital method and comparison to the willingness-to-pay method.

Fautrel B, Clarke AE, Guillemin F, Adam V, St-Pierre Y, Panaritis T, Fortin PR, Menard HA, Donaldson C, Penrod JR

Med Decis Making. 2007 Mar-Apr;27(2):138-50.

Adaptation and validation of a telephone questionnaire--Serbian version for case detection of rheumatoid arthritis and spondyloarthropathy (multicentric Eular study).

Zlatkovic-Svenda MI, Stojanovic RM, Milenkovic MP, Vlajinac HD, Le Bihan E, Guillemin F

Clin Exp Rheumatol. 2007 Jan-Feb;25(1):75-84.

Associations of social and material deprivation with tobacco, alcohol, and psychotropic drug use, and gender: a population-based study.

Baumann M, Spitz E, Guillemin F, Ravaud JF, Choquet M, Falissard B, Chau N

Int J Health Geogr. 2007 Nov 9;6:50.

Clinical practice format for choosing a second-line disease modifying anti-rheumatic drug in early rheumatoid arthritis after failure of 6 months' first-line DMARD therapy

Meyer O, de Bandt M, Berthelot JM, Cantagrel A, Combe B, Fautrel B, Flipo RM, Liote F, Maillefert JF, Saraux A, Wendling D, Guillemin F, Le Loet X

Joint Bone Spine. 2007 Jan;74(1):73-8

Rheumatoid arthritis and spondyloarthropathies: geographical variations in prevalence in France.

Roux CH, Saraux A, Le Bihan E, Fardellone P, Guggenbuhl P, Fautrel B, Masson C, Chary-Valckenaere I, Cantagrel A, Juvin R, Flipo RM, Euller-Ziegler L, Coste J, Guillemin F

J Rheumatol. 2007 Jan;34(1):117-22

Development and testing of a specific quality-of-life questionnaire for knee and hip osteoarthritis: OAKHQOL (OsteoArthritis of Knee Hip Quality Of Life).

Rat AC, Pouchot J, Coste J, Baumann C, Spitz E, Retel-Rude N, Baumann M, Le Quintrec JS, Dumont-Fischer D, Guillemin F

Joint Bone Spine. 2006 Dec;73(6):697-704

French adaptation and validation of the helping alliance questionnaires for child, parents, and therapist.

Kermarrec S, Kabuth B, Bursztejn C, Guillemin F

Can J Psychiatry. 2006 Dec;51(14):913-22.

Respiratory adenomatoid hamartoma must be suspected on CT-scan enlargement of the olfactory clefts.

Lima NB, Jankowski R, Georgel T, Grignon B, Guillemin F, Vignaud JM

Rhinology. 2006 Dec;44(4):264-9.

Excess risk of cancer in renal transplant patients.

Kessler M, Jay N, Molle R, Guillemin F

Transpl Int. 2006 Nov;19(11):908-14.

Occurrence of coronary artery disease has an adverse impact on health-related quality of life: a longitudinal controlled study.

Boini S, Briancon S, Guillemin F, Galan P, Hercberg S

Int J Cardiol. 2006 Nov 10;113(2):215-22

Quality of life and continence in patients with spina bifida.

Lemelle JL, Guillemin F, Aubert D, Guys JM, Lottmann H, Lortat-Jacob S, Mouriquand P, Ruffion A, Moscovici J, Schmitt M

Qual Life Res. 2006 Nov;15(9):1481-92

TNFalpha antagonist therapy in ankylosing spondylitis and psoriatic arthritis: recommendations of the French Society for Rheumatology.

Pham T, Guillemin F, Claudepierre P, Luc M, Miceli-Richard C, Fautrel B, de Bandt M, Breban M, Goupille P, Maillefert JF, Masson C, Saraux A, Schaeverbeke T, Wendling D, Mariette X, Combe B

Joint Bone Spine. 2006 Oct;73(5):547-53

Staging practices of primary non-small-cell lung cancer: a literature review.

Alzahouri K, Martinet Y, Briançon S, Guillemin F

Eur J Cancer Care (Engl). 2006 Sep;15(4):348-54

Laboratory and imaging studies used by French rheumatologists to evaluate patients with early arthritis.

Saraux A, Fautrel B, Maillefert JF, Flipo RM, Kaye O, Lafforgue P, Gourves K, Guillemin F

J Rheumatol. 2006 May;33(5):897-902

The Cochrane Collaboration is in its fourteenth year.

Guillemin F

Joint Bone Spine. 2006 May;73(3):236-8

Fatigue in multiple sclerosis is related to disability, depression and quality of life.

Pittion-Vouyovitch S, Debouverie M, Guillemin F, Vandenberghe N, Anxionnat R, Vespignani H

J Neurol Sci. 2006 Apr 15;243(1-2):39-45

Do clinical presentation and pre-operative quality of life predict satisfaction with care after total hip or knee replacement?

Baumann C, Rat AC, Osnowycz G, Mainard D, Delagoutte JP, Cuny C, Guillemin F

J Bone Joint Surg Br. 2006 Mar;88(3):366-73.

A multicentre study of the management of disorders of defecation in patients with spina bifida.

Lemelle JL, Guillemin F, Aubert D, Guys JM, Lottmann H, Lortat-Jacob S, Moscovici J, Mouriquand P, Ruffion A, Schmitt M

Neurogastroenterol Motil. 2006 Feb;18(2):123-8.

A multicenter evaluation of urinary incontinence management and outcome in spina bifida.

Lemelle JL, Guillemin F, Aubert D, Guys JM, Lottmann H, Lortat-Jacob S, Moscovici J, Mouriquand P, Ruffion A, Schmitt M

J Urol. 2006 Jan;175(1):208-12.

Clinical practice decision tree for the choice of the first disease modifying antirheumatic drug for very early rheumatoid arthritis: a 2004 proposal of the French Society of Rheumatology.

Le Loet X, Berthelot JM, Cantagrel A, Combe B, De Bandt M, Fautrel B, Flipo RM, Liote F, Maillefert JF, Meyer O, Saraux A, Wendling D, Guillemin F

Ann Rheum Dis. 2006 Jan;65(1):45-50

Lean mass plays a gender-specific role in familial resemblance for femoral neck bone mineral density in adult subjects.

Blain H, Vuillemin A, Jeandel C, Jouanny P, Guillemin F, Le Bihan E

Osteoporos Int. 2006;17(6):897-907

Prevalence of sensory and cognitive disabilities and falls, and their relationships: a community-based study.

Gauchard GC, Deviterne D, Guillemin F, Sanchez J, Perrin PP, Mur JM, Ravaud JF, Chau N

Neuroepidemiology. 2006;26(2):108-18

Psychometric properties of the DUKE Health Profile-adolescent version (DHP-A): a generic instrument for adolescents.

Vo TX, Guillemin F, Deschamps JP

Qual Life Res. 2005 Dec;14(10):2229-34.

Use of a decision analysis model to assess the cost-effectiveness of 18F-FDG PET in the management of metachronous liver metastases of colorectal cancer.

Lejeune C, Bismuth MJ, Conroy T, Zanni C, Bey P, Bedenne L, Faivre J, Arveux P, Guillemin F

J Nucl Med. 2005 Dec;46(12):2020-8.

[Prevalence of impairments and social inequalities].

Chau N, Ravaud JF, Otero-Sierra C, Legras B, Macho-Fernandez J, Guillemin F, Sanchez J, Mur JM

Rev Epidemiol Sante Publique. 2005 Dec;53(6):614-28.

Prevalence of rheumatoid arthritis in France: 2001.

Guillemin F, Saraux A, Guggenbuhl P, Roux CH, Fardellone P, Le Bihan E, Cantagrel A, Chary-Valckenaere I, Euller-Ziegler L, Flipo RM, Juvin R, Behier JM, Fautrel B, Masson C, Coste J

Ann Rheum Dis. 2005 Oct;64(10):1427-30

Prevalence of spondyloarthropathies in France: 2001.

Saraux A, Guillemin F, Guggenbuhl P, Roux CH, Fardellone P, Le Bihan E, Cantagrel A, Chary-Valckenaere I, Euller-Ziegler L, Flipo RM, Juvin R, Behier JM, Fautrel B, Masson C, Coste J

Ann Rheum Dis. 2005 Oct;64(10):1431-5

Use of a decision analysis model to assess the medicoeconomic implications of FDG PET imaging in diagnosing a solitary pulmonary nodule.

Lejeune C, Al Zahouri K, Woronoff-Lemsi MC, Arveux P, Bernard A, Binquet C, Guillemin F

Eur J Health Econ. 2005 Sep;6(3):203-14.

Leisure time physical activity and health-related quality of life.

Vuillemin A, Boini S, Bertrais S, Tessier S, Oppert JM, Hercberg S, Guillemin F, Briancon S

Prev Med. 2005 Aug;41(2):562-9.

Development and validation of a French obesity-specific quality of life questionnaire: Quality of Life, Obesity and Dietetics (QOLOD) rating scale.

Ziegler O, Filipecki J, Girod I, Guillemin F

Diabetes Metab. 2005 Jun;31(3 Pt 1):273-83.

Reproducibility and sensitivity to change of 5 methods for scoring hand radiographic damage in patients with rheumatoid arthritis.

Guillemin F, Billot L, Boini S, Gerard N, Ødegaard S, Kvien TK

J. Rheumatol.. 2005 May;32(5):778-86

Cost-effectiveness analysis of strategies introducing FDG-PET into the mediastinal staging of non-small-cell lung cancer from the French healthcare system perspective.

Alzahouri K, Lejeune C, Woronoff-Lemsi MC, Arveux P, Guillemin F

Clin Radiol. 2005 Apr;60(4):479-92

Impact of musculoskeletal disorders on quality of life: an inception cohort study.

Roux CH, Guillemin F, Boini S, Longuetaud F, Arnault N, Hercberg S, Briancon S

Ann Rheum Dis. 2005 Apr;64(4):606-11

Modification of the infra hyoid musculo-cutaneous flap.

Dolivet G, Gangloff P, Sarini J, Ton Van J, Garron X, Guillemin F, Lefebvre JL

Eur J Surg Oncol. 2005 Apr;31(3):294-8.

Valuing a hypothetical cure for rheumatoid arthritis using the contingent valuation methodology: the patient perspective.

Fautrel B, Clarke AE, Guillemin F, Adam V, St-Pierre Y, Panaritis T, Fortin PR, Menard HA, Donaldson C, Penrod JR

J Rheumatol. 2005 Mar;32(3):443-53.

Health related quality of life of adolescents in Vietnam: cross-cultural adaptation and validation of the Adolescent Duke Health Profile.

Hanh VT, Guillemin F, Cong DD, Parkerson GR Jr, Thu PB, Quynh PT, Briancon S

J Adolesc. 2005 Feb;28(1):127-46.

Comparison of intravenous and intra-arterial urokinase thrombolysis for acute ischaemic stroke.

Ducrocq X, Bracard S, Taillandier L, Anxionnat R, Lacour JC, Guillemin F, Debouverie M, Bollaert PE

J Neuroradiol. 2005 Jan;32(1):26-32.

Incidence and prevalence: two demanding indicators.

Guillemin F

Joint Bone Spine. 2005 Jan;72(1):7-9.

OAKHQOL: a new instrument to measure quality of life in knee and hip osteoarthritis.

Rat AC, Coste J, Pouchot J, Baumann M, Spitz E, Retel-Rude N, Le Quintrec JS, Dumont-Fischer D, Guillemin F

J Clin Epidemiol. 2005 Jan;58(1):47-55.

Are there more than cross-sectional relationships of social support and support networks with functional limitations and psychological distress in early rheumatoid arthritis? the European Research on Incapacitating Diseases and Social Support Longitudinal

Demange V, Guillemin F, Baumann M, Suurmeijer TP, Moum T, Doeglas D, Briançon S, van den Heuvel WJ

Arthritis Rheum.. 2004 Oct;51(5):782-91

Characteristics of patients with rheumatoid arthritis in France: a study of 1109 patients managed by hospital based rheumatologists.

Sany J, Bourgeois P, Saraux A, Durieux S, Lafuma A, Daurès JP, Guillemin F, Sibilia J

Ann. Rheum. Dis.. 2004 Oct;63(10):1235-40

EULAR standardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing committees.

Dougados M, Betteridge N, Burmester GR, Euller-Ziegler L, Guillemin F, Hirvonen J, Lloyd J, Ozen S, Da Silva JA, Emery P, Kalden JR, Kvien T, Matucci-Cerinic M, Smolen J,

Ann. Rheum. Dis.. 2004 Sep;63(9):1172-6

Costs of workups for the diagnosis of early arthritis: results of a nationwide survey.

Fautrel B, Saraux A, Maillefert JF, Kaye O, Lafforgue P, Flipo RM, Penrod JR, Guillemin F,

Arthritis Rheum.. 2004 Aug;51(4):507-12

Validity of the childhood health assessment questionnaire is independent of age in juvenile idiopathic arthritis.

Pouchot J, Ecosse E, Coste J, Guillemin F, ,

Arthritis Rheum.. 2004 Aug;51(4):519-26

Costs of rheumatoid arthritis in France: a multicenter study of 1109 patients managed by hospital-based rheumatologists.

Guillemin F, Durieux S, Daurès JP, Lafuma A, Saraux A, Sibilia J, Bourgeois P, Sany J

J. Rheumatol.. 2004 Jul;31(7):1297-304

Prognosis and quality of life in patients with acute low back pain: insights from a comprehensive inception cohort study.

Coste J, Lefrançois G, Guillemin F, Pouchot J,

Arthritis Rheum.. 2004 Apr;51(2):168-76

Adherence to an annual PSA screening program over 3 years for brothers and sons of men with prostate cancer.

Roumier X, Azzouzi R, Valeri A, Guillemin F, Fournier G, Cussenot O, Mangin P, Cormier L

Eur Urol. 2004 Mar;45(3):280-5; author reply 285-6.

Agreement between rheumatologist visit and lay interviewer telephone survey for screening for rheumatoid arthritis and spondyloarthropathy.

Saraux A, Guillemin F, Fardellone P, Guggenbuhl P, Behier JM, Cantagrel A, Euller-Ziegler L, Flipo RM, Juvin R, Le Loet X, Masson C, Sany J, Schaeverbeke T, Coste J,

Joint Bone Spine. 2004 Jan;71(1):44-50

Impact of cancer occurrence on health-related quality of life: a longitudinal pre-post assessment.

Boini S, Briancon S, Guillemin F, Galan P, Hercberg S

Health Qual Life Outcomes. 2004 Jan 9;2:4.

Quality of life among disease-free survivors of rectal cancer.

Rauch P, Miny J, Conroy T, Neyton L, Guillemin F

J Clin Oncol. 2004 Jan 15;22(2):354-60.

Prognostic factors for joint destruction in rheumatoid arthritis: a prospective longitudinal study of 318 patients.

Guillemin F, Gérard N, van Leeuwen M, Smedstad LM, Kvien TK, van den Heuvel W,

J. Rheumatol.. 2003 Dec;30(12):2585-9

Relationships of job and some individual characteristics to occupational injuries in employed people: a community-based study.

Bhattacherjee A, Chau N, Sierra CO, Legras B, Benamghar L, Michaely JP, Ghosh AK, Guillemin F, Ravaud JF, Mur JM,

J Occup Health. 2003 Nov;45(6):382-91

Use of the EQ-5D among patients suffering from dementia.

Ankri J, Beaufils B, Novella JL, Morrone I, Guillemin F, Jolly D, Ploton L, Blanchard F

J Clin Epidemiol. 2003 Nov;56(11):1055-63

Detection of cases of inflammatory rheumatic disorders: performance of a telephone questionnaire designed for use by patient interviewers.

Guillemin F, Saraux A, Fardellone P, Guggenbuhl P, Behier JM, Coste J,

Ann. Rheum. Dis.. 2003 Oct;62(10):957-63

[Missing data mechanisms of the questionnaire SF-36's items in the SU.VI.MAX study].

Vercherin P, Gutknecht C, Guillemin F, Ecochard R, Mennen LI, Mercier M

Rev Epidemiol Sante Publique. 2003 Oct;51(5):513-25

Costs of ankylosing spondylitis in three European countries: the patient's perspective.

Boonen A, van der Heijde D, Landewé R, Guillemin F, Spoorenberg A, Schouten H, Rutten-van Mölken M, Dougados M, Mielants H, de Vlam K, van der Tempel H, van der Linden S

Ann. Rheum. Dis.. 2003 Aug;62(8):741-7

Direct costs of ankylosing spondylitis and its determinants: an analysis among three European countries.

Boonen A, van der Heijde D, Landewé R, Guillemin F, Rutten-van Mölken M, Dougados M, Mielants H, de Vlam K, van der Tempel H, Boesen S, Spoorenberg A, Schouten H, van der Linden S

Ann. Rheum. Dis.. 2003 Aug;62(8):732-40

Final height in children with chronic renal failure who have not received growth hormone.

André JL, Bourquard R, Guillemin F, Krier MJ, Briançon S

Pediatr. Nephrol.. 2003 Jul;18(7):685-91

How to assess musculoskeletal conditions. Assessment of disease activity.

Guillemin F

Best Pract Res Clin Rheumatol. 2003 Jun;17(3):415-26

MRI morphological and volumetric study of the cingulate gyrus and its relevance in partial epileptic patients.

Kremer S, Braun M, Kahane P, Guillemin F, Le Bas JF, Benabid AL

Epileptic Disord. 2003 Jun;5(2):101-7

Health related quality of life and related factors in 539 persons with amputation of upper and lower limb.

Demet K, Martinet N, Guillemin F, Paysant J, André JM

Disabil Rehabil. 2003 May;25(9):480-6

Quality of life in women with fibromyalgia syndrome: validation of the QIF, the French version of the fibromyalgia impact questionnaire.

Perrot S, Dumont D, Guillemin F, Pouchot J, Coste J,

J. Rheumatol.. 2003 May;30(5):1054-9

Reliability of the Wisconsin Sleep Questionnaire: a French contribution to international validation.

Teculescu D, Guillemin F, Virion JM, Aubry C, Hannhart B, Michaely JP, Gueguen R

J Clin Epidemiol. 2003 May;56(5):436-40

Economic evaluation of programs or interventions in the management of rheumatoid arthritis: defining a consensus-based reference case.

Maetzel A, Tugwell P, Boers M, Guillemin F, Coyle D, Drummond M, Wong JB, Gabriel SE,

J. Rheumatol.. 2003 Apr;30(4):891-6

[Small bowel obstruction from adhesions: which CT severity criteria to research?].

Catel L, Lefèvre F, Lauren V, Canard L, Bresler L, Guillemin F, Régent D

J Radiol. 2003 Jan;84(1):27-31

[Fatigue scales used in multiple sclerosis].

Debouverie M, Pittion S, Guillemin F, Vespignani H

Rev. Neurol. (Paris). 2002 Nov;158(11):1139-43

Validation of the French version of the Childhood Health Assessment Questionnaire (CHAQ) in juvenile idiopathic arthritis.

Pouchot J, Larbre JP, Lemelle I, Sommelet D, Grouteau E, David L, Duquesne A, Deslandre CJ, Koné Paut I, Pillet P, Goumy L, Barbier C, Guyot MH, Mazingue F, Laloum SG, Fischbac M, Quartier P, Guyot C, Jean S, Legall E, Plouvier E, Bost M, de Lumley L, Brégeon C, Guillemin F, Coste J, Prieur AM,

Joint Bone Spine. 2002 Oct;69(5):468-81

Nottingham Health Profile: reliability in a sample of 542 subjects with major amputation of one or several limbs.

Demet K, Guillemin F, Martinet N, André JM

Prosthet Orthot Int. 2002 Aug;26(2):120-3

[Measure of quality of life in patients with metastatic colorectal cancer: techniques and main results].

Conroy T, Guillemin F, Kaminsky MC

Rev Med Interne. 2002 Aug;23(8):703-16

Laboratory and imaging studies used by French rheumatologists to determine the cause of recent onset polyarthritis without extra-articular manifestations.

Saraux A, Maillefert JF, Fautrel B, Flipo RM, Kaye O, Lafforgue P, Guillemin F, Botton E

Ann. Rheum. Dis.. 2002 Jul;61(7):626-9

Impact of prostate cancer screening on health-related quality of life in at-risk families.

Cormier L, Guillemin F, Valéri A, Fournier G, Cussenot O, Mangin P, Litwin MS

Urology. 2002 Jun;59(6):901-6

Self-rating of quality of life provides additional prognostic information in heart failure. Insights into the EPICAL study.

Alla F, Briançon S, Guillemin F, Juillière Y, Mertès PM, Villemot JP, Zannad F,

Eur. J. Heart Fail.. 2002 Jun;4(3):337-43

Worry and attitude of men in at-risk families for prostate cancer about genetic susceptibility and genetic testing.

Cormier L, Valeri A, Azzouzi R, Fournier G, Cussenot O, Berthon P, Guillemin F, Mangin P

Prostate. 2002 Jun 1;51(4):276-85.

Diagnosis of female bladder outlet obstruction and relevance of the parameter area under the curve of detrusor pressure during voiding: preliminary results.

Cormier L, Ferchaud J, Galas JM, Guillemin F, Mangin P

J. Urol.. 2002 May;167(5):2083-7

Work status and productivity costs due to ankylosing spondylitis: comparison of three European countries.

Boonen A, van der Heijde D, Landewé R, Spoorenberg A, Schouten H, Rutten-van Mölken M, Guillemin F, Dougados M, Mielants H, de Vlam K, van der Tempel H, van der Linden S

Ann. Rheum. Dis.. 2002 May;61(5):429-37

Cost of illness studies in rheumatic diseases.

Fautrel B, Guillemin F

Curr Opin Rheumatol. 2002 Mar;14(2):121-6

Serum leptin level is a predictor of bone mineral density in postmenopausal women.

Blain H, Vuillemin A, Guillemin F, Durant R, Hanesse B, de Talance N, Doucet B, Jeandel C

J. Clin. Endocrinol. Metab.. 2002 Mar;87(3):1030-5

Factors determining inpatient satisfaction with care.

Nguyen Thi PL, Briancon S, Empereur F, Guillemin F

Soc Sci Med. 2002 Feb;54(4):493-504.

Health-care use by rheumatoid arthritis patients compared with non-arthritic subjects.

Girard F, Guillemin F, Novella JL, Valckenaere I, Krzanowska K, Vitry F, Vittecoq O, Eschard JP, Blanchard F, Le Loët X

Rheumatology (Oxford). 2002 Feb;41(2):167-75

Effect on osteoarthritis of spa therapy at Bourbonne-les-Bains.

Guillemin F, Virion JM, Escudier P, De Talancé N, Weryha G

Joint Bone Spine. 2001 Dec;68(6):499-503

Radiographic scoring methods as outcome measures in rheumatoid arthritis: properties and advantages.

Boini S, Guillemin F

Ann. Rheum. Dis.. 2001 Sep;60(9):817-27

A method for shortening instruments using the Rasch model. Validation on a hand functional measure.

Luquet C, Chau N, Guillemin F, Nadif M, Moreau T, Gavillot C, Pétry D

Rev Epidemiol Sante Publique. 2001 Jun;49(3):273-86

Differential influence of physical activity on lumbar spine and femoral neck bone mineral density in the elderly population.

Vuillemin A, Guillemin F, Jouanny P, Denis G, Jeandel C

J. Gerontol. A Biol. Sci. Med. Sci.. 2001 Jun;56(6):B248-53

Quality of life profiles in the first years of rheumatoid arthritis: results from the EURIDISS longitudinal study.

Suurmeijer TP, Waltz M, Moum T, Guillemin F, van Sonderen FL, Briançon S, Sanderman R, van den Heuvel WJ

Arthritis Rheum.. 2001 Apr;45(2):111-21

OMERACT 5 Economics Working Group: summary, recommendations, and research agenda.

Gabriel S, Drummond M, Suarez-Almazor ME, Ruff B, Guillemin F, Bombardier C, Boers M, Maetzel A, Ruof J, Cranney A, Marentette M, Tugwell P

J. Rheumatol.. 2001 Mar;28(3):670-3

[Coordinated organization of symptoms management and support in all the stages of cancer disease: putting in place pluridisciplinary structures of supportive oncological care].

Krakowski I, Chardot C, Bey P, Guillemin F, Philip T

Bull Cancer. 2001 Mar;88(3):321-8

Adverse reactions to cotrimoxazole in HIV-infected patients: predictive factors and subsequent HIV disease progression.

Rabaud C, Charreau I, Izard S, Raffi F, Meiffredy V, Leport C, Guillemin F, Yeni P, Aboulker JP,

Scand. J. Infect. Dis.. 2001 ;33(10):759-64

Prevalence of impairments, disabilities, handicaps and quality of life in the general population: a review of recent literature.

Barbotte E, Guillemin F, Chau N,

Bull. World Health Organ.. 2001 ;79(11):1047-55

A comparison of agreement and sensitivity to change between AIMS2 and a short form of AIMS2 (AIMS2-SF) in more than 1,000 rheumatoid arthritis patients.

Haavardsholm EA, Kvien TK, Uhlig T, Smedstad LM, Guillemin F

J. Rheumatol.. 2000 Dec;27(12):2810-6

Guidelines for the process of cross-cultural adaptation of self-report measures.

Beaton DE, Bombardier C, Guillemin F, Ferraz MB

Spine. 2000 Dec;25(24):3186-91

[Evaluation of professional practices]

Briancon S, Girard F, Empereur F, Guillemin F

Rev Epidemiol Sante Publique. 2000 Dec;48(6):541-50.

Polymorphism of angiotensin converting enzyme, angiotensinogen, and angiotensin II type 1 receptor genes and end-stage renal failure in IgA nephropathy: IGARAS--a study of 274 Men.

Frimat L, Philippe C, Maghakian MN, Jonveaux P, Hurault de Ligny B, Guillemin F, Kessler M

J. Am. Soc. Nephrol.. 2000 Nov;11(11):2062-7

Occupational exposure to blood: search for a relation between personality and behavior.

Rabaud C, Zanea A, Mur JM, Blech MF, Dazy D, May T, Guillemin F

Infect Control Hosp Epidemiol. 2000 Sep;21(9):564-74

[Quality of life assessment one year after total hip or knee arthroplasty].

Mainard D, Guillemin F, Cuny C, Mejat-Adler E, Galois L, Delagoutte J

Rev Chir Orthop Reparatrice Appar Mot. 2000 Sep;86(5):464-73

Functional disability and quality-of-life assessment in clinical practice.

Guillemin F

Rheumatology (Oxford). 2000 Jun;39 Suppl 1:17-23

Self-administered questionnaire compared with interview to assess past-year physical activity.

Vuillemin A, Oppert JM, Guillemin F, Essermeant L, Fontvieille AM, Galan P, Kriska AM, Hercberg S

Med Sci Sports Exerc. 2000 Jun;32(6):1119-24

A computer-assisted assessment of lifetime physical activity: reliability and validity of the QUANTAP software.

Vuillemin A, Guillemin F, Denis G, Huot J, Jeandel C

Rev Epidemiol Sante Publique. 2000 Apr;48(2):157-67

Selection of quality-of-life measures for a prevention trial: a psychometric analysis.

Bouchet C, Guillemin F, Paul-Dauphin A, Briancon S

Control Clin Trials. 2000 Feb;21(1):30-43.

Compliance with drug therapy in rheumatoid arthritis. A longitudinal European study.

Viller F, Guillemin F, Briançon S, Moum T, Suurmeijer T, van den Heuvel W

Joint Bone Spine. 2000 ;67(3):178-82

Impact de la qualit

Desandes E, Conroy T, Briancon S, Guillemin F, Empereur F, Guillemin F, L

Rev Epidemiol Sant

Prevalence of rheumatoid arthritis and spondyloarthropathy in Brittany, France. Société de Rhumatologie de l'Ouest.

Saraux A, Guedes C, Allain J, Devauchelle V, Valls I, Lamour A, Guillemin F, Youinou P, Le Goff P

J. Rheumatol.. 1999 Dec;26(12):2622-7

Bias and precision in visual analogue scales: a randomized controlled trial.

Paul-Dauphin A, Guillemin F, Virion JM, Briançon S

Am. J. Epidemiol.. 1999 Nov;150(10):1117-27

Compliance to drug treatment of patients with rheumatoid arthritis: a 3 year longitudinal study.

Viller F, Guillemin F, Briançon S, Moum T, Suurmeijer T, van den Heuvel W

J. Rheumatol.. 1999 Oct;26(10):2114-22

The value of utility: assumptions underlying preferences and quality adjusted life years.

Guillemin F

J. Rheumatol.. 1999 Sep;26(9):1861-3

Multivariate analysis of predictors of cerebral vasospasm occurrence after aneurysmal subarachnoid hemorrhage.

Charpentier C, Audibert G, Guillemin F, Civit T, Ducrocq X, Bracard S, Hepner H, Picard L, Laxenaire MC

Stroke. 1999 Jul;30(7):1402-8

Quality of life in ankylosing spondylitis: validation of the ankylosing spondylitis Arthritis Impact Measurement Scales 2, a modified Arthritis Impact Measurement Scales Questionnaire.

Guillemin F, Challier B, Urlacher F, Vançon G, Pourel J

Arthritis Care Res. 1999 Jun;12(3):157-62

Quality of life in advanced colorectal cancer.

Conroy T, Guillemin F

J. Clin. Oncol.. 1999 May;17(5):1644

[Quality of life in patients with colorectal cancer].

Conroy T, Rauch P, Guillemin F

Gastroenterol. Clin. Biol.. 1999 Apr;23(4):489-501

[Mammography use among 35-50-year-old women. Descriptive study of a population seeking services at the centers of health tests].

Spyckerelle Y, Kuntz C, Guillemin F, Giordanella JP, Allemand H

J Gynecol Obstet Biol Reprod (Paris). 1998 Dec;27(8):765-71

[Corticosteroid osteoporosis in the adult].

Weryha G, Klein M, Guillemin F, Leclère J

Presse Med. 1998 Oct;27(32):1641-6

[Diagnostic value of ERTL4: a screening test of language disorders in 4-year-old children].

Alla F, Guillemin F, Colombo MC, Roy B, Maeder C

Arch Pediatr. 1998 Oct;5(10):1082-8

Use of spa therapy to improve the quality of life of chronic low back pain patients.

Constant F, Guillemin F, Collin JF, Boulangé M

Med Care. 1998 Sep;36(9):1309-14

Recommendations for the health economics analysis to be performed with a drug to be registered in prevention or treatment of osteoporosis.

Dere W, Avouac B, Boers M, Buxton M, Christiansen C, Dawson A, Gennari C, Guillemin F, Lawaetz H, Lawetz H, Ornskov F, Roumagnac I, Reginster JY

Calcif. Tissue Int.. 1998 Aug;63(2):93-7

Pretransplant hepatitis C virus infection: a predictor of proteinuria after renal transplantation.

Hestin D, Guillemin F, Castin N, Le Faou A, Champigneulles J, Kessler M

Transplantation. 1998 Mar;65(5):741-4

Antibodies against phospholipids and beta 2-glycoprotein I increase the risk of recurrent venous thromboembolism in patients without systemic lupus erythematosus.

Wahl DG, De Maistre E, Guillemin F, Regnault V, Perret-Guillaume C, Lecompte T

QJM. 1998 Feb;91(2):125-30

[A review of evaluation questionnaires for physical activity].

Vuillemin A, Denis G, Guillemin F, Jeandel C

Rev Epidemiol Sante Publique. 1998 Feb;46(1):49-55

Meta-analysis of the risk of venous thrombosis in individuals with antiphospholipid antibodies without underlying autoimmune disease or previous thrombosis.

Wahl DG, Guillemin F, de Maistre E, Perret-Guillaume C, Lecompte T, Thibaut G

Lupus. 1998 ;7(1):15-22

[Measurement of functional inability and quality of life in cardiac failure. Transcultural adaptation and validation of the Goldman, Minnesota and Duke questionnaires].

Briançon S, Alla F, Méjat E, Guillemin F, Villemot JP, Mertes PM, Zannad F

Arch Mal Coeur Vaiss. 1997 Dec;90(12):1577-85

[To evaluate the quality of life of osteoarthritic patient: why and how? (Report of round table)].

Brégeon C, Guillemin F, Marty M

Rev Prat. 1997 Nov;47(17 Suppl):S46-50

Life events and disability in rheumatoid arthritis: a European cohort.

Leymarie F, Jolly D, Sanderman R, Briançon S, Marchand AC, Guillemin F, Eschard JP, Suurmeijer T, Poitrinal P, Blanchard F, van den Heuvel W

Br. J. Rheumatol.. 1997 Oct;36(10):1106-12

Seroreactivity to Borrelia burgdorferi antigens in early rheumatoid arthritis: a case-control study.

Chary-Valckenaere I, Guillemin F, Pourel J, Schiele F, Heller R, Jaulhac B

Br. J. Rheumatol.. 1997 Sep;36(9):945-9

The AIMS2-SF: a short form of the Arthritis Impact Measurement Scales 2. French Quality of Life in Rheumatology Group.

Guillemin F, Coste J, Pouchot J, Ghézail M, Bregeon C, Sany J

Arthritis Rheum.. 1997 Jul;40(7):1267-74

Measurement methods of drug consumption as a secondary judgment criterion for clinical trials in chronic rheumatic diseases.

Constant F, Guillemin F, Herbeth B, Collin JF, Boulangé M

Am. J. Epidemiol.. 1997 May;145(9):826-33

Methodological approaches to shortening composite measurement scales.

Coste J, Guillemin F, Pouchot J, Fermanian J

J Clin Epidemiol. 1997 Mar;50(3):247-52

[Influence of the transfer mode on short-term outcome in neonates with high perinatal risk].

Fresson J, Guillemin F, André M, Abdouch A, Fontaine B, Vert P

Arch Pediatr. 1997 Mar;4(3):219-26

[The DUKE health profile: a generic instrument to measure the quality of life tied to health].

Guillemin F, Paul-Dauphin A, Virion JM, Bouchet C, Briançon S

Sante Publique. 1997 Mar;9(1):35-44

Health-related quality of life in long-term oxygen-treated chronic obstructive pulmonary disease patients.

Hoang Thi TH, Guillemin F, Cornette A, Polu JM, Briançon S

Lung. 1997 ;175(1):63-71

Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus--a meta-analysis.

Wahl DG, Guillemin F, de Maistre E, Perret C, Lecompte T, Thibaut G

Lupus. 1997 ;6(5):467-73

Prognostic factors for quality of life after trochanteric fracture : Inter-regional study S.O.T.EST.

Guillemin F, Cao MM, Delagoutte JP, Mainard D

Eur J Orthop Surg Traumatol. 1996 Sep;6(3):157-164

Correlates of functional disability in early rheumatoid arthritis: a cross-sectional study of 706 patients in four European countries.

Smedstad LM, Moum T, Guillemin F, Kvien TK, Finch MB, Suurmeijer TP, van den Heuvel WJ

Br. J. Rheumatol.. 1996 Aug;35(8):746-51

Validation of the French version of the arthritis impact measurement scales 2 and comparison with the french version of the Nottingham Health Profile. "Quality of Life in Rheumatology" Task Force.

Pouchot J, Guillemin F, Coste J, Brégeon C, Sany J

Rev Rhum Engl Ed. 1996 Jun;63(6):389-404

[Unidimensionality of a functional measure for patient with an injured upper limb].

Luquet C, Chau N, Nadif M, Guillemin F, Gavillot C, Petry D, Moreau T, Bourgkard E, Hecquet B, André JM, Mur JM

Rev Epidemiol Sante Publique. 1996 Jun;44(3):248-61

Nonspecific effects in longitudinal studies: impact on quality of life measures.

Bouchet C, Guillemin F, Briançon S

J Clin Epidemiol. 1996 Jan;49(1):15-20

Validity, reliability, and sensitivity to change of a French version of the arthritis impact measurement scales 2 (AIMS2) in patients with rheumatoid arthritis treated with methotrexate.

Pouchot J, Guillemin F, Coste J, Brégeon C, Sany J

J. Rheumatol.. 1996 Jan;23(1):52-60

[Quality of life after orthopedic surgery of the lower limbs. A new approach].

Guillemin F, Mainard D

Rev Chir Orthop Reparatrice Appar Mot. 1996 ;82(6):549-56

[Validation of the St George's questionnaire for measuring the quality of life in patients with chronic obstructive pulmonary disease].

Bouchet C, Guillemin F, Hoang Thi TH, Cornette A, Briançon S

Rev Mal Respir. 1996 ;13(1):43-6

Segregation analysis and variance components analysis of bone mineral density in healthy families.

Guéguen R, Jouanny P, Guillemin F, Kuntz C, Pourel J, Siest G

J. Bone Miner. Res.. 1995 Dec;10(12):2017-22

The assessment of functional status in rheumatoid arthritis: a cross cultural, longitudinal comparison of the Health Assessment Questionnaire and the Groningen Activity Restriction Scale.

Doeglas D, Krol B, Guillemin F, Suurmeijer T, Sanderman R, Smedstad LM, Briançon S, van den Heuvel W

J. Rheumatol.. 1995 Oct;22(10):1834-43

Development of a criterion for response to therapy at 6 months in multiple myeloma.

Guillemin F, Guerci AP, Feugier P, Péré P, Pourel J, Guerci O

Eur. J. Haematol.. 1995 Aug;55(2):110-6

Effectiveness of spa therapy in chronic low back pain: a randomized clinical trial.

Constant F, Collin JF, Guillemin F, Boulangé M

J. Rheumatol.. 1995 Jul;22(7):1315-20

Antivitamin K prevents heterotopic ossification after hip arthroplasty in diffuse idiopathic skeletal hyperostosis. A retrospective study in 67 patients.

Guillemin F, Mainard D, Rolland H, Delagoutte JP

Acta Orthop Scand. 1995 Apr;66(2):123-6

Cross-cultural adaptation and validation of health status measures.

Guillemin F

Scand. J. Rheumatol.. 1995 ;24(2):61-3

Environmental and genetic factors affecting bone mass. Similarity of bone density among members of healthy families.

Jouanny P, Guillemin F, Kuntz C, Jeandel C, Pourel J

Arthritis Rheum.. 1995 Jan;38(1):61-7

[Comparison of 3 quality of life instruments in the longitudinal study of rheumatoid arthritis].

Bouchet C, Guillemin F, Briançon S

Rev Epidemiol Sante Publique. 1995 ;43(3):250-8

[Evaluation of the quality of life in chronic respiratory diseases].

Guillemin F, Briançon S

Rev Mal Respir. 1995 ;12(6):517-9

[Measurement of quality of life in rheumatic practice].

Pouchot J, Guillemin F, Coste J

Presse Med. 1994 Oct;23(29):1328-30

Gastrointestinal manifestations of systemic sclerosis.

Abu-Shakra M, Guillemin F, Lee P

Semin. Arthritis Rheum.. 1994 Aug;24(1):29-39

The Groningen Activity Restriction Scale for measuring disability: its utility in international comparisons.

Suurmeijer TP, Doeglas DM, Moum T, Briançon S, Krol B, Sanderman R, Guillemin F, Bjelle A, van den Heuvel WJ

Am J Public Health. 1994 Aug;84(8):1270-3

Functional disability in early rheumatoid arthritis: description and risk factors.

Guillemin F, Suurmeijer T, Krol B, Bombardier C, Briançon S, Doeglas D, Sanderman R, van den Heuvel W

J. Rheumatol.. 1994 Jun;21(6):1051-5

Group education interventions for people with low back pain. An overview of the literature.

Cohen JE, Goel V, Frank JW, Bombardier C, Peloso P, Guillemin F

Spine. 1994 Jun;19(11):1214-22

[Usefulness of measurements of health-related quality of life].

Guillemin F

Rev Rhum Ed Fr. 1994 Apr;61(4):239-42

Short and long-term effect of spa therapy in chronic low back pain.

Guillemin F, Constant F, Collin JF, Boulange M

Br. J. Rheumatol.. 1994 Feb;33(2):148-51

Low incidence of rheumatoid arthritis in France.

Guillemin F, Briançon S, Klein JM, Sauleau E, Pourel J

Scand. J. Rheumatol.. 1994 ;23(5):264-8

Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines.

Guillemin F, Bombardier C, Beaton D

J Clin Epidemiol. 1993 Dec;46(12):1417-32

Cancer in systemic sclerosis.

Abu-Shakra M, Guillemin F, Lee P

Arthritis Rheum.. 1993 Apr;36(4):460-4

Functional disability in rheumatoid arthritis: two different models in early and established disease.

Guillemin F, Briançon S, Pourel J

J. Rheumatol.. 1992 Mar;19(3):366-9

Worsening of Felty's syndrome with methotrexate.

Guillemin F, Pourel J

Ann. Rheum. Dis.. 1991 Sep;50(9):658

[Measurement of the functional capacity in rheumatoid polyarthritis: a French adaptation of the Health Assessment Questionnaire (HAQ)].

Guillemin F, Brainçon S, Pourel J

Rev Rhum Mal Osteoartic. 1991 Jun;58(6):459-65

Delayed methotrexate pneumonitis in rheumatoid arthritis.

Pourel J, Guillemin F, Fener P, Webanck L, Bene MC, Delorme N

J. Rheumatol.. 1991 Feb;18(2):303-4

Sciatic nerve compression by hematoma. Case report of a late complication of Harrington's operation.

Guillemin F, Czorny A, Pourel J

Spine. 1991 Feb;16(2):237-9

[Incidence of cancers and socio-professional status: data from the Bas-Rhin tumor Registry from 1975 to 1979].

Guillemin F, Hedelin G, Schaffer P

Bull Cancer. 1991 ;78(2):145-53

[The early diagnosis of cancer of the breast remains insufficient. A study of breast monitoring in women over 50 years of age in Lorraine-Champagne].

Aubry C, Martin E, Fournier B, Guillemin F, Longis MJ, Monneau JP, Deschamps JP

J Gynecol Obstet Biol Reprod (Paris). 1991 ;20(6):775-82

[Young people and cancers. Knowledges, behaviors and attitudes of young people aged from 16 to 25 years with regard to cancers].

Algalarrondo F, Spyckerelle Y, Aubry C, Guillemin F, Deschamps JP

Pediatrie. 1991 ;46(6-7):549-54

Pre-B lymphocytes with intracytoplasmic mu chains in the peripheral blood of rheumatoid arthritis patients.

Guillemin F, Bene MC, Aussedat R, Klein JM, Sahmani K, Gaucher A, Faure GC, Pourel J

Clin. Immunol. Immunopathol.. 1990 Nov;57(2):308-16

Long-term disability and prolonged sick leaves as outcome measurements in ankylosing spondylitis. Possible predictive factors.

Guillemin F, Briançon S, Pourel J, Gaucher A

Arthritis Rheum.. 1990 Jul;33(7):1001-6

Fatal agranulocytosis in sulfasalazine treated rheumatoid arthritis.

Guillemin F, Aussedat R, Guerci A, Lederlin P, Trechot P, Pourel J

J. Rheumatol.. 1989 Aug;16(8):1166-7

Hypogammaglobulinemia associated with gold therapy: evidence for a partial maturation blockade of B cells.

Guillemin F, Bene MC, Aussedat R, Bannwarth B, Pourel J

J. Rheumatol.. 1987 Oct;14(5):1034-5

Evaluation of the quality of life in dementia with a generic quality of life questionnaire: the Duke Health Profile.

Novella J, Ankri J, Morrone I, Guillemin F, Jolly D, Jochum C, Ploton L, Blanchard F

Dement Geriatr Cogn Disord. ;12(2):158-66

Feasibility, acceptability and internal consistency reliability of the nottingham health profile in dementia patients.

Bureau-Chalot F, Novella JL, Jolly D, Ankri J, Guillemin F, Blanchard F

Gerontology. ;48(4):220-5

Influence of muscle strength and body weight and composition on regional bone mineral density in healthy women aged 60 years and over.

Blain H, Vuillemin A, Teissier A, Hanesse B, Guillemin F, Jeandel C

Gerontology. ;47(4):207-12

Is quality of life affected by season and weather conditions in ankylosing spondylitis?

Challier B, Urlacher F, Vançon G, Lemelle I, Pourel J, Guillemin F

Clin. Exp. Rheumatol.. ;19(3):277-81

Longitudinal study of rheumatoid arthritis patients discloses sustained elevated serum levels of soluble CD106 (V-CAM).

Kolopp-Sarda MN, Guillemin F, Chary-Valckenaere I, Béné MC, Pourel J, Faure GC

Clin. Exp. Rheumatol.. ;19(2):165-70

The French version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ).

Pouchot J, Ruperto N, Lemelle I, Sommelet D, Grouteau E, David L, Duquesne A, Job Deslandre C, Kone Paut I, Pillet P, Goumy L, Barbier C, Guyot MH, Mazingue F, Gandon Laloum S, Fischbach M, Quartier P, Guyot C, Jean S, Le Gall E, Plouvier E, Bost M, de Lumley L, LePlège A, Larbre JP, Guillemin F, Coste J, Landgraf JM, Prieur AM,

Clin. Exp. Rheumatol.. ;19(4 Suppl 23):S60-5

Validity and discriminant ability of the HAQ Functional Index in early rheumatoid arthritis.

Guillemin F, Briançon S, Pourel J

Disabil Rehabil. ;14(2):71-7

Which patients with rheumatoid arthritis, spondyloarthritis, or juvenile idiopathic arthritis receive TNF-α antagonists in France? The CORPUS cohort study.

Saraux A, Benichou J, Guillevin L, Idbrik L, Job-Deslandre C, Sibilia J, Soudant M, Wendling D, Guillemin F

Clin. Exp. Rheumatol.. ;33(5):602-10

[Clinical research, evaluation of care and quality assurance].

Girard F, Empereur F, Guillemin F, Briançon S

Therapie. ;53(6):559-63

[Cost of medical imaging practices in acute abdominal syndromes].

Guillemin F, Cao MM, Girard F, Tortuyaux JM, Chone L, Toussaint E, Bressler L, Regent D, Boissel P

Presse Med. ;29(15):829-34

[Peripheral neuropathy and rhizomelic pseudo-polyarthritis: Lyme disease].

Pourel J, Jouanny P, Fener P, Guillemin F

Rev Med Interne. ;12(4):312

[Prognostic factors of pregnancy and delivery complications in Senegalese adolescents and their newborn].

Dia AT, Diallo I, Guillemin F, Deschamps JP

Sante. ;11(4):221-8